Obstructive sleep apnoea and driver performance: prevalence, correlates and implications for driver fatigue by Desai, Anup Vijayendra
Obstructive Sleep Apnoea and Driver Performance: 
Prevalence, Correlates, and Implications for Driver Fatigue 
 
 
Anup Desai M.B., B.S.  FRACP 
 
 
 
A thesis submitted to the  
Faculty of Medicine, University of Sydney, in fulfillment 
of the requirements for the degree of 
Doctor of Philosophy 
 
 
 
Woolcock Institute of Medical Research    University of Sydney  
Royal Prince Alfred Hospital 
 
   
December 2002 
Statement 
 
The work described in this thesis was carried out in the Woolcock Institute of Medical 
Research and Royal Prince Alfred Hospital under the supervision of A/Professors R. 
Grunstein and G. Marks.  Unless otherwise stated, it is the original work of the author 
and has neither been presented nor is it currently being presented for any other degree. 
 
              Anup Desai 
Acknowledgements and Dedication 
 
Acknowledgements 
 
Firstly, I would like to thank Associate Professor Ron Grunstein for his constant 
assistance and support with this huge undertaking. From the early days when we 
struggled with recruitment issues, to the last months of repeated thesis revisions, he has 
always provided good advice, ample help, and an impressive knowledge of the area. In 
addition to being involved in the minutia of every day protocols and activities, he has 
always also held a broader perspective of my work, which has helped to guide this thesis 
to its timely completion.  
 
I would also like to thank Associate Professor Guy Marks, my co-supervisor, who in 
particular provided excellent guidance in statistical analysis and interpretation. Through 
his direction, I feel I have also learnt a lot about scientific writing and methodology. 
 
I would like to thank the late Professor Ann Woolcock, whose input and encouragement 
at the very start of this thesis I now appreciate even more. It was her intervention in 
particular, that helped me understand the importance of undertaking and formalizing 
research of this nature into the body of work that it is now. I have known Ann Woolcock 
since my childhood, and I have always been aware of how important research is to her. I 
am sure she would be very happy and hopefully also very proud to see this thesis in its 
final form. In addition, I am grateful to her for introducing me to the Woolcock Institute 
of Medical Research (formally known as the Institute of Respiratory Medicine), a world 
class research facility that has provided me with a supportive and friendly working 
environment from the start. Particular thanks to Victoria Keena, information manager, 
Anthony Williams, research officer, Courtney Rogers, librarian, and Susan Forrest-
Blythe, research assistant.  
 
There are so many others to thank in a work of this size. I would like to thank Dr. Mark 
Howard, for his assistance with the design and running of the Commercial Drivers Study, 
and Dr. David Joffe, for his assistance with recruitment, access to Royal North Shore 
Hospital, and advice on neurocognitive testing. Dr. David Jankelson and Dr. David 
Barnes also assisted with recruitment of research subjects and I thank them for this. Dr. 
Delwyn Bartlett has helped me throughout this work with advice, knowledge, and 
assistance with testing, and for all this I am very grateful to her. Dr. Michael Barnett 
generously agreed to proof read part of this work, and I thank him for his excellent 
advice.  
 
Gunnar Ungar’s assistance with computer and data management has been invaluable. 
Benjamin Harris and Jonathon Williamson assisted tremendously with testing at Royal 
North Shore Hospital, while Brad Wilsmore, Qiao Yang and James Newcombe all 
assisted with testing at Royal Prince Alfred Hospital. I thank Brad Wilsmore in particular 
for his good cheer when assisting with difficult statistics. I would like to thank my 
scorers, Jane Downey and Adele Bailey for their hard work, my night sleep technician 
Andrew Dong for his constant work and dependability, the staff at Royal Prince Alfred 
Hospital and Royal North Shore Hospital for their assistance with the research protocols, 
all my research subjects for their time and patience, and finally, the NSW Transport 
Workers Union, for their help with the Commercial Drivers Study. 
 
On a more personal note, I would like to thank my parents, for their encouragement and 
confidence in my abilities, which has helped to empower me with the commitment to 
finish such a substantive body of work, but most of all, I would like to thank my wife, 
Ankita, who has supported me unconditionally throughout the long process of this thesis. 
In particular, she has had to share the first year of our marriage with the rigorous 
demands of this thesis. This thesis is as much hers, as it is mine.   
 
Dedication 
 
I would like to dedicate this thesis to my beautiful wife, Ankita 
 
 
 
 
 
 
 
 
 
Table of Contents 
STATEMENT ................................................................................................................... 2 
ACKNOWLEDGEMENTS AND DEDICATION......................................................... 3 
TABLE OF CONTENTS ................................................................................................. 6 
INDEX OF TABLES AND FIGURES.......................................................................... 11 
ABBREVIATIONS AND DEFINITIONS.................................................................... 15 
SUMMARY ..................................................................................................................... 19 
AIMS ................................................................................................................................ 22 
CHAPTER 1: BACKGROUND .................................................................................... 24 
1.1 DRIVER FATIGUE ...................................................................................................... 24 
1.1.1 Importance of Driver Fatigue ........................................................................... 24 
1.1.2 Economic Costs of Fatigue Related Accidents.................................................. 26 
1.2 FACTORS INFLUENCING DRIVER FATIGUE ................................................................ 31 
1.2.1 Sleep Loss or Sleep Deprivation ....................................................................... 32 
1.2.2 Circadian Timing of Drive ................................................................................ 41 
1.2.3 Sleep Disorders: Obstructive Sleep Apnoea ..................................................... 47 
1.2.4 Length of Driving without Rest ......................................................................... 76 
1.2.5 Alcohol Consumption ........................................................................................ 77 
1.3 ADDITIVE FATIGUE EFFECTS .................................................................................... 79 
1.3.1 Additive Effects of Mild OSA and Other Fatigue Promoting Factors .............. 80 
1.3.2 The Effect of Sleep Deprivation on Obstructive Sleep Apnoea......................... 81 
CHAPTER 2: METHODS ............................................................................................. 84 
2.1 COMMERCIAL DRIVERS STUDY ................................................................................ 84 
2.1.1 Project Design................................................................................................... 84 
2.1.2 Subjects.............................................................................................................. 85 
2.1.3 Protocol............................................................................................................. 88 
2.1.4 Data Collection Instruments ............................................................................. 90 
2.1.5 Statistical Analysis .......................................................................................... 108 
2.2 MILD OBSTRUCTIVE SLEEP APNOEA STUDY .......................................................... 111 
2.2.1 Project Design................................................................................................. 111 
2.2.2 Subjects............................................................................................................ 112 
2.2.3 Protocol........................................................................................................... 113 
2.2.4 Data Collection Instruments ........................................................................... 117 
2.2.5 Statistical Analysis .......................................................................................... 128 
2.3 MEDICO-LEGAL CASE SERIES ................................................................................ 130 
2.3.1 Polysomnography............................................................................................ 130 
2.3.2 Objective Tests of Daytime Sleepiness ............................................................ 130 
CHAPTER 3: RESULTS: PREVALENCE OF OSA................................................ 132 
3.1 RESPONSE RATES .................................................................................................... 132 
3.1.1 Drivers surveyed in the field ........................................................................... 132 
3.1.2 Drivers undergoing sleep studies.................................................................... 134 
3.2 DEMOGRAPHIC AND PHYSICAL CHARACTERISTICS................................................. 135 
3.2.1 Physical Characteristics ................................................................................. 135 
3.2.2 Driving Characteristics 1................................................................................ 136 
3.2.3 Driving Characteristics 2................................................................................ 137 
3.2.4 Medical Health................................................................................................ 138 
3.2.5 Accident rates.................................................................................................. 139 
3.3 PREVALENCE OF DAYTIME SLEEPINESS.................................................................. 140 
3.4 PREVALENCE OF OBSTRUCTIVE SLEEP APNOEA ..................................................... 142 
3.4.1 Prevalence of OSA and Sleep Apnoea Syndrome............................................ 142 
3.4.2 Analysis of Accuracy of Maislin Prediction of OSA ....................................... 144 
CHAPTER 4: RESULTS: CORRELATES OF OSA................................................ 147 
4.1 RELATIONSHIP OF OBSTRUCTIVE SLEEP APNOEA TO DRIVER SLEEPINESS ............. 147 
4.2 RELATIONSHIP OF OSA TO SELF-REPORTED ACCIDENT RATES ............................. 148 
4.2.1 Drivers Surveyed in the Field.......................................................................... 148 
4.2.2 Drivers Studied in the Sleep Laboratory......................................................... 150 
4.3 RELATIONSHIP OF OSA TO DRIVING IMPAIRMENT (DRIVING SIMULATOR) ............ 151 
4.3.1 Obstructive Sleep Apnoea ............................................................................... 152 
4.3.2 Sleep Apnoea Syndrome .................................................................................. 154 
4.4 REGRESSION MODELS............................................................................................. 159 
4.4.1 Factors Predicting Driver Sleepiness ............................................................. 159 
4.4.2 Factors Predicting Reported Accidents .......................................................... 161 
4.4.3 Factors Predicting Driving Impairment (Driving Simulator)......................... 162 
4.4.4 Factors Predicting Obstructive Sleep Apnoea ................................................ 163 
4.5 EFFECT OF OSA/SLEEPINESS ON VIGILANCE (PSYCHOMOTOR VIGILANCE TASK).. 164 
4.6 EFFECT OF OSA/SLEEPINESS ON NEUROPSYCHOLOGICAL MEASURES..................... 166 
4.7 SUMMARY OF RESULTS FOR CHAPTERS 3 AND 4..................................................... 167 
CHAPTER 5: RESULTS: INTERACTIVE EFFECTS OF MILD OSA ................ 172 
5.1 DEMOGRAPHIC AND PHYSICAL MEASURES............................................................. 172 
5.2 LIFESTYLE DETAILS................................................................................................ 172 
5.3 DRIVER DETAILS .................................................................................................... 174 
5.4 BASELINE POLYSOMNOGRAPHY ............................................................................. 174 
5.5 DAYTIME DRIVING PERFORMANCE AND COGNITIVE FUNCTION OUTCOMES .......... 175 
5.5.1 Effect of Time of Day and Sleep Deprivation.................................................. 175 
5.5.2 Effect of Obstructive Sleep Apnoea Status ...................................................... 181 
5.5.3 Impact of Sleep Deprivation on Diurnal Variation Differed with OSA Status 181 
5.6 NIGHT TIME DRIVING PERFORMANCE AND COGNITIVE FUNCTION OUTCOMES ...... 183 
5.6.1 Effect of Time of Day....................................................................................... 183 
5.6.2 Effect of OSA Status ........................................................................................ 186 
5.7 EFFECT OF SLEEP DEPRIVATION ON POLYSOMNOGRAPHIC MEASURES ON OSA .... 186 
CHAPTER 6: RESULTS: CASE SERIES ................................................................. 188 
6.1 CASES..................................................................................................................... 188 
Case A: under-treated OSA and undiagnosed Periodic Limb Movement Disorder 188 
Case B: undiagnosed mild OSA and upper airway resistance syndrome ................ 189 
Case C: “sleep attack” in a private driver .............................................................. 189 
Case D: undiagnosed OSA in a truck driver............................................................ 190 
Case E: undiagnosed idiopathic hypersomnolence in a truck driver ...................... 190 
Case F: undiagnosed OSA in a truck driver ............................................................ 191 
Case G: untreated OSA in a truck driver................................................................. 192 
CHAPTER 7: DISCUSSION ....................................................................................... 194 
7.1 COMMERCIAL DRIVERS STUDY .............................................................................. 194 
7.2 MILD OBSTRUCTIVE SLEEP APNOEA STUDY .......................................................... 203 
7.3 MEDICO-LEGAL CASE SERIES ................................................................................ 210 
7.4 FINAL SUMMARY AND IMPLICATIONS..................................................................... 215 
CHAPTER 8: PUBLICATIONS ................................................................................. 217 
8.1 PAPERS ................................................................................................................... 217 
8.2 ABSTRACTS ............................................................................................................ 217 
REFERENCES.............................................................................................................. 219 
ATTACHMENTS ......................................................................................................... 244 
Index of Tables and Figures 
 
Table 1 Site visits for drivers surveyed in the field ........................................................ 133 
Table 2 Age and obesity: comparison between subjects in the field study and laboratory 
study........................................................................................................................ 135 
Table 3 Age & obesity in laboratory study: comparison of participants and non-
participants.............................................................................................................. 136 
Table 4 Driving characteristics of participants in the field study and the laboratory study
................................................................................................................................. 137 
Table 5 Sleep and other habits of drivers in the field study and laboratory study.......... 138 
Table 6 Medical health of drivers in the field study and laboratory study ..................... 139 
Table 7 Self-reported accidents for field and laboratory drivers .................................... 140 
Table 8 Relation between OSA and pathological sleepiness in drivers in the field study
................................................................................................................................. 142 
Table 9 Prevalence of OSA for drivers studied in laboratory......................................... 143 
Table 10 Prevalence of sleep apnoea syndrome for drivers studied in laboratory ......... 144 
Table 11 Likelihood ratios for predicting OSA for Maislin score quartiles ................... 146 
Table 12 Prevalence of sleep apnoea syndrome for drivers in the field and laboratory. 147 
Table 13 Comparison of accident rates between drivers with and without sleep apnoea 
syndrome................................................................................................................. 149 
Table 14 OSA (RDI) in drivers with and without a history of accidents ....................... 150 
Table 15 AusEd mean reaction time by OSA status....................................................... 153 
Table 16 Effect of sleep apnoea syndrome on driving simulator performance .............. 155 
 11
Table 17 Predictor variables for driver sleepiness.......................................................... 159 
Table 18 Predictors of excessive driver sleepiness......................................................... 160 
Table 19 Driving simulator variables partially explained by RDI.................................. 162 
Table 20 Driving simulator variables explained by sleep apnoea syndrome.................. 163 
Table 21 Predictor variables of OSA.............................................................................. 164 
Table 22 Effect of sleep apnoea syndrome on PVT performance, adjusted for diurnal 
variation .................................................................................................................. 166 
Table 23 Demographic & physical measures: comparison between OSA & control groups
................................................................................................................................. 172 
Table 24 Lifestyle details: comparison between OSA and control groups..................... 173 
Table 25 Caffeine intake and sleep hours immediately prior to testing weekends......... 173 
Table 26: Driver details: comparison between OSA and control groups ....................... 174 
Table 27 Baseline polysomnography: comparison between controls and OSA subjects175 
Table 28 Effect of sleep deprivation on outcomes (adjusted for diurnal variation) ....... 176 
Table 29 Effect of time of day on outcomes (adjusted for intervention)........................ 179 
Table 30 Impact of sleep deprivation on diurnal variation differed with OSA status .... 182 
Table 31 Effect of time of day on outcomes in the sleep deprived state (adjusted for OSA 
status) ...................................................................................................................... 185 
Table 32 Effect of sleep deprivation on PSG measures (adjusted for group)................. 187 
Table 33 Case details of fall asleep road fatalities.......................................................... 192 
 12
   
Figure 1 Temporal profile of mean (standard error of mean) PVT lapses after baseline 
nights (B1, B2), after each of seven consecutive sleep restriction nights (P1-P7), and 
after a recovery night of sleep (R1) (Dinges et al. 1997) ......................................... 36 
Figure 2 Performance in the sustained wakefulness condition expressed as mean relative 
performance and the percentage blood alcohol concentration equivalent (Dawson 
and Reid 1997).......................................................................................................... 38 
Figure 3 Standard deviation of speed across the day during control and sleep deprivation 
conditions (+/- SE) (Lenne et al. 1998) .................................................................... 39 
Figure 4 Driving simulator reaction time (RT) across time of day (Lenne et al. 1997)... 43 
Figure 5 The risk of heavy lorry accidents in Sweden (Kecklund and Akerstedt 1994) .. 47 
Figure 6 Prevalence of OSA and sleep apnoea syndrome in middle-aged men (Bearpark 
et al. 1995;Young et al. 1993) .................................................................................. 50 
Figure 7 Effect of CPAP treatment on accidents (George 2001)...................................... 66 
Figure 8 Distribution of accidents in patients with OSA (George 2001) ......................... 66 
Figure 9 AusEdTM driving simulator view........................................................................ 95 
Figure 10 The road layout of AusEdTM............................................................................. 98 
Figure 11: Flow chart of study protocol ......................................................................... 115 
Figure 12 Accident rate of drivers in the 2 study groups................................................ 140 
Figure 13 Driver sleepiness: drivers surveyed in the field ............................................. 141 
Figure 14 Driver sleepiness: drivers studied in the laboratory ....................................... 141 
Figure 15 ROC curve: Maislin prediction of OSA ......................................................... 146 
Figure 16 Correlation between driver sleepiness and OSA............................................ 148 
 13
Figure 17 Accidents compared to RDI for drivers studied in the  laboratory................. 151 
Figure 18 AusEd mean reaction time by OSA status ..................................................... 153 
Figure 19 AusEd mean reaction times for drivers with and without sleep apnoea 
syndrome................................................................................................................. 157 
Figure 20 Tracking ability in drivers with and without sleep apnoea syndrome............ 158 
Figure 21 Impact of sleep deprivation on diurnal variation differed with OSA status... 183 
 
 14
Abbreviations and Definitions 
 
General 
AI:  arousal index (see section 2.1.4.5.2) 
AHI:  apnoea hypopnoea index (see section 1.2.3.1) 
CI:  confidence interval 
CPAP: continuous positive airway pressure (see section 1.2.3.7) 
EDS:  excessive daytime sleepiness 
ESS:  Epworth sleepiness scale (see section 2.1.4.1.2) 
Effect Size:    describes how many standard deviation units the experimental group was 
different from the control group; for reference, an effect size of 0.20 is 
considered small, 0.50 is considered medium, and 0.80 or greater is 
considered to be large (Hedges and Olkin 1985). 
MSLT:           multiple sleep latency test, a polysomnographic test of sleep tendency, that  
requires subjects to try to fall asleep during four or five daytime nap 
opportunities (see section 2.3.2). (Association of Sleep Disorders Centers 
Task Force on Daytime Sleepiness 1986) 
MVA:  motor vehicle accident 
MWT: maintenance of wakefulness test, a polysomnographic test of sleep  
tendency, where subjects are asked to stay awake under soporific 
conditions several times during the day for 20 or 40 minutes at a time (see 
section 2.3.2) (Mitler et al. 1982) 
NAB:  neurobehavioural assessment battery (see section 2.2.4.4) 
 15
OSA:  obstructive sleep apnoea (see section 1.2.3.1) 
OSLER: Oxford sleep resistance test (see section 2.2.4.6) 
PLMs: periodic limb movements, where subjects show repeated stereotyped 
movements, usually of the lower limbs, in certain stages of their sleep 
(O'Keeffe 1996). 
PSG:  polysomnography (see section 2.1.4.5) 
PVT:  psychomotor vigilance task (see section 2.1.4.3) 
RDI:  respiratory disturbance index (see section 1.2.3.1) 
REM:  rapid eye movement sleep 
SAS: sleep apnoea syndrome, clinical definition requiring the presence of both 
OSA on polysomnography, together with excessive daytime sleepiness 
(see section 1.2.3.1) 
SDB:  sleep disordered breathing 
SD:  sleep deprivation 
 
AusEdTM - Australia Edinburgh Driving Simulator 
Steering Variables: 
Median lane position (cm):    median lane position adopted on the road for the 
duration of the simulator drive 
Sd lane position median (cm):  standard deviation (sd) of lane position from the 
median lane position  
Area steer dev median (cm ms):  area of steering deviation (steer dev) from the 
median lane position 
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Av steer dev median (cm):  average (av) steering deviation (steer dev) from the 
median lane position  
Area dev steering centre (cm ms):  area of steering deviation (dev) from the centre of 
the left hand lane  
Av dev steering centre (cm):  average (av) steering deviation (dev) from the 
centre of the left hand lane  
Sd of lane position (cm):   standard deviation (sd) of mean lane position 
Reaction Time Variables: 
RT mean (ms):  mean reaction time (RT) for braking after the 
sudden appearance of  trucks 
RT sd mean (ms):  standard deviation (sd) from the mean reaction time 
(RT) for braking 
RT median (ms):    median reaction time (RT) for braking  
RT sd median (ms):  standard deviation (sd) from the median reaction 
time (RT) for braking 
RT 95% percentile (ms):  ninety fifth percentile of reaction times (RT) for 
braking 
Speed Variables: 
Area speed dev zone (km/h ms):  area of speed deviation (dev) outside the 60-80 
km/hr zone 
Av speed dev zone (km/h):  average (av) speed deviation (dev) outside the 60-
80 km/hr zone 
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Crash Variable: 
Crashes:  number of crashes of all types during the duration 
of the simulator drive 
 
Psychomotor Vigilance Task (PVT) 
PVT median (ms):    median reaction time for the trial 
Lapses:  number of reaction times at least 500ms in duration. 
The lapse count can be transformed (square root 
(x) + square root (x+1)) for analysis to remove zero 
scores and normalise the distribution 
Fast 10% (ms):  mean optimum response domain for the trial (mean 
of fastest 10% of responses) 
1/RT slow 10% (1/ms):  this represents the worst (slowest) response domain 
for the trial (reciprocal of mean of slowest 10% of 
responses) 
Errors:  number of false-starts on depressing the button, the 
use of the 'wrong' button, or holding the button 
down for more than three seconds 
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Summary 
 
Obstructive sleep apnoea (OSA) is characterised by repetitive reductions or pauses in 
breathing during sleep due to upper airway narrowing or closure. Due to disruption to 
normal sleep patterns, many patients with OSA suffer from increased daytime sleepiness. 
Epidemiological studies have established a link between OSA and driver fatigue and 
accidents, generally showing a two to seven times increased risk of road traffic accidents 
in non-commercial drivers with OSA. There is emerging evidence that commercial 
drivers have a higher prevalence of OSA than the general population, being 
predominately male, middle-aged and overweight, three important risk factors for OSA. 
However, little is known about the relationship between OSA and driver sleepiness in 
commercial drivers, whether road accidents are increased in commercial drivers with 
OSA, and whether OSA interacts with other fatigue promoting factors, such as sleep 
deprivation, to further escalate road accident risk. 
 
One thousand randomly selected commercial drivers were surveyed in the field. In 
addition, 61 randomly selected NSW commercial drivers had in hospital sleep studies and 
daytime performance testing, including a PC based driving simulator task. The 
prevalence of OSA, defined as Respiratory Disturbance Index (RDI) > 10, was 
approximately 50% in NSW commercial drivers. Approximately one quarter of the 
drivers reported pathological daytime sleepiness, and 12-14% had both OSA and 
pathological daytime sleepiness. A diagnosis of OSA was the most important factor 
predicting excessive daytime sleepiness in these drivers: OSA was more important than 
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15 other work-related, lifestyle and medical factors that could be expected to promote, or 
be associated with, daytime sleepiness. Drivers with sleep apnoea syndrome (both OSA 
and pathological daytime sleepiness) had an increased driving accident risk, using driving 
simulator and daytime performance testing as proxy measures for accident risk. These 
results demonstrate the importance of OSA as a cause of driver fatigue in commercial 
drivers and suggest that all commercial drivers should be screened for the presence of 
sleep apnoea syndrome in order to potentially reduce road accident risk through 
treatment. 
 
A separate, but related body of work examined the combined effects of mild OSA and 
other fatigue promoting factors (sleep deprivation and circadian influences) on driving 
performance. Twenty nine subjects, consisting of a group with mild OSA and a group of 
non-OSA controls, were tested on several occasions throughout the night and day using 
an intensive performance battery, under both baseline conditions and after a period of 36 
hours of total sleep deprivation. The results suggest that drivers with mild OSA are not 
different to the control group in their response to sleep deprivation or time of day 
influences. However, the subjects with mild OSA were less aware of their impairment 
due to sleep deprivation, which is of concern if drivers with OSA are relying on their 
subjective awareness of fatigue to make decisions about when to stop driving.  
 
A final perspective on OSA and driver fatigue is provided through a clinical case series 
of seven fall-asleep fatality associated MVA’s associated with unrecognised or under-
treated sleep disorders. As well as demonstrating the day to day potential for devastating 
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road accidents due, at least in part, to un-recognised or untreated sleep disorders, these 
cases also serve to highlight some of the current medico-legal controversies and 
difficulties in this area of driver fatigue.   
 
In conclusion, this body of work has provided novel information about the epidemiology 
and implications of OSA in commercial drivers, and about how OSA interacts with other 
fatigue promoting factors. Finally, it has explored some of the medico-legal issues that 
relate to sleep disorders and driver fatigue. As well as providing much needed 
information in the area of driver fatigue, at the same time this work raises many more 
questions and suggests areas of future research. For instance, such research should 
examine the relationship between objective accident rates and OSA/sleep apnoea 
syndrome in commercial drivers, the interaction between mild sleep apnoea syndrome 
and other fatigue risk factors, and driver perception of sleepiness prior to sleep onset in 
drivers with sleep disorders. 
 
 21
Aims 
 
Aims: Commercial Drivers Study 
 
 To determine the prevalence of obstructive sleep apnoea and excessive daytime 
sleepiness in commercial drivers in NSW 
 
 To examine the relationship between obstructive sleep apnoea and excessive 
daytime sleepiness in commercial drivers in NSW 
 
 To examine the effect of obstructive sleep apnoea on driving and other 
neurobehavioural outcomes in commercial drivers in NSW   
 
 To determine factors which predict obstructive sleep apnoea, excessive daytime 
sleepiness and driving impairment in commercial drivers in NSW 
 
Aims: Mild Obstructive Sleep Apnoea Study 
 
 To assess daytime driving performance and cognitive function in subjects with 
mild OSA, compared with subjects without OSA. 
 
 To assess daytime diurnal variation in driving performance and cognitive function 
in subjects with mild OSA and subjects without OSA, and to compare the diurnal 
variation between these two groups. 
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 To assess the effect of sleep deprivation on daytime driving performance and 
cognitive function in subjects with mild OSA and subjects without OSA and to 
compare the effect of sleep deprivation between these two groups. 
 
 To assess the effect of sleep deprivation on daytime diurnal variation in driving 
performance and cognitive function in subjects with mild OSA and subjects 
without OSA and to compare the effect of sleep deprivation on the diurnal 
variation between these two groups. 
 
 To compare night time driving performance and cognitive function in subjects 
with mild OSA and subjects without OSA. 
 
 To determine polysomnographic changes in subjects with mild OSA and subjects 
without OSA after one night’s sleep deprivation. 
 
Aims: Medico-Legal Case Series 
 
 To identify a cohort of fatigue-related road fatalities on NSW roads, where the 
driver who caused the accident suffered from a sleep disorder 
 
 To describe the medical, licensing and legal outcomes of these cases 
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Chapter 1: Background  
 
1.1 Driver Fatigue 
 
1.1.1 Importance of Driver Fatigue 
Driver fatigue is an operational term, which includes within its meaning concepts such as 
drowsiness, sleepiness, impaired vigilance and inattention as well as falling asleep. 
Fatigue is a well recognised and common cause of motor vehicle accidents. Some of the 
evidence linking driver fatigue and motor vehicle accidents will be discussed later in this 
chapter.  
 
Published statistics on driver fatigue include: 
 In the four year period of 1996-2000, NSW Roads and Traffic Authority (RTA) 
statistics describe fatigue as a causal factor in 18% of all fatal crashes on NSW 
roads. Of all fatigue-related fatal crashes in NSW, 25% occurred on metropolitan 
roads in Sydney, Newcastle or Woollongong, 12% occurred on country urban 
roads, and 63% occurred on country non-urban roads (Roads and Traffic 
Authority of New South Wales 2001). 
 Twenty five percent of all crashes in Victoria have been attributed to driver 
fatigue (Naughton M and Pierce R 1991). 
 Fifteen to twenty five percent of all road accidents in England are believed to be 
sleep related (Horne and Reyner 1995).  
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Truck driver fatigue in particular is very important, as will be discussed later: 
 Twenty to sixty percent of truck accidents in Australia are believed to be sleep 
related (Traffic Accident Commission 1994). In one Australian study, 28% of 
truck drivers reported feeling fatigued on most or every trip they made. Only 15% 
said it was a rare event. Further, 35% considered fatigue to be a major or 
substantial problem for themselves (Williamson et al. 1992). 
 In 1999, NSW RTA figures indicated that of 1595 persons killed or injured on 
NSW roads in heavy truck crashes, truck driver speeding was seen to contribute to 
170 casualties, truck driver fatigue to 98 casualties and insecure loads to 25 
casualties (Quinlan 2001).  
 Of 830 persons killed or injured in crashes involving articulated trucks, truck 
driver speeding contributed to 130 casualties, driver fatigue to 70 and insecure 
loads to 15 deaths or injuries (Quinlan 2001). 
 In the USA, driver fatigue was recently judged to be the number one problem in 
commercial transportation (Department of Transportation 1995). 
 
Driver fatigue is one of the three commonest causes of motor vehicle accidents and the 
effect of driver fatigue has been underestimated in the past due to difficulties in 
identifying fatigue as the cause of a crash. The problem of driver fatigue of course moves 
far beyond just road vehicles to all modes of transportation, being an important factor in 
rail, sea and air accidents as well. The Exxon Valdez oil spill and the destruction of the 
Space Shuttle Challenger are both examples of fatigue related disasters that have had 
devastating consequences (Coren 1996a;Mitler et al. 1988). 
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Driver fatigue commonly causes “fall asleep” motor vehicle accidents. These tend to be 
more severe or fatal compared with other road accidents. This is because they often 
involve a single vehicle running off the road at high speed, they tend to occur on higher 
speed roadways, and braking or other preventative measures may be absent (Horne and 
Reyner 1995). If truck drivers are involved, the potential to cause death or serious injury 
to other road users is greatly increased. 
 
1.1.2 Economic Costs of Fatigue Related Accidents 
 
1.1.2.1 All accidents 
Recently the US National Highway Traffic Safety Administration published a technical 
report examining the economic impact of motor vehicle accidents (MVAs) in the USA in 
1994 (NCDR/NHTSA Expert Panel on Driver Fatigue and Sleepiness 1998). The key 
findings are summarised below (all data in $US): 
 The cost of motor vehicle crashes that occurred in 1994 was $150.5 billion. This 
total represented the present value of lifetime economic costs for 40,676 fatalities, 
5.2 million non-fatal injuries, 3.7 million uninjured occupants and 27 million 
damaged vehicles. These incidents included both police-reported and unreported 
crashes. Property damage costs of $52.1 billion accounted for the most significant 
portion of the total cost, followed by lifetime losses in marketplace production of 
$42.4 billion. 
 Economic cost components included productivity losses, property damage, 
medical costs, rehabilitation costs, travel delay, legal and court costs, emergency 
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service costs, insurance administration costs, premature funeral costs and costs to 
employers.  
 
Significant findings on cost included: 
 The cost of motor vehicle crashes that occurred in 1994 was $150.5 billion, the 
equivalent of $580 for every person living in the United States, or 2.2 percent of 
the US Gross Domestic Product. 
   Each fatality resulted in lifetime economic costs to society of over $830,000. Over 
85% of this cost is due to lost workplace and household productivity. 
  The average cost for each critically injured survivor was $706,000 - nearly as high 
as for a fatality. Medical costs and lost productivity accounted for 84% of the cost 
for these Maximum Abbreviated Injury Scale (MAIS) level five injuries. 
   Present and future medical costs due to injuries occurring in 1994 were $17 
billion, representing 11% of total costs. However, medical costs accounted for 
22% of non-fatal injury crash costs. 
   Lost market productivity totaled $42.4 billion, accounting for 28% of total costs, 
and lost household productivity totaled $12.3 billion, representing 8% of total 
costs. 
   Because of their high incidence, crashes of vehicles that sustained only property 
damage were the most costly type of occurrence, totaling $38.9 billion and 
accounting for 26% of total motor vehicle crash costs. 
   Property damage in all crashes (fatal and injury) as well as property-damage-only 
crashes totaled $52.1 billion and accounted for 35% of all costs, more than any 
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other cost category. 
   About 24% of medical care costs resulting from motor vehicle crashes are paid 
from public revenues, with Federal revenues accounting for 14% and states and 
localities 10%. 
   Roughly nine percent of all motor vehicle crash costs are paid from public 
revenues. Federal revenues account for six percent and states and localities paid 
for about three percent. Private insurers pick-up 55% while individual crash 
victims absorb about 29%. Overall, sources other than the individual crash 
victims pay about 70% of all motor vehicle crash costs, primarily through 
insurance premiums and taxes. Motor vehicle crash costs funded through public 
revenues cost taxpayers $13.8 billion in 1994, the equivalent of $144 in added 
taxes for each household in the United States. 
 
Significant findings on incidence include: 
   5.2 million persons were injured in motor vehicle crashes in 1994; 1.1 million of 
these, or roughly 22%, were injured in crashes that were not reported to police. 
   27 million vehicles were damaged in motor vehicle crashes in 1994; 86% of these 
were damaged in property-damage-only impacts, with injuries occurring in, or 
pedestrian injuries caused by, the remaining 14%. 
   Roughly half of all property-damage-only crashes and over a fifth of all non-fatal 
injuries are not reported to police. 
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An analysis was conducted of trends in motor vehicle crash costs since 1990: 
 Inflation increased the cost of motor vehicle crashes by over 16% since 1990. 
 A variety of factors including increased safety belt use, decreased driving under 
the influence of alcohol, safer vehicles, and improved roadways reduced the 
incidence of crashes, death and injury. This offset about half of the potential cost 
increases due to inflation, leaving costs 8.1% higher than in 1990. 
 If fatality and injury rates had remained at 1990 levels, 1994 crash costs would 
have been $29.7 billion (or 20%) higher than the $150.5 billion measured in this 
study. 
 
1.1.2.2 Fatigue Related MVA Costs 
To derive the economic costs of fatigue related MVAs, one could multiply the total 
economic cost of MVAs by the proportion of MVAs believed to be due to sleepiness. If 
one used estimates of either 15 or 30% of accidents being fatigue related, then in the 
USA in 1994 the cost of fatigue related accidents ranged from $US 22.6-45.2 billion 
(0.33-0.66 % of US GDP). 
 
However, when performing an economic analysis for fatigue related motor vehicle 
accidents, it is important to consider several points generally established regarding 
fatigue related accidents. Fatigue related MVAs are more likely to be fatal, more likely to 
involve young drivers and more likely to involve heavy vehicles. This would suggest that 
the true economic cost of fatigue related MVAs in the USA is in fact greater than the 
$US 22.6-45.2 billion estimate. 
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There is no recent analysis of MVA economic cost in Australia equivalent to the NHTSA 
report. If one simply assumes that economic cost is proportional to population, then the 
cost of fatigue related accidents in Australia would be in the range of  $A 2-4 billion.  
 
1.1.2.3 Sleep Apnoea-MVA’s Related Costs 
It is possible to estimate the economic cost of sleep apnoea attributable MVAs. 
Approximately 28% of drivers are men aged 30-60, and in this age group the attributable 
risk expressed as a percentage varies from 12% to 46% (see section 1.2.3.6). This would 
suggest that sleep apnoea attributable MVAs would have an economic cost of  $70-600 
million in Australia, depending on prevalence rates and relative risk values used in 
calculations. 
 
There have also been other more recent economic analyses of OSA-related MVAs 
(Douglas N and George CF 2002;Findley and Suratt PM 2001). These have been centred 
around the cost-effectiveness of treating OSA patients with CPAP. Based on studies 
showing a reduction in accident rates with CPAP (Findley et al. 2000b;George 2001) (see 
section 1.2.3.7), Findley and Suratt estimated the economic savings from the reduction in 
serious motor vehicle crashes and personal injuries of treating 500 OSA patients for three 
years would exceed US$1,000,000 (Findley and Suratt PM 2001). Similarly, Douglas and 
George have calculated the cost savings for the UK economy (Douglas N and George CF 
2002). They estimate, that by treating 500 patients with CPAP for five years in the UK, 
the total accident related cost saving would be 5.335 million pounds compared with a 
treatment cost of 0.4 million pounds (500 CPAP units at 300 pounds and 100 pounds per 
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annum for consumables and follow up costs), giving a saving of 4.935 million pounds at 
a 12.3 fold return on pounds spent. Of course, these savings do not even take into account 
those from the marked improvements in work performance, quality of life, and blood 
pressure; and the decrease in hospitalisation costs resulting from CPAP treatment 
(Douglas N and George CF 2002). 
 
1.2 Factors Influencing Driver Fatigue 
Although driver fatigue can occur in any driver, research has shown that there are a 
number of clear risk factors that increase the propensity for driver fatigue. Often it is 
difficult to separate out the effects of fatigue and other potential causes. For example, 
inattention and sleepiness associated with fatigue may be additive to the accident risk 
associated with speeding. There may also be other indirect effects of these factors 
contributing to sleep related accidents. For example, both sleep deprivation and alcohol 
have been shown to increase risk-taking behaviour (Harrison and Horne 1998;Soderstrom 
et al. 2001). 
 
Any one driver may be vulnerable to multiple fatigue promoting factors. These factors 
may be additive or perhaps even multiplicative to create a very dangerous sleep 
propensity. Many truck drivers, for example, are required to drive continuously for many 
hours at night, oftentimes with prior sleep deprivation, and are possibly further impaired 
by sleep disorders such as obstructive sleep apnoea. 
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Important risk factors for driver fatigue include – 
 
1.2.1 Sleep Loss or Sleep Deprivation 
Sleep deprivation is an important cause of driver fatigue that is perhaps underestimated in 
fatigue research compared with other causes, such as driving hours. 
 
1.2.1.1 Sleep is as Essential as Eating and Drinking 
Sleep is a basic homeostatic process, i.e. it is essential for normal organ function and life. 
As an individual deprives himself of sleep, there is an increase in the drive or “pressure” 
for sleep. Sleep drive is similar to other homeostatic processes, such as hunger or thirst 
e.g. if a person does not eat they become progressively more hungry and a similar pattern 
of function relates to sleep. In animal experiments, where rats have been totally and 
continuously deprived of sleep, the early response to sleep deprivation is debilitation and 
weight loss, but ultimately the animal dies in an average of 16 days (Horne 1985).  
 
1.2.1.2 Types of Sleep Loss/Deprivation 
Sleep loss can occur acutely if sleep is curtailed to commence an early drive. A common 
example would be waking early and starting a long drive in association with a family 
vacation or for work purposes (Kecklund et al. 1994). However, more commonly, sleep 
loss occurs on a chronic partial basis in many people who shorten their sleep hours to less 
than eight hours per day due to lifestyle, work or family commitments. Increasing 24 
hour operation of industry and services, work hour deregulation and globalisation will 
also increasingly compromise sleep time for many individuals in the future. 
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Although there is a (probably genetic) inter-subject variability in the effects of sleep 
deprivation on performance, a progressive decrement in performance and increased 
likelihood of falling asleep with progressive hours of sleep deprivation exists in all 
individuals. Section 1.2.1.4 below describes important physiological and behavioural 
consequences of sleep deprivation that are particularly relevant to the driving task. 
Generally, the degree of sleep propensity and likelihood of falling asleep whilst driving is 
a combination of immediate sleep deprivation (past 24 hours) and accumulated sleep 
deprivation (over preceding week or weeks). 
 
1.2.1.3 Prevalence of Sleep Deprivation 
Sleep deprivation is very common in today’s society at large, in many occupational 
settings, such as shift work, and in populations of drivers.  
 
Available evidence suggests that society is becoming increasingly sleep deprived with the 
average sleep duration in the population now well below 8 hours: Four decades ago, the 
reported modal sleep duration was at least eight hours (Gallup 1979). In the mid-1980’s, 
the US National Health Interview Survey found that middle-aged adults reported sleeping 
seven to eight hours at night (Schoenborn 1986). According to the 1995 Gallup survey, 
the modal sleep duration had decreased to seven hours (Gallup 1995). Then, in 1998, the 
“Sleep in America Poll” found an average reported sleep duration of 6.57 hours (Gallup 
1998). These chronically reduced sleep hours have been confirmed in a contemporary 
population-based study of sleep patterns using actigraphy (a wrist watch like device that 
provides an objective measurement of sleep duration) (Jean-louis G et al. 2000a). A 
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recent article in Sleep Medicine Alert argued that society today may be sleeping 25% less 
than its forefathers 100 years ago (Jean-louis G et al. 2000b;Mahowald 1999). 
 
On top of this background of chronic partial sleep deprivation, drivers frequently acutely 
curtail their sleep time, thereby further increasing their sleep propensity and accident risk. 
In a large European study, 2200 automobile drivers were randomly stopped on a major 
interstate motorway and asked to complete a questionnaire about sleep, wake and travel 
habits (Philip et al. 1999a). Fifty percent of the drivers had decreased their total sleep 
time in the 24 hours before the interview compared with their regular self-reported sleep 
time. Twelve and a half percent presented an acute sleep debt of greater than three hours 
and three percent presented a sleep debt of greater than five hours.  
 
The problem of driving sleep deprived may be even worse for commercial drivers. A 
study on the working habits of Australian truck drivers found that 38% of on-duty truck 
drivers were exceeding 14 hours of driving per 24 hours at the time of the report, with a 
further 13% exceeding 14 hours of total work, including loading and paperwork (Arnold 
et al. 1997). Of these drivers, 12.5% reported at least one episode of less than four hours 
sleep whilst working. Mitler and co-workers, using round-the-clock 
electroencephalographic (EEG) monitoring of long haul truck drivers, showed that the 
average sleep time in this group on the job is only 4.8 hours per day, compared to a self-
reported ideal of 7.1 hours (Mitler et al. 1997).  Drivers on fixed 13 hour night shifts had 
the least sleep at an average of 3.8 hours per day.  This group of drivers showed facial 
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signs of drowsiness, as recorded on video tape, for 11.6% of their time on the road, by far 
the worst of all schedules.   
 
1.2.1.4 Effects of Sleep Deprivation on Performance and Accident Risk 
In experimental studies, sleep deprivation results in reduced alertness, mood changes, and 
poorer motor and cognitive performance (Dinges et al. 1997;Krueger 1989;Pilcher and 
Huffcutt 1996). Importantly, this has been shown even for chronic, partial sleep 
deprivation, suggesting that this seemingly mild sleep debt is harmful and that people do 
not adapt to it. In one study, 16 healthy young adults had their sleep restricted to an 
average of approximately five hours a night for seven consecutive nights (Dinges et al. 
1997). Subjective alertness (measured with several sleepiness scales), objective alertness 
(measured polysomnographically with the multiple sleep latency test, MSLT) and mood 
all deteriorated with sleep restriction. Similarly, motor performance, measured with a 
reaction time/sustained attention task (psychomotor vigilance task, PVT (Dinges and 
Powell 1985) was worse with sleep restriction: figure 1 below shows that the mean 
number of lapses (reaction times greater than 500ms) on the PVT increased significantly 
on day two of sleep restriction, then appeared to level off at the higher level between the 
second and sixth day, finally to rise again quite markedly on the seventh day of partial 
sleep deprivation. Even one night of recovery sleep did not return the PVT performance 
to baseline levels. An increase in performance “unevenness” or variability (manifested 
here by increasing lapse frequency) is an important effect of sleep loss on reaction time 
tasks involving sustained attention (Dinges and Kribbs 1991). Performance unevenness 
can also be evident by slowing of response time, increased errors, reduction in the speed 
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of the fastest response times (optimal reaction time) and an increased number of false 
responses because of variability in response inhibition (false responses) (Dinges 
1992;Weaver 2001). 
 
Figure 1 Temporal profile of mean (standard error of mean) PVT lapses after 
baseline nights (B1, B2), after each of seven consecutive sleep restriction nights (P1-
P7), and after a recovery night of sleep (R1) (Dinges et al. 1997) 
 
   
 
A recent meta-analysis (n = 2000) has further examined the effects of sleep deprivation 
on performance (Pilcher and Huffcutt 1996). Three main performance outcome measures 
were investigated: cognitive performance, motor performance and mood. Sleep 
deprivation strongly impaired human functioning in all three of these domains. The effect 
of sleep deprivation was greatest for mood (effect size = -3.16), followed by cognitive 
task performance (effect size = -1.55), and then motor task performance (effect size = -
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0.87). Any effect size greater than 0.80 is generally considered a large experimental 
effect (Hedges and Olkin 1985). This study included papers that had examined the effects 
of short-term sleep deprivation (less than 45 hours), long-term sleep deprivation (greater 
than 45 hours) and partial sleep deprivation (less than five hours sleep in a 24 hour 
period) on human daytime function.  
 
In order to illustrate the risks associated with sleep deprivation more simply, Dawson and 
co-workers have equated the performance impairment caused by sleep deprivation with 
that due to alcohol intoxication (Dawson and Reid 1997). They have shown that moderate 
levels of fatigue produce higher levels of impairment than the proscribed level of alcohol 
intoxication. To do this, they compared the performance on a computer administered test 
of hand-eye coordination between subjects kept awake for 28 hours and subjects who 
consumed 10 – 15 g of alcohol at 30 minute intervals until their mean blood alcohol 
concentration reached 0.10%. They found a very strong linear correlation between 
increasing performance impairment and increasing hours of sustained wakefulness 
(r=0.96). When this performance impairment was compared to the impairment seen in the 
subjects who consumed alcohol, they were able to show that after 17 hours of sustained 
wakefulness, performance impairment had decreased to a level equivalent to that 
observed at a blood alcohol concentration of 0.05%, which is the proscribed level of 
alcohol intoxication in many western countries. Further, after 24 hours without sleep, 
performance decreased to a level equivalent to that observed at a blood alcohol 
concentration of roughly 0.10% (see figure 2 below). 
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Figure 2 Performance in the sustained wakefulness condition expressed as mean 
relative performance and the percentage blood alcohol concentration equivalent 
(Dawson and Reid 1997) 
 
 
 
 
Thus, from the above work, it is clear that sleep deprivation results in important daytime 
physiological and behavioural consequences. The effects of sleep deprivation have also 
been examined specifically in the context of driving.  In a recent study which investigated 
the effects of acute total sleep deprivation on driving, subjects completed a driving 
simulator task for 20 minutes at five different times of day after a normal nights sleep and 
after one night without sleep (sleep deprivation condition) (Lenne et al. 1998). The 
driving task measured variables relating to speed, position on the road and reaction time 
to a secondary task (an indicator of the ability to cope with distracting stimuli while 
driving). Drivers were less able to maintain a steady position in the lane or a stable speed, 
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and showed a slower reaction time to the secondary reaction time task after 24 hours of 
sleep deprivation compared to their baseline testing conditions (see figure 3 below). 
 
Figure 3 Standard deviation of speed across the day during control and sleep 
deprivation conditions (+/- SE) (Lenne et al. 1998) 
  
 
 
 
Other studies have also shown impaired driving simulator performance after sleep 
deprivation (Fairclough and Graham 1999) (Roehrs et al. 1994). Similar to the work 
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described above by Dawson et al, impaired driving performance from sleep deprivation 
in these studies was at levels comparable to that seen with alcohol intoxication.  
 
Following on from an article published in Science in the 1970s which showed that 
measurable changes in sleep pattern persist for up to five days after each time shift 
associated with daylight saving (Monk and Folkard 1976), Coren and co-workers have 
published an interesting article looking at the effect of daylight saving time zone changes 
on Canadian road accident rates (Coren 1996b). Using road accident data from the 
Canadian Ministry of Transport for the years 1991 and 1992 (in total approximately 
20,000 reported accidents) they were able to show that the spring shift to daylight savings 
time, and the concomitant loss of one hour of sleep, resulted in an average increase in 
traffic accidents of approximately eight percent, whereas the fall shift resulted in a 
decrease in accidents of approximately the same magnitude immediately after the time 
shift. This suggested that even small changes in the amount of sleep people obtain can 
have major consequences on everyday activities, including the risk of traffic accidents. 
However, a similar study, reported more recently, did not show a measurable immediate 
effect on crash rates in Sweden associated with the shift to and from daylight savings 
time (Lambe and Cummings 2000). 
 
Prior sleep deprivation is also reported to be an important factor in commercial driver 
fatigue related crashes. In a study conducted by the US National Transportation Safety 
Board in 1995, the duration of the driver’s last sleep period, the total sleep obtained 
during the 24 hours preceding the crash, and fragmented sleep patterns were the most 
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important predictors of sleepiness-related single vehicle large truck crashes. This study 
also suggested that night driving after relatively little sleep was a better predictor of 
fatigue-related crashes than night driving alone (National Transport Safety Board 1995). 
 
1.2.2 Circadian Timing of Drive 
 
1.2.2.1 Circadian Periodicity of Biological Functions 
Well over 100 human bodily functions and biochemical processes have been found to 
vary in accordance with a 24 hour schedule (Rhoades and Pflanzer 1989). This daily or 
circadian periodicity (circa – “approximately”, dies – “day”) of biological functions is 
most evident in the sleep-wake cycle. The suprachiasmatic nuclei of the hypothalamus 
act as the central neural pacemakers of the circadian timing system. The period and phase 
of the endogenous neural oscillators are normally synchronized to the 24 hour period of 
the environmental light-dark cycle. Entrainment of the human circadian rhythms by the 
light-dark cycle is mediated via a neural pathway linking the retina of the eye to the 
hypothalamus (retinohypothalamic tract).  
 
The timing and internal architecture of sleep is directly coupled to the output of the 
endogenous pacemaker. Spontaneous sleep duration, sleepiness, rapid eye movement 
(REM) sleep propensity, and both the ability and the tendency to sleep vary with the 
circadian phase as marked by the endogenous circadian temperature cycle in humans. 
Sleep tendency, sleepiness, and REM sleep propensity all peak just after the nadir of the 
endogenous circadian temperature cycle (approximately two to three hours before 
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awakening). Eighty five percent of all spontaneous awakenings of subjects living in 
constant environmental conditions occur on the rising slope of the temperature cycle. 
Furthermore, there are certain times (wake maintenance zones) when it is very difficult to 
fall asleep, even for subjects who are sleep deprived. Misalignment of the output of the 
endogenous circadian pacemaker with the desired sleep-wake cycle is thought to be 
responsible for certain types of insomnia, as well as for some of the decrements of 
alertness and performance seen in certain settings, such as night shift work (Isselbacher et 
al. 1994). 
 
1.2.2.2 Circadian Variability in Performance Testing 
From the very earliest studies of sleep loss that involved repeated measurements within a 
day, it was clear that there was a circadian pattern modulating the course of performance 
during each 24 hour period of wakefulness (Dinges and Kribbs 1991).  The circadian 
patterns of sleepiness, temperature and performance seem to be closely related and have 
important effects on daytime physiological function and road accident risk. The time of 
day pattern of performance tends to show a maximum in the late afternoon and a trough 
in the early morning around 0500 hours (Akerstedt 1995), correlating closely with 
circadian changes in sleepiness.  
 
In order to assess whether driving performance varied across the day, Lenne and co-
workers tested 11 male subjects on a driving simulator for 30 minutes at six times of day 
(Lenne et al. 1997). Subjects were instructed to maintain a stable position in the left hand 
lane and to drive at a constant speed of 80km/hr. In addition, subjects performed a 
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secondary reaction time task. This study showed that the mean and standard deviation of 
speed, together with driver reaction time, varied significantly across the day. Performance 
was more impaired at 0600 and 0200, with improvements in driving performance 
between 1000 and 2200 hours and an early afternoon dip (see figure 4 below). The 
impairments in driving performance in the early afternoon were of similar magnitude to 
those occurring in the late evening and early morning. Such ‘post-lunch dips’ in 
performance have also been identified previously for a range of other performance 
measures (Smith and Miles 1986) (Blake 1971). 
 
Figure 4 Driving simulator reaction time (RT) across time of day (Lenne et al. 1997) 
 
 
 
 
 
 
 
 
 
In another study by Lenne and co-workers, discussed previously, there was a significant 
and similar variation in driving simulator performance across the time of day (Figure 3 
above) (Lenne et al. 1998). In addition, this study showed no significant interaction 
between the sleep condition (normal sleep hours or sleep deprivation) and time of day. In 
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other words, the variability in performance across the day was similar after a night of 
normal sleep and after a night of sleep deprivation. This emphasizes the strong effect of 
circadian influences on performance, showing that they persist unaltered even after total 
sleep deprivation.  
 
One study has compared daytime and night time performance of professional drivers on a 
simulated truck driving task (Gillberg et al. 1996). This study found that night driving 
was slower and was associated with greater variability of speed and lane position. 
Subjective and objective measures of sleepiness (measured by electroencephalogram 
(EEG), which measures brain activity) were also clearly higher during the nighttime. 
However, reaction time performance was not different between day and night driving, 
and neither a 30 minute nap nor a 30 minute rest period during the night time drive had 
any effect on sleepiness or driving performance. 
 
The circadian effects on performance are additive to those performance changes seen 
with sleep deprivation. This becomes particularly important at night time, when there is 
both a circadian nadir in performance and the accumulating effects on performance from 
sleep deprivation due to extended wakefulness. 
 
1.2.2.3 Circadian Variability in Accident Rates 
Circadian effects are clearly evident in road accident data, with accident risk being 
highest in the early morning hours and in the mid-afternoon, corresponding with time of 
day influences. 
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In a study that investigated the characteristics of crashes attributed to the driver being 
asleep, crash statistics for all police reported crashes in North Carolina from 1990-1992 
inclusive were analysed (Pack et al. 1995). By state law in North Carolina, police officers 
must fill out a crash report for any accident on a public road where there is personal 
injury or property damage greater than US$500. During the years 1990-1992, there were 
4333 crash reports in which the driver was judged to be asleep, but not intoxicated. The 
temporal distribution of these crashes followed that anticipated from what is known about 
circadian influences on performance: they occurred predominantly at night (midnight to 
seven am) and there was a secondary, albeit smaller peak, at the mid-afternoon period 
(around three pm). Fall-asleep crashes were also primarily of the drive-off-the-road type 
and took place at higher speeds. 
 
In a recent European study, Swedish highway accident data were used to compute the 
relative risk of being injured or killed in a traffic accident at different times of day 
(Akerstedt et al. 2001). Traffic density data was used to control for driving exposure. 
After removing accidents due to alcohol, approximately 10,000 accidents remained for 
analysis. The highest total accident risk was seen at 0400 (OR=5.7, CI 5.6-5.8), with an 
OR of 11.4 (CI=10.3-12.5) for fatal accidents at the same point. Further, in order to 
investigate whether darkness may be involved in the higher accident rate at night, 
accident patterns around the winter and summer solstices were analysed, since these two 
times of year differ greatly in daylight patterns at 58 – 61 degrees North, from which 
latitudes most of the data was obtained. This later analysis showed that, during the 
winter, the peak of total accidents occurred at 0300, five hours before sunrise, whereas 
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the summer peak occurred at 0400 hours, shortly after the summer sunrise and with 
consistently higher night time risk than for winter driving. It was concluded that the night 
time accident risk seemed related to sleepiness, but not to darkness.  
 
Local NSW data also demonstrate the importance of time of day in accident rates. They 
show that at the circadian periods of increased sleepiness, the proportion of fatal 
accidents due to fatigue increases: for the four year period of 1996 – 2000, fatigue was 
identified as a factor in 32% of all fatal crashes between 4 - 8 am and 21% of all fatal 
crashes between 12 noon – 2 pm (Roads and Traffic Authority of New South Wales 
2001).   
 
For commercial drivers, circadian influences on accident rates appear similar. Several 
researchers have shown an association between driver fatigue and time of day (Harris 
1972;Mackie and Miller 1978;Wylie et al. 1996). Some have clearly demonstrated that 
night time driving is associated with a higher crash risk (see figure 5 below) (Hertz 
1988;Jovanis et al. 1991;Kecklund and Akerstedt 1993;Kecklund and Akerstedt 1994). 
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Figure 5 The risk of heavy lorry accidents in Sweden (Kecklund and Akerstedt 
1994) 
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reductions (hypopnoeas) or pauses (apnoeas) in breathing during sleep due to upper 
airway narrowing or closure. These respiratory events can last from a few seconds to 
minutes in duration, depending on severity. Clinicians use a definition of at least five 
events per hour to define OSA, but in severe cases these respiratory events can occur 100 
times per hour. Most of these events are terminated by a brief awakening, which restores 
normal breathing, until the next event develops. This in turn is terminated by another 
arousal, which restores normal breathing again. This repetitive cycling between sleep and 
awakening in OSA causes the sleep to become very fragmented. As a consequence of the 
broken sleep and the repetitive falling of blood oxygen levels with respiratory events, 
patients with OSA usually suffer from excessive daytime sleepiness (Guilleminault C. 
1989). The term “sleep apnoea syndrome” is frequently used to describe people who have 
both OSA on an overnight sleep study and are excessively sleepy (Lawrence 1990). 
 
Most patients with OSA are overweight. Increased fatty tissue in the neck region and 
upper airway may contribute to the airway closure during sleep by structurally 
compromising airway lumen space. However, other factors are also felt to be important in 
the development of OSA in overweight individuals (McNamara S et al. 1993). OSA 
shows a male predominance (Bearpark et al. 1995;Young et al. 1993), with the highest 
prevalence in the middle-aged group (Bixler et al. 1998). 
 
It is currently standard in clinical practice and epidemiological studies to assess the 
severity of OSA by combining the number of apnoeas and hypopnoeas per hour of sleep 
in an index called the apnoea-hypopnoea index (AHI) or the respiratory disturbance index 
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(RDI). A common grading of severity is shown below (American Academy of Sleep 
Medicine Task force 1999): 
 
 Normal: less than 5 events per hour 
 Mild OSA: 5 – 15 events per hour 
 Moderate OSA: 15 – 30 events per hour 
 Severe OSA: greater than 30 events per hour 
 
Numerous studies have looked at the prevalence of OSA in the general population. Some 
have used questionnaire data alone to define OSA prevalence, others have used 
questionnaires initially which have then been then validated by full polysomnography or 
nocturnal respiratory monitoring in a random or selected subpopulation, while in other 
studies, all or most patients have undergone full sleep studies or nocturnal respiratory 
monitoring (McNamara S et al. 1993). When only those studies with in-laboratory 
polysomnography conducted on large samples are compared, the prevalence estimates for 
OSA in predominantly white men and women show that roughly 1 of every 5 adults has 
at least mild OSA and 1 of every 15 has at least moderate OSA (Young T et al. 2002) 
 
In a large American study, Young et al studied a random sample of 602 employed men 
and women from 30 to 60 years old with overnight polysomnography (Young et al. 
1993). They found 24% of men and 9% of women had OSA (defined by an RDI > 5/hr). 
Fifty seven percent of the men and sixty one percent of the women who were diagnosed 
with OSA had mild OSA (RDI 5 – 14). The prevalence of “sleep apnoea syndrome” (RDI 
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> 5/hr, together with excessive daytime sleepiness) was four percent for men and two 
percent for women. However, in interpreting the prevalence of sleep apnoea syndrome in 
this study, the authors noted that the subjective measures of sleepiness they used to define 
excessive daytime sleepiness probably underestimated the true physiological state of 
sleepiness, and thus the actual prevalence of daytime hypersomnolence and sleep apnoea 
syndrome may be higher than these data indicate. Bearpark et al studied the prevalence of 
OSA in Busselton, Western Australia using home monitoring to measure sleep apnoea 
(Bearpark et al. 1995). In total they studied 294 men aged 40-65 years. Twenty six 
percent had an RDI of at least five per hour, and most of these had mild OSA (62% of 
OSA patients had an RDI between 5 and 9/ hr). Three percent met the diagnostic criteria 
for “sleep apnoea syndrome”.  
 
Figure 6 Prevalence of OSA and sleep apnoea syndrome in middle-aged men 
(Bearpark et al. 1995;Young et al. 1993) 
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Much of OSA remains undiagnosed and untreated. However, little in known about the 
progression of untreated OSA. Preliminary data suggest that substantial progression can 
occur over relatively short time periods. In an eight year follow up study of 282 
participants in the Wisconsin Sleep Cohort, there was a significant increase in RDI over 
this time period. The overall mean RDI increased by 2.6 events/hr, from 2.5 at baseline to 
5.1 at follow up (Young T et al. 2002). Similarly, Redline and co-workers monitored 232 
participants from the Cleveland Family Study with AHI less than five at baseline and 
reported a five year increase from a baseline mean (SD) RDI of 2.0 (1.4) to a follow-up 
AHI of 6.2 (7.9) (Redline et al. 2001). In two studies of patients with mild to moderate 
OSA who have refused treatment and were later restudied, significant progression was 
found (Pendlebury et al. 1997) (Svanborg and Larsson 1993). 
 
1.2.3.2 Obstructive Sleep Apnoea: Consequences 
OSA has many important medical and psychosocial consequences. The next section 
(1.2.3.4) will describe the association between OSA and motor vehicle accidents. 
However, it is important to first note other major effects and associations of OSA.  
 
Excessive daytime sleepiness is a common symptom in patients with OSA. It is 
frequently used as part of the diagnostic criteria as discussed above. This excessive 
sleepiness is readily apparent both on subjective questionnaires and on objective tests, 
such as the maintenance of wakefulness test (MWT), a polysomnographic test of sleep 
tendency in which subjects are asked to stay awake under soporific conditions several 
times during the day for 20 or 40 minutes at a time. In one study, which used the MWT to 
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measure daytime sleepiness, OSA patients fell asleep considerably more readily than 
healthy controls, averaging 16 minutes, compared with 27 minutes for the healthy 
controls (Sforza and Kreiger J 1997). Similarly, OSA patients show a marked increase in 
their sleep tendency on the Oxford sleep resistance test (OSLER), a recently developed 
tool which objectively measures daytime sleepiness (Bennett et al. 1997).  
 
Instead of sleepiness, subjects with OSA may alternatively report fatigue, tiredness or 
lack of energy. One study has found that these complaints may be even more common 
than subjective reports of sleepiness in OSA patients (Chervin 2000). This appears to be 
especially true for women. 
 
OSA is associated with impaired cognitive performance. Studies have demonstrated mild 
and moderate decrements across a broad range of psychophysiological, attentional, 
perceptual and executive cognitive functions, including response speed and manual 
dexterity; attention and vigilance; verbal and visual memory; constructional skills; verbal 
fluency and planning (Engleman H and Joffe D 1999). In one case-control study, a 
comprehensive cognitive battery was administered to 10 patients with moderate OSA, 10 
patients with severe OSA and 10 controls who were matched for age, education and 
intellect (Bedard et al. 1991). The moderate OSA patients showed poorer performance in 
the order of one to two standard deviations on tests of manual dexterity, visual memory 
and executive function, compared to the controls. This performance impairment was even 
more marked for the severe group (up to three standard deviations). In addition, the 
severe group showed other significant deficits - in response latency, general intellectual 
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performance, attention, verbal fluency, constructional skills, mental flexibility, planning 
and sequential thinking.  
 
There appears to be an association between the severity of OSA and the degree of 
cognitive impairment (Engleman H and Joffe D 1999). Mild OSA patients show fewer 
cognitive deficits, but they are still apparent (Redline et al. 1997) (Engleman H et al. 
1999) (Engleman H et al. 1997b) (Kim et al. 1997). In one case-control study of 32 mild 
OSA patients (mean RDI 17), scores for attention and immediate verbal memory were 
reduced by up to one standard deviation in subjects with mild OSA and a trend for 
increased perseverative errors on a frontal lobe sorting test was observed (Redline et al. 
1997). The mild OSA patients in this study did not differ from the controls (RDI < 5) in 
terms of objective or subjective sleepiness, suggesting that sleepiness was not a factor in 
explaining the difference observed between the groups. The importance of mild OSA has 
been most reliably demonstrated in a large scale, population based sample of over 800 
subjects who were tested with a cognitive battery (Kim et al. 1997). This study showed a 
significant negative association between RDI and psychomotor efficiency, independent of 
age, gender, and educational status (p=0.017). This relationship was not explained by 
self-reported sleepiness.  Expressing the decrement associated with mild OSA in a more 
simple way, the authors estimated that an RDI of 15 was equivalent to a decrement in 
psychomotor efficiency associated with five additional years of age, or to 50% of the 
decrement associated with hypnosedative use. 
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There are other broad psychosocial consequences of OSA. In a large epidemiological 
study of 1300 overweight subjects, those with nocturnal and daytime symptoms of OSA 
were 15 times as likely to report impaired work performance, four times as likely to have 
experienced multiple divorce, and three times as likely to have had psychiatric care 
(Grunstein et al. 1995). Studies which have measured general health-related quality of 
life in OSA patients have concluded that OSA affects quality of life on a par with other 
chronic disorders of moderate severity (Baldwin et al. 2001;Finn et al. 1998). One study 
that assessed quality of life in a sample of older black volunteers with self-reported 
sleepiness and snoring found that OSA was related to general physical and mental 
function over the range of RDI 1 to 15 events per hour (Stepnowsky et al. 2000).   
 
Occupational accidents are a major social problem. There is evidence that OSA is 
associated with increased occupational accidents outside of driving (see section 1.2.3.4). 
In a recently published large Swedish study, men with a history of both snoring and 
excessive daytime sleepiness had a greater than two fold increased risk of occupational 
accidents during 10 years of follow up (Lindberg et al. 2001). In this study, data on 
occupational accidents was obtained from a government maintained national register of 
occupational accidents and accidents occurring during travel to or from work were 
excluded. 
 
There is a growing consensus that OSA is an important risk factor for hypertension, 
independent of excess weight and other potentially confounding factors (Peppard P et al. 
2000;Young T et al. 2002). An association appears to be present even at the mild end of 
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the OSA severity spectrum. One prospective population-based study showed that a 
minimally elevated RDI at baseline (0 < RDI < 5) was associated with a 42% (95% CI, 
13 to 5.6) increased odds of developing hypertension over a four year follow up period. A 
dose response relationship was observed for more severe categories of OSA, with an odds 
ratio of 2.9 (95% CI, 1.5 to 5.6) for an RDI of 15 or greater versus an RDI of zero events 
per hour (Peppard P et al. 2000;Peppard P and Young T 2000). Although the magnitude 
of the association between OSA and hypertension in studies to date has generally been 
modest, the high prevalence of OSA suggests that it may be responsible for a substantial 
portion of the population burden for hypertension. Many researchers now view OSA as a 
cause of secondary hypertension (Young T et al. 2002). Further, myocardial infarction, 
stroke, cardiovascular morbidity and mortality have all been linked to OSA in various 
studies. However, strong empirical evidence for these associations and precise estimates 
of the magnitude of the associations will have to await the outcomes of further studies, 
many of which are currently ongoing.  
 
1.2.3.3 Obstructive Sleep Apnoea: Effect on Driving (Simulator Studies) 
Driving simulators have been used widely in motor accident research to assess driving 
impairment associated with recognised risk factors. They have been shown to detect 
performance deficits due to alcohol and drug consumption as reliably as on-road studies 
(Moskowitz H and Robinson CD 1990;Smiley A 1986;Smiley A 1987). In fatigue 
research, they have been used to describe driving performance deficits in association with 
sleep deprivation (Fairclough and Graham 1999;Lenne et al. 1998), circadian variability 
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(Lenne et al. 1997), long driving hours (Philip et al. 1999b), and sleep apnoea (Findley et 
al. 1989;George CF et al. 1996;Juniper et al. 2000).  
 
Early studies demonstrated that severe apnoeics (RDI > 50) performed significantly 
worse in all parameters of a film driving simulator than controls (Findley et al. 1989).  
Furthermore, on a simple reaction-time test in which subjects avoid obstacles on the road 
('Steer Clear'), apnoeics hit over four times as many obstacles as controls.  In another 
study using a more advanced PC based driving simulator, which incorporated two 
essential features of driving, tracking and visual search, George et al showed that OSA 
patients (AHI 73 + 29) as a group performed much worse than control subjects in a test of 
steering ability (“tracking error”). In fact, half of the OSA patients were worse than any 
control subject, with some showing performance worse than control subjects impaired by 
alcohol (George CF et al. 1996).  
 
Recently, Juniper and co-workers reported that drivers with sleep apnoea syndrome (RDI 
> 10, together with daytime sleepiness) performed significantly worse than controls on 
their PC based driving simulator (Juniper et al. 2000). The driving simulator that was 
used in this study allowed the separate assessment of two visual tasks required for 
steering a car, immediate positioning on the road with reference to the road edges, and 
assessment of the curve of the oncoming road which allows faster driving. The sleep 
apnoea syndrome patients appeared to be particularly impaired on the two drives when 
only part of the road ahead was available to guide steering, suggesting that they may be 
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more disadvantaged compared to normal subjects when the view of the road ahead is 
limited (such as in fog). 
 
1.2.3.4 Obstructive Sleep Apnoea: Accident Risk in Non-Commercial Drivers 
The presence of sleepiness and/or cognitive dysfunction associated with OSA is likely to 
interact in the substantially increased risk of road traffic accidents seen in non-
commercial drivers with OSA. Epidemiological studies have established a link between 
OSA and motor vehicle accidents (MVAs), generally showing a two to seven times 
increased risk of road traffic accidents in non-commercial drivers with OSA (Barbe et al. 
1998a;Findley et al. 1988;Findley et al. 1992;Teran-Santos et al. 1999b;Wu and Yan-Go 
1996a;Young et al. 1997a).  
 
The evidence linking OSA and MVAs in the general population comes from several 
sources. Firstly, early questionnaire studies reported that about a third of sleep apnoea 
patients had a MVA in the past five years (Gonzalez-Roth R et al. 1988), 19-27% had a 
MVA due to falling asleep (Bearpark 1990;Guilleminault C. et al. 1978) and 22-57% had 
habitual sleepy spells whilst driving their motor vehicle (Bearpark 1990;Haraldsson PO 
et al. 1990). Studies that have compared self-reported accident rates in sleep apnoea 
patients to those of controls have consistently shown OSA patients to have higher 
accident rates (Haraldsson PO et al. 1990;Horstmann S et al. 200;Masa J et al. 2000;Wu 
and Yan-Go 1996b). Wu et al reported that sleep apnoea patients (RDI > 5) were three 
times as likely to have been involved in an MVA as non-OSA patients (Wu and Yan-Go 
1996b). One Swedish questionnaire study found a seven-fold increase in the number of 
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single MVAs in sleep apnoea sufferers (defined as the habitual occurrence of the clinical 
triad of snoring, awakenings and/or history of sleep apnoeas, and daytime somnolence) 
when compared with controls (Haraldsson PO et al. 1990).  
 
However, because of the limitation of questionnaire studies, which rely on subject 
participation, honesty and memory (in other words, they are subject to ‘recall bias’), other 
researchers have confirmed the increased accident risk of sleep apnoea sufferers using 
objective government records or insurance accident data. However, it is important to 
realise that even this objective data may underestimate the frequency of road traffic 
accidents in this population because OSA patients are prone to single vehicle accidents, 
which may sometimes go unreported. Similarly, more trivial accidents, which do not 
require mandatory government or insurance reporting, would not be included in these 
figures. In one study, Findley et al compared the number of reported MVAs in proven 
OSA patients (RDI > 5) with that in age and sex matched controls with negative sleep 
studies and with the total 3.7 million licensed drivers of Virginia (Findley et al. 1988). 
They found that the number of accidents per driver per five years was 0.41, 0.06, and 
0.16 in the three groups respectively, indicating that drivers in the OSA group were seven 
times more likely to be involved in a MVA compared with controls and almost three 
times more likely compared with the general population. The general population may 
have had a higher incidence of accidents than the control group due to hidden medical 
conditions such as stroke, epilepsy, sleep apnoea, etc (Naughton M and Pierce R 1991). 
Barbe et al obtained objective accident data from insurance companies and compared 60 
consecutive patients with sleep apnoea (RDI > 20) and 60 aged and sex matched controls 
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(Barbe et al. 1998b). They demonstrated that sleep apnoea patients had a 2.3 times 
greater risk of accidents and a 5.2 times greater risk of multiple accidents, compared with 
controls.  
 
Recently, Teran-Santos and co-workers conducted a case-control study of the relationship 
between sleep apnoea and the risk of traffic accidents (Teran-Santos et al. 1999a). They 
performed sleep studies on patients presenting to hospital after a highway vehicle crash 
and on a control group of primary care patients. They found a seven-fold increase of OSA 
(RDI > 10) in the highway accident victims. This relation remained significant after 
adjustment for potential confounders, such as alcohol consumption, visual refraction 
disorders, body mass index, years of driving, age, history with respect to traffic accidents, 
use of medications causing drowsiness, and sleep schedule. When the presence of OSA 
was combined with having consumed alcohol on the day of the accident, the odds ratio 
was 11 for accident victims compared with controls.  
 
In arguably the best study to date that has examined the risk of having a MVA associated 
with undiagnosed OSA, Young et al reported on 913 employed public servants in 
Wisconsin (Young et al. 1997b). This was a population based sample, and hence free 
from clinic selection bias. All subjects underwent full sleep studies. Motor vehicle 
accident history was obtained from a state wide database of all traffic violations and 
accidents from 1988 to 1993. Overall, men with sleep disordered breathing (SDB - 
habitual snorers, RDI > 5) had three times the odds of having at least one motor vehicle 
accident in five years compared to those without SDB (p<0.001). Men with only mild 
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OSA (5–15 apnoeas per hour of sleep) were 4.2 times more likely to have had a motor 
vehicle accident compared to those without SDB. Observed odds ratios did not increase 
with OSA severity, and there were no associations for women. In contrast, the odds ratios 
for SDB and multiple reported crashes were positive for both men and women – men and 
women combined with more than 15 apnoeas per hour of sleep were 7.3 times more 
likely to have multiple motor vehicle accidents in five years than those with no SDB.  
 
In the study by Young et al above, there was no association between OSA severity and 
MVA risk. This lack of a dose-response relationship between OSA severity and accident 
risk has been discussed by several authors (Barbe et al. 1998b;Engleman H and Joffe D 
1999;George 2001). It suggests mild OSA patients may share the same MVA risk as 
severe apnoeics.  Given the relative frequency of mild OSA, its individual contribution to 
road accidents is therefore potentially very large. The significance of mild OSA to driver 
fatigue will be discussed in more detail in section 1.3 of this chapter. 
 
1.2.3.5 Obstructive Sleep Apnoea: Prevalence & Accident Risk in Commercial Drivers 
Specific and robust data on the prevalence and accident risk with respect to OSA in 
commercial drivers is generally lacking. Commercial drivers are thought to constitute a 
high risk group for OSA, being predominantly male, and often middle aged and 
overweight - 3 important risk factors for OSA (Dealberto et al. 1994;Diaz et al. 
2001;Redline et al. 1994).  
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In a Finnish study, the frequency of sleep apnoea syndrome and its contribution to driver 
sleepiness was assessed by questionnaires in a sample of both long haul (n=184) and 
short haul (n=133) drivers (Hakkanen and Summala 2000). This study found that only 
four percent of the long haul drivers and two short haul drivers reported the clinical 
syndrome of snoring heavily and loudly at least three nights per week, respiratory 
disturbances at least one night per week, and excessive daytime sleepiness  (Epworth 
Sleepiness Score above 10). Sleep apnoea syndrome contributed only slightly (R2 < 5%) 
to predicting driver sleepiness-related problems (difficulty in staying alert during work 
driving, microsleeps, or near misses). This study was limited by a non random selection 
of Finnish truck drivers (all the drivers surveyed were from the one trucking company), a 
variable and inadequate response rate (from 10% to 95% for different sub groups of 
drivers), and the need to rely on symptoms alone to define sleep apnoea syndrome; age 
and body mass index were measured, but not incorporated into a multivariate prediction 
formula for OSA (Rowley et al. 2000), and there was no driver polysomnography.   
 
Stoohs et al. used portable screening devices to investigate the prevalence of OSA in a 
group of long haul truck drivers from a single US trucking company (Stoohs et al. 
1995a). They performed limited sleep studies on 41% of all the drivers who presented to 
a truck loading hub over the study period. Different prevalence rates were reported for 
different degrees of severity of OSA. They found that 78% of the drivers had an oxygen 
desaturation index (ODI, a measure of nocturnal breathing disturbance, like the ‘RDI’) of 
at least 5, 46% had an ODI at least 10, and 10% had severe OSA (ODI at least 30). These 
high prevalence figures for OSA in commercial drivers are similar to those obtained in a 
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recent study of commercial bus drivers from one bus company in Hong Kong (Hui et al. 
2002). This study also used limited sleep studies to measure OSA (MESAM IV device). 
They found that 61% of drivers had an RDI of at least 5 per hour of sleep, 41% had an 
RDI of at least 10 per hour of sleep, and 10% had an RDI of at least 5 per hour together 
with excessive daytime sleepiness (ESS > 10). 
 
Stoohs’ alarmingly high prevalence rates for OSA led the US Department of 
Transportation to fund a further study of sleep apnoea prevalence in commercial drivers. 
Pack et al from the University Of Pennsylvania have recently completed and presented 
their results in abstract form (Pack et al. 2000b). In this study, commercial drivers were 
first sent a survey which contained questions that stratified the drivers into high and low 
risk groups for OSA. However, the response rate from this survey was only 31%. Then, 
approximately one half from the higher risk strata and one fifth from the lower risk strata 
had full in laboratory polysomnography (n=408). The weighted prevalence for OSA was 
found to be 25% (RDI > 5/hr) and 5% of the drivers had severe OSA (RDI > 30/hr). 
Shortfalls of this study include a limited response rate and a low percentage of long 
distance drivers (approximately 11%). A similar prevalence figure has been reported in 
abstract form for Spanish long-haul professional drivers (Diaz et al. 2001). These authors 
found that the prevalence of OSA (AHI > 5) was 25% amongst a cohort of 188 drivers 
who had full polysomnography. However, the prevalence of sleep apnoea syndrome was 
disproportionately high in this Spanish study (8.6%). The studies by Pack et al and Diaz 
et al report much lower prevalence figures for OSA in commercial drivers than those by 
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Stoohs et al and Hui et al, but these lower figures are in line with estimates from 
prevalence studies in other populations.  
 
It is clear that adequate data on the prevalence of OSA in commercial drivers is lacking; 
much of the existing data is of poor quality (diagnosis of OSA by symptoms or limited 
sleep studies), lacks generalisability (select populations, poor response rates), or is only 
reported in abstract form. However, there is even less data on the accident risk associated 
with OSA in this occupational group.  
 
In one study which investigated factors associated with falling asleep at the wheel in a 
sample of 600 truck drivers, symptoms and signs of a sleep disorder (higher body weight, 
snoring, breathing stopping during sleep, and self-reported poor sleep at home) were one 
of 6 variables found to be significant predictors of a driver ever having fallen asleep at 
the wheel (McCartt et al. 2000). Other predictors included more arduous work schedules; 
shorter, poorer sleep on the road; and a greater tendency to night time drowsy driving. 
Another study has reported that heavy goods vehicle drivers who report regular snoring 
or who are obese or who have a noticeably large collar size have higher accident rates 
than those not exhibiting these characteristics (Maycock 1997). Other information on 
accident risk due to OSA in commercial drivers comes from a recently published abstract. 
This has shown greater sleepiness and driving impairment (based on MSLT, driving 
simulator, and PVT tests) with increasing RDI in commercial drivers, especially among 
those with an RDI > 30 (Dinges et al. 1998). 
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Finally, in an extension of the study by Stoohs et al. discussed above, the authors have 
reported on self-reported and company recorded accident rates in their long haul truck 
driver cohort (Stoohs et al. 1994b). They found that truck drivers with sleep disordered 
breathing had a two-fold higher accident rate per mile than drivers without sleep 
disordered breathing. Accident frequency was not dependent on the severity of the sleep 
disordered breathing. Obese drivers with a body mass index of at least 30kg/m2 also 
presented a two-fold higher accident rate than non-obese drivers.  
 
1.2.3.6 How many MVAs are caused by sleep apnoea? 
In a recent submission to the Australian Commonwealth Parliamentary Enquiry into 
Fatigue and Transport, the population attributable risk for sleep apnoea was estimated as 
between 12% and 46% depending on which sleep apnoea prevalence figure and which 
relative risk value is used in the calculation (Neville 2000). Using this measurement and 
NSW RTA figures for 1997, between 5164 and 19794 accidents involving male drivers 
aged 30-60 are estimated to be attributable to sleep apnoea in NSW annually. In other 
words, completely eliminating the risk of sleep apnoea in the NSW population would 
reduce the number of annual road accidents by this figure (for more detailed discussion, 
see Attachment 1). 
 
1.2.3.7 Reduction of Fatigue Accidents with OSA Treatment 
OSA can be effectively treated with nasal continuous positive airway pressure (CPAP). 
This device, placed by the patient's bedside, generates air pressure and delivers it through 
a sealed face mask, thus splinting open the upper airway during sleep (Sullivan et al. 
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1981). In this way CPAP prevents recurrent upper airway obstruction during sleep and 
treats OSA on a night-to-night basis whenever it is used. 
 
Regular use of CPAP improves self-reported MVA rates (Cassel et al. 1996a;Engleman 
et al. 1996b;Krieger et al. 1997;Yamamoto et al. 2000) and objective MVA rates 
(Findley et al. 2000a;George 2001). In a self-report study of 59 drivers, Cassel and co-
workers found a decrease from 0.8 accidents per 100,000 km driven to 0.15 after 
treatment (Cassel et al. 1996b). Recently, Findley et al showed a marked reduction in 
objective reports of motor vehicle crashes over two years in 36 subjects with sleep 
apnoea (mean RDI 37/hr) treated with CPAP (0.07 versus 0 crashes per driver per year) 
while, in contrast, the crash rate did not fall in 14 subjects with sleep apnoea who did not 
accept treatment (0.07 crashes per driver before and after diagnosis) (Findley et al. 
2000b). This study found that successful treatment of sleep apnoea prevented five motor 
vehicle crashes in 36 patients during two years of treatment. The state reported crashes 
analysed in this study were serious “at fault crashes”, where the driver was given a traffic 
citation and caused property damage and/or personal injury (Findley and Suratt PM 
2001). In a larger group of patients with sleep apnoea (mean AHI 54/hr), George 
confirms that those who are treated with nasal CPAP have a decrease in objectively 
measured crashes (George 2001). His study found that successful treatment of sleep 
apnoea with CPAP prevented 75 motor vehicle crashes in 210 patients during three years 
of treatment (a decrease of 0.12 crashes/driver per year) (Findley and Suratt PM 2001). 
These were also serious crashes resulting in property damage and/or personal injury (see 
figures below).  
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Figure 7 Effect of CPAP treatment on accidents (George 2001) 
Mean (SD) accident rates for - 
(A)  patients with OSA during the 3 years before and after treatment with CPAP and  
(B) control subjects during the same time frame 
 
 
Figure 8 Distribution of accidents in patients with OSA (George 2001) 
(A) during the 3 years before and  
(B) during the 3 years after treatment with CPAP 
and in controls during the same time frame (C, D) 
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Both of the above studies show an improvement in objectively measured accident rates 
after commencing CPAP treatment (Findley et al. 2000b;George 2001). These findings 
extend the data that show improvements in self-reported accident rates in OSA patients 
who are treated with CPAP. However, a placebo controlled, randomized prospective trial 
is lacking to more definitively show this important effect of CPAP on MVA rates.   
 
A recent study has reported on the ability of a driving simulator test (C.A.R.) to 
demonstrate an improvement in accident risk in OSA patients on CPAP treatment (Ortho 
et al. 2002). In this study, driving simulator performance was measured in 31 patients 
with OSA (RDI 24.8 +/- 21.5/h) before, 2 and 42 days after initiation of CPAP, and was 
compared to 10 healthy controls in whom OSA was excluded by polysomnography. 
Driving simulator performance before treatment was significantly worse in OSA patients 
as compared to healthy controls, especially in terms of accident frequency and 
concentration faults. However, on CPAP, accident frequency and the frequency of 
concentration faults were lowered significantly for both the short and medium terms of 
therapy. Others have also demonstrated significant improvements in driving simulator 
performance in OSA patients on CPAP therapy (Findley et al. 1989;George CF et al. 
1997;Munoz et al. 2000), including one study in which patients who had been 
randomized to therapeutic CPAP showed improved steering performance and reaction 
times, compared to OSA patients randomized to subtherapeutic nasal CPAP (control 
group) (Juniper et al. 2000). 
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1.2.3.8 Legal Discussion of OSA and Road Safety in Commercial Drivers 
Ian Callinan, Q.C., currently a Justice of the High Court of Australia, addressed some of 
the legal issues relating to OSA and commercial driving in Australia in a discussion paper 
in 1993 (Attachment 2). The framework for his discussion of the issue of OSA in 
commercial drivers was that of hypothetical situations which could in the future confront 
an employee, employer or an insurance company in this area.  
 
In his opening remarks, he likened the current thinking about sleep apnoea to early 
thinking about Asbestosis and AIDS, commenting on the inevitable greater public 
awareness of both sleep apnoea and “its very serious implications”.  
 
1.2.3.8.1 Driver Issues 
When discussing sleep apnoea in the context of employee drivers, Justice Callinan briefly 
explored some legal aspects of fall asleep road accidents, where the driver who caused 
the accident thinks he might suffer from OSA. He explained that if the accident was 
caused by a sudden and unpredictable event without any warning (e.g., falling asleep 
suddenly), then it does not constitute criminal conduct. The key to this defence is the 
“suddenness and unexpected nature” of the precipitating event. However, he went on to 
state that: 
 
 “a driver who suspects that he might suffer Sleep Apnoea can hardly claim that if he is 
overtaken by sleep at the wheel he has been overtaken by a sudden and unpredictable 
 68
event. Such a driver runs the serious risk of being charged in respect of the accident 
caused by his falling asleep.” 
 
This important issue of whether falling asleep at the wheel can occur without warning is 
very controversial. In 1992, in Jiminez v the Queen (Commonwealth Law Reports 1992), 
the High Court of Australia set an important precedent in their judgement on a case of a 
fall-asleep road accident. In this judgement, they said that just because an accident is 
caused by a driver falling asleep, this does not necessarily mean that the driver has had 
sufficient warning to allow himself or herself to stop driving. In other words, they 
believed that a driver can fall asleep without warning or remembering. Since sleep is an 
involuntary state, and people cannot be charged for involuntary acts, a “Jiminez-defence” 
potentially provides many drivers with the legal ability to escape any blame in the case of 
fall-asleep road accidents. A significant number of other cases in NSW which may have 
been charged under section 52A of the Crimes Act (NSW 1900) have been the subject of 
successful application that there be no further proceedings because of sleep or blackouts 
(Gray 1998). Since the Jiminez findings, there have also been a series of unsuccessful 
prosecutions or successful appeals (1995) based on the defence that the driver fell asleep 
without warning or did not remember falling asleep.   
 
The premise that sleep can occur without warning, however, is at odds with legal opinion 
in other countries and current medical evidence (Ellis and Grunstein 2001). The Canadian 
and English courts maintain that, regardless of the circumstances, the ordinary person 
who allows themselves to fall asleep at the wheel is liable for their actions.  These 
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judgements are predicated on the “prior fault” principle (McCutcheon JP 1997) that there 
was a period of time prior to being asleep, of voluntary conduct when a person chose to 
take the risk of continuing to drive. This way of thinking was recently used in the United 
Kingdom to convict a driver who had fallen asleep at the wheel after driving sleep- 
deprived, and subsequently caused an extensive rail crash involving two trains and killing 
10 people (Leeds Crown Court 2002). This rail disaster, occurring in February, 2001, 
attracted extensive world-wide press at the time. 
 
Although the view of the Australian High Court allows for the possibility of pathological 
conditions such as narcolepsy or sleep apnoea to suddenly be expressed, this view is 
difficult to justify in patients who do not have these conditions and does not agree with 
medical evidence. A recently published study (Reyner and Horne 1998) has shown that 
healthy people do not fall asleep without significant symptoms of sleepiness for some 
period of time.  In this study, 28 healthy drivers had their sleep restricted to five hours on 
the night before they were required to drive an (immobile) car for two hours under 
realistic simulation. In the twelve subjects who had accidents that were related to 
sleepiness, in each case these incidents were preceded by periods where the subjects had 
forewarning of moderately severe sleepiness for an average of 43.5 minutes.  This would 
certainly amount to sufficient warning to allow an individual to stop driving and take 
some remedial action. Similar evidence has been reported by Lisper and co-workers, 
using drivers in real cars on a closed track (Lisper HO et al. 1986). Further, in another 
study where subjects were acutely sleep deprived and then underwent serial performance 
testing, subjects reported a systematic increase in subjective sleepiness in the period 
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leading up to their first sleep episodes (Atzram et al. 2001). All of these studies have used 
healthy volunteers. Similar evidence looking at an individual’s perception of sleepiness 
prior to sleep onset is now needed for other groups, especially for those with OSA. It is 
important to note that, in order to be aware that one has fallen asleep, a person has to be 
asleep for at least a minute or so (Bonnet and Moore 1982). People who are woken in less 
than that time, genuinely disbelieve that they have been asleep. A driver who dozes 
momentarily at the wheel of a vehicle is likely to be woken spontaneously or crash before 
waking and is unlikely to remember being asleep.  However, this “amnesia” would not be 
expected to extend to a period of drowsiness prior to actually falling asleep.  
 
1.2.3.8.2 Employer Issues 
When discussing OSA in the context of employer obligations, Justice Callinan felt that a 
driver with obvious signs of sleep apnoea can certainly be legally removed from duties 
until he has been tested and treated: “Indeed, in my opinion, he must be”. Furthermore, 
he writes that if a driver was found to have sleep apnoea after a fall asleep road accident, 
even if his symptoms prior to the accident were not apparent: “I still think that an 
employer, today (1993), if not today, certainly tomorrow, runs the risk of being found to 
be negligent, by failing to have a system which keeps susceptible drivers off the road”.  
 
1.2.3.8.3 Insurance Issues 
When discussing sleep apnoea in the context of driver insurance, Justice Callinan felt that 
there was a clear obligation for a driver to inform his insurer of sleep apnoea, as it might 
affect his capacity to drive, in a similar way that epilepsy or partial blindness might be 
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reported. Furthermore, he felt that “it would be perfectly reasonable for any insurer of 
fleet owners to request that they screen their drivers (for sleep apnoea) as a condition of 
the obtaining of a policy”.  
 
1.2.3.9 The Licensing Issue of OSA 
One area Justice Callinan did not address in his paper is the responsibility of licensing 
authorities to have appropriate policies in place to deal with OSA and driver fatigue. 
Indeed, recent licensing decisions in NSW concerning fall asleep road accidents in the 
setting of undiagnosed or under treated sleep disorders have been very variable (Desai et 
al. 2002). As part of a strategy to deal with this, on August 17, 2001, the NSW 
government introduced new regulations giving the NSW RTA explicit power to suspend 
a license immediately where there has been loss of consciousness and death or injury, 
modifying the Road Transport (Driver Licensing) Regulation of 1999. This has 
effectively removed some of the legal constraints on license suspension which had 
previously handicapped the RTA in managing fall asleep MVAs. Similarly, Austroads 
has recently updated the 1998 “Assessing Fitness To Drive” Guidelines for Medical 
Practitioners in the area of sleep disorders to more accurately reflect current knowledge 
about the dangers of sleep apnoea and driving for both private and commercial drivers 
(Australian Sleep Association 2002). These new guidelines will increase the pressure for 
all types of drivers with OSA to be effectively treated and followed up medically in order 
to remain licensed to drive. 
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1.2.3.10 Difficulties in Identifying Drivers with OSA at Most Accident Risk 
Parts of the preceding sections of this chapter have shown that as a group non-
commercial drivers with OSA have increased road accident rates and poorer driving 
simulator performance. In fact, George et al. have demonstrated that many subjects with 
OSA show driving impairment equal to or greater than that due to alcohol, strengthening 
the argument that many patients with untreated OSA should not drive (George CF et al. 
1996). However, in the study by George et al., it is important to also note that some 
drivers with OSA were as good as, if not better than, the control subjects in terms of their 
driving performance. This is consistent with the clinical impression that not all patients 
with OSA are poor drivers or have accidents.  
 
No studies have yet been able to determine which individuals with OSA have the greatest 
risk of road accidents. Importantly, there does not appear to be a clear dose-dependent 
relationship between RDI and either real-world or laboratory-assessed driving ability 
(Engleman H and Joffe D 1999;Engleman et al. 1996a;Flemons et al. 1993;George 
2001;Stoohs et al. 1994a;Young et al. 1997b). Young et al, in their important paper 
describing the positive relationship between sleep-disordered breathing and motor vehicle 
accidents in a large population based sample, found that the odds ratios for having an 
MVA did not increase with RDI severity of OSA (Young et al. 1997b); in fact, the group 
of men with only mild OSA (AHI 5 to 15) showed the greatest odds ratio for having a 
single vehicle accident in the five year study period (OR 4.2, 95% CI 1.6 to 11.3), 
compared to private drivers without sleep disordered breathing. The frequency of self-
reported actual accidents (Stoohs et al. 1994a) and near misses (Engleman et al. 1996a) 
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has also been shown to have no significant correlations with RDI, either in a clinical 
series (Engleman et al. 1996a) or in a community sample of transport drivers (Stoohs et 
al. 1994a). Finally, in 180 consecutive OSA patients, Flemons and co-workers found no 
significant correlation between RDI and obstacles hit during Steer Clear (Flemons et al. 
1993). Hence, OSA severity, as measured by the RDI, does not seem to predict road 
accident risk.  
 
Other clinical or physiological markers commonly used to describe OSA disease severity 
(e.g., degree of daytime sleepiness, nocturnal hypoxaemia) do not appear to be able to 
clearly differentiate those OSA patients at higher risk of having an automobile accident. 
The MSLT has not been shown to predict accident risk in OSA patients in two studies 
(Aldrich M 1989;Young et al. 1997b). Two studies have shown that the degree of 
nocturnal hypoxaemia on a sleep study does help to predict accident risk in OSA patients 
(Aldrich M 1989;Noda et al. 1998), whereas one has reported that it does not (Barbe et 
al. 1998b). Several researchers have investigated whether hypersomnolence on the 
Epworth Sleepiness Scale (ESS) might identify those drivers with OSA at most risk of 
road accidents (Barbe et al. 1998b;Masa J et al. 2000;Maycock 1996;Noda et al. 
1998;Teran-Santos et al. 1999a;Young et al. 1997b). These studies have for the most part 
been negative in this respect (Barbe et al. 1998b;Masa J et al. 2000;Teran-Santos et al. 
1999a;Young et al. 1997b). In the study by Young et al, the addition of ESS scores into 
their analyses did not substantially change the magnitude or the statistical significance of 
any of the odds ratios for SDB and accident history. Also, the combination of both 
sleepiness and SDB did not significantly predict accident history in their sample (Young 
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et al. 1997b). Similarly, Teran-Santos and co-workers, in their case-control study of 
highway accident victims, did not find that self-reported sleepiness using the ESS 
explained the association of OSA and motor vehicle crash history (Teran-Santos et al. 
1999a).  
 
While studies have generally not shown that sleepiness as measured by the ESS can 
predict road accident risk in those drivers with OSA, there is a small amount of 
encouraging data which suggests that other questions asking specifically about driver 
sleepiness may help to identify those with OSA at greatest accident risk (Lloberes et al. 
2000;Masa J et al. 2000). One reason for this may be that the ESS lacks adequate 
sensitivity and specificity with regard to driving performance.  Alternatively, the lack of 
finding sleepiness as a clear explanatory factor in the OSA-motor vehicle crash 
association is concerning because it may indicate that drivers with OSA do not perceive 
performance impairment, and thus may not be likely to take extra precautions when 
driving.  
 
There is still therefore an urgent need to identify those subgroups of drivers with OSA 
who are most at risk of MVAs. From a road safety point of view, however, it is 
comforting that CPAP treatment of drivers with OSA significantly reduces, and possibly 
even eliminates, their accident risk from OSA (see section 1.2.3.7). 
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1.2.4 Length of Driving without Rest 
A fourth cause of driver fatigue will be discussed briefly in this section. This factor is 
targeted extensively in local road safety advertising e.g. the ‘Stop, Revive, Survive’ 
campaign of the NSW RTA. 
 
The effects of prolonged driving on fatigue are well documented. Common findings are 
that driving performance deteriorates steadily within a four to six hour driving session, 
and that these deteriorations are apparent much sooner during night time driving 
(Dureman and Boden 1982;Haworth et al. 1987;Kecklund and Akerstedt 
1993;Riemersma et al. 1977).  
 
In a recent European study, 300 drivers who had driven into a highway rest stop were 
interviewed about their drive and previous sleep/wake patterns, and tested with a reaction 
time test (Philip et al. 1999b). Time of day of testing was controlled for in the analysis. 
These authors found that the duration of driving, the absence of rest stops, and the 
driver’s age were significant predictors of poor reaction time performance.  
 
In an ambulatory EEG study of night driving in long distance truck drivers, Kecklund and 
co-workers reported an increase in drivers’ subjective sleepiness and objective sleepiness 
(as measured by greater alpha and theta EEG burst activity) during the last three hours of 
a night drive (Kecklund and Akerstedt 1993). Regression analyses showed that total work 
hours and total break time predicted 66% of the variance of the alpha burst activity 
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during the end of the drive, suggesting that extended work hours, together with reduced 
break time, were the major factors causing the drivers’ sleepiness.  
 
Similar to the other fatigue promoting factors discussed in previous sections, prolonged 
driving without rest has been shown to be associated with increased MVA rates. Much of 
the evidence for this comes from studies of commercial drivers (Hamerlin 1987;Harris 
1977;Hertz 1988;Jones and Stein 1987;Lin et al. 1994). In one study, using operational 
data from a US national motor carrier, researchers reported that total driving time had a 
greater effect on crash risk among truck drivers than either time of day or driving 
experience (Lin et al. 1994). In another study, Jones and Stein observed that tractor-
trailer drivers who violated logbook regulations (OR=2.6) or who drove more than eight 
hours at a stretch (OR=1.8) were at increased risk of being involved in crashes (Jones and 
Stein 1987). Finally, Hertz found a significantly increased risk of fatal crash involvement 
associated with splitting the required eight hours of rest into two consecutive sessions in a 
sleeper berth (OR=3.0) (Hertz 1988). 
 
1.2.5 Alcohol Consumption 
Alcohol has well known effects on vigilance and attention and there is also strong 
evidence indicating that the vigilance impairing effects of alcohol are exacerbated by 
sleepiness & fatigue.  
 
Studies have shown that during periods of increased circadian propensity to sleep, 
alcohol produces greater impairment in performance than corresponding alcohol levels 
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tested at other times (Horne and Baumber 1991;Koelega 1995). In a study by Horne et al, 
young women with blood alcohol concentrations within the United Kingdom legal limits 
underwent a 40 minute monotonous motorway driving task in the early afternoon 
(increased sleep propensity time) and these results were compared with a six pm drive 
(low sleep propensity time) (Horne and Baumber 1991). Alcohol significantly affected 
performance on this task, especially during the early afternoon.  
 
In another study, subjects who had been sleep restricted (to four hours time in bed the 
night before) and had blood alcohol concentrations of around 0.01, performed 
significantly worse on a driving simulator task in the afternoon than a control group who 
had been similarly sleep restricted, but whom had taken oral placebo drinks (Roehrs et al. 
1994). In other words, in the setting of sleepiness or fatigue, blood alcohol levels well 
below the accepted legal limits are associated with important impairments of driving 
skills. 
 
In a major review of the effects of alcohol on vigilance, Koelega et al extensively 
reviewed the literature in this area, examining 38 studies which compared the effects of 
alcohol and placebo on vigilance tasks (Koelega 1995). These studies showed that the 
main effect of moderate doses of alcohol is on attention and information processing. The 
capacity to divide and sustain attention is already impaired at blood alcohol levels of 0.02 
to 0.03%. The effects of alcohol appeared to some extent time dependant and were 
greatest during periods of sleepiness (the early afternoon and after midnight). This author 
stated that on the evidence from the literature, the blood alcohol standard for driving 
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should be lowered to 0.02% for driving after midnight and for special risk groups (young 
and less experienced drivers).  
 
1.3 Additive Fatigue Effects 
It is clear that many of the above factors that promote driver fatigue are unlikely to 
operate in isolation. Any one driver may be vulnerable to multiple fatigue promoting 
factors, creating an enhanced sleep propensity and road accident risk. For instance –  
 
 both acute and chronic sleep deprivation are very frequent in society and likely to 
co-exist in a driver 
 driving at night may be coupled with driving acutely sleep deprived if an 
individual starts the night drive without sleeping during the preceding day. In this 
situation, the individual’s driver fatigue may be even further increased by 
prolonged driving, if insufficient breaks are made during the night drive 
 driving under the effects of alcohol may be coupled with night time or early 
afternoon (post lunch) driving   
 
Commercial drivers, in particular, are vulnerable to compounded fatigue promoting 
factors. Their schedules usually require them to work long hours, frequently at times 
which conflict with natural circadian rhythms, both acute and chronic sleep debt are 
common (section 1.2.1.3), and there is evidence that they have a very high prevalence of 
sleep disorders (section 1.2.3.5). As an occupational group with a high level of driving 
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exposure, and who operate heavy and dangerous motor vehicles, driver fatigue and the 
additive factors promoting it clearly represent important safety issues.  
 
1.3.1 Additive Effects of Mild OSA and Other Fatigue Promoting Factors 
Just as fatigue associated with prolonged driving or alcohol is enhanced by circadian 
factors (sections 1.2.4, 1.2.5), it is intuitive that OSA should show additive fatigue effects 
when combined with other fatigue promoting factors, such as time of day or sleep 
deprivation. There has been some limited work on the additive effect of sleep deprivation 
and OSA. This has shown that the coincidence of OSA and sleep deprivation may have a 
multiplicative adverse effect on OSA outcomes (section 1.3.2 below). However, the 
interaction of OSA and other fatigue promoting factors has never been studied 
specifically in the context of driving. This issue is very important, particularly for the 
large group of drivers with only mild OSA, who may not be aware of their diagnosis or 
who may not accept treatment. Should patients with mild sleep apnoea avoid driving if 
they have been unable to sleep more than seven hours per night over the preceding 
nights? Should mild sleep apnoea patients avoid night driving all together?   
 
Most patients with mild OSA are undiagnosed and untreated. Since many of these people 
experience few daytime symptoms, they often do not present to doctors and, if they do, 
they may not necessarily be treated; in the medical community, there is debate about the 
importance of treating patients with mild OSA (Engleman H 2002). Most clinicians 
would agree that patients with moderate to severe OSA require treatment, usually with 
nasal CPAP. However, mild OSA patients, who typically have between 5 to 15 
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respiratory events per hour of sleep, have a less disrupted sleep pattern than those patients 
with more severe disease. Advocates of CPAP treatment for mild OSA point to the 
neurocognitive deficits (including sleepiness), the risk of hypertension and the risk of 
MVAs associated with mild OSA (sections 1.2.3.4, 1.2.3.5), while those against CPAP 
treatment for this group are concerned with the difficulties patients have complying to 
nasal CPAP, especially if reported symptoms are minimal, and the huge numbers of 
individuals that would need CPAP treatment if all patients with mild OSA were treated. 
 
Trying to ascertain the added effect of other fatigue promoting factors on driving in mild 
OSA patients will have important implications for advice about driving habits and 
accident risk for this large group of drivers, but will also aid in decisions about therapy 
for mild OSA, especially in the setting of high risk occupational groups such as 
commercial drivers. 
 
1.3.2 The Effect of Sleep Deprivation on Obstructive Sleep Apnoea 
There is a small amount of published work, which shows that sleep deprivation (acute 
and chronic partial) worsens OSA. There are several physiological reasons why this 
might occur. Firstly, breathing responses to hypoxia may be decreased after sleep 
deprivation (White et al. 1983); second, sleep deprivation has been shown to have a 
depressant effect on upper airway dilator muscle activity, which is important in 
maintaining upper airway patency during sleep (Leitter et al. 1985); and finally, sleep 
deprivation subsequently increases REM sleep, where apnoeas are more likely to occur. 
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Some of the earliest published work on sleep disordered breathing noted the deleterious 
effect of sleep deprivation on nocturnal breathing (Guilleminault C. 1980;Lugaresi et al. 
1978;Sullivan C et al. 1984). Sleep deprivation was reported to exacerbate snoring 
(Lugaresi et al. 1978) and increase the frequency and severity of sleep-related obstructive 
breathing disorders in both snorers (Sullivan C et al. 1984) and patients with mild-
moderate OSA (Guilleminault C. 1980). 
 
More recent work has shown that the loss of one night's sleep results in an increase in the 
RDI of OSA patients of over 200% (Persson and Svanborg 1996). Haraldsson and co-
workers have also reported similar results (Haraldsson PO et al. 1992). Furthermore, a 
small pilot study investigating the effect of chronic partial sleep deprivation (reduced 
sleep below normal levels for multiple nights) on OSA revealed an increase in RDI of 
over 50% after six nights of only four hours sleep per night (Stoohs and Dement 1993). 
In addition, this study reported that the minimum oxygen saturation was significantly 
reduced following sleep deprivation. Guilleminault and co-workers have also shown a 
general trend towards longer apnoeic events during sleep and a lowering of blood oxygen 
saturation secondary to apnoeic events following acute sleep deprivation of a small 
number of mild-moderate OSA subjects (Guilleminault C. and Rosekind 1981).  
 
Given the interaction between sleep deprivation and OSA described above, one could 
easily imagine a “self-feedback loop”, in which sleep deprivation would worsen OSA, 
which would, in turn, have a negative impact on nocturnal sleep quality and sleep hours, 
worsening sleep deprivation even further. Hence, the coincidence of OSA and sleep 
 82
deprivation may even have a multiplicative, rather than an additive, adverse effect on 
daytime function, e.g. with respect to driving. 
 
 
 
 
 83
Chapter 2: Methods 
 
The data for the “Commercial Drivers Study” were collected over a 21 month period 
from June 2000 to February 2002 in two groups of NSW transport drivers. One group 
consisted of 1000 transport drivers who were surveyed at their workplace. The other 
group consisted of 61 transport drivers who had detailed testing in a hospital sleep 
laboratory. Data for the “Mild Obstructive Sleep Apnoea Study” were collected over a 10 
month period from February to November 2001 from a sample of 29 subjects. The third 
study consisted of a “Medico-Legal Case Series”. These clinical cases were identified by 
an audit of consecutive referrals to the Sleep Disorders Centres at Royal Prince Alfred 
Hospital (n = 6) and Westmead Hospital (n=1), Sydney, for medico-legal opinions in fall 
asleep road accidents, where the driver who caused the accident survived. This chapter 
describes the research protocols, subjects, data collection instruments, and statistical 
analyses for these studies.  
 
2.1 Commercial Drivers Study 
 
2.1.1 Project Design 
One group of drivers were asked to complete an anonymous questionnaire at their 
workplaces (truck yards and truck stops) by researchers who traveled out to these 
locations. The second group of drivers, who had more comprehensive testing, were tested 
in a hospital sleep laboratory. By testing this second, smaller group of drivers in a more 
detailed fashion, the prevalence of OSA and its effect on driving performance could be 
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determined more accurately for commercial drivers. The administration of the same 
survey to both groups enabled some direct comparisons between the groups to be made. 
In this later cohort, participant anonymity was not possible, but all results were kept 
strictly confidential. These drivers were also compensated for their time and the 
inconvenience of participating in the study.   
  
The full protocol was approved by the Central Sydney Area Health Service Ethics 
Committee (RPA zone), Royal North Shore Hospital Ethics Committee and the 
University of Sydney Ethics Committee. 
 
2.1.2 Subjects 
2.1.2.1 Target Population 
Transport drivers operating in NSW were targeted for this study. Transport drivers could 
include truck drivers, bus drivers and forklift drivers.  
 
2.1.2.2 Eligibility 
Subjects were eligible if they were current drivers, i.e. not retired. Subjects needed to be 
able to understand the study requirements and had to agree to participate. 
 
As the field study was anonymous, there was no record of drivers who had completed the 
questionnaire in the field. Hence, avoidance of multiple questionnaires from individual 
drivers relied on the subjects themselves, when approached, indicating that they had 
previously completed the questionnaire. Drivers with an established diagnosis of OSA 
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were not excluded from the study. However, when studied in the sleep laboratory, they 
were asked to not use any prescribed sleep apnoea treatment (e.g., CPAP or dental 
splints) for several nights prior to presenting to the hospital and on the night of the sleep 
study, so that their OSA severity could be recorded off treatment.  
 
2.1.2.3 Recruitment 
2.1.2.3.1 Field Questionnaire Collection 
The subjects for the field questionnaire were recruited from three sources. Firstly, truck 
yard sites in and around Sydney, which had been selected at random by the NSW 
Transport Workers Union (TWU). Secondly, truck stops in and around NSW, which were 
initially selected at random from a list of major NSW truck stops provided by the NSW 
TWU. After this list was exhausted, additional truck stops that were on major freeways 
and that had a large daily throughput of transport drivers were surveyed. All transport 
drivers who were spending at least 10 minutes at the truck stop (time taken to complete 
the questionnaire) were asked if they would like to participate. Thirdly, drivers were 
surveyed at several large meetings, which occurred periodically throughout the 
recruitment period. One was a yearly delegates meeting of the NSW TWU, where drivers 
from all over the state were represented. Another was a fundraising event in Orange. And 
the third was a fatigue workshop for a large transport driving company within Sydney.  
 
It was initially expected that all the survey data would be obtained from drivers at the 
truck yard sites within NSW, with access to the yards obtained with the help of the NSW 
TWU. Unfortunately, partly due to limited resources within the NSW TWU, it proved 
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very difficult to obtain adequate and frequent access to these yard sites. Rather than 
considerably compromising progress of the study, other drivers were surveyed in the 
broader way outlined above. 
 
2.1.2.3.2 Sleep Study & Driving Impairment Investigation 
The subjects for the sleep laboratory investigations were recruited from a list of transport 
drivers provided by the NSW TWU. This list was generated by them at random from 
their database of members. Specifically, the TWU selected all member drivers that were 
born on a particular day of the year and supplied their names and contact details. In 
batches of twenty, drivers on the list were mailed a letter to their home address, which 
detailed the laboratory testing and asked if they would like to participate. These drivers 
were then telephoned one to two weeks later to discuss the study more fully and gauge 
their interest. However, on some occasions, if the TWU contact details did not include a 
current telephone number, and the driver could not be found through work or a telephone 
directory search, the driver was not contactable; drivers who were not contactable were 
removed from the recruitment list. There could be many reasons for a driver to have not 
been contactable; for instance, the driver may have given insufficient contact details to 
the TWU, moved house, or died. Alternatively, some drivers considered uncontactable 
may merely have been non-responders, choosing not to respond to both the mail out and 
telephone enquiries. 
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2.1.3 Protocol 
2.1.3.1 Field Questionnaire Collection 
Eligible drivers were informed about the study, and if they agreed to participate, written 
informed consent was obtained. Drivers then completed the questionnaire, which 
generally took 10 to 20 minutes. Participants were supervised while completing the 
questionnaire, and were free to ask questions to clarify any parts of the survey that they 
did not understand. After completing the surveys, their height, weight and neck 
circumferences were recorded using portable measuring equipment.  Drivers then placed 
their completed surveys and signed consent forms into separate sealed collection boxes. 
By separating the driver information at this point, driver anonymity and confidentiality 
were assured.  
 
2.1.3.2 Sleep Study and Driving Impairment Investigation 
Enrolled subjects used a sleep diary for the week preceding their arrival in the sleep 
laboratory. Subjects were permitted to maintain their usual caffeine intake in the days 
prior to attending the sleep laboratory. This usual level was recorded in questionnaire 
responses.  
 
On arrival in the sleep laboratory on the Friday evening (seven pm) subjects were 
familiarized with the laboratory and the testing schedule, and their consent was obtained. 
Caffeine products and cigarette smoking were not allowed for the duration of the 
laboratory testing. The drivers then practised the driving simulator test and the 
psychomotor vigilance task (PVT), parts of the subsequent performance testing battery.  
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At 8 pm, the first performance testing battery commenced. This consisted of a 10 minute 
PVT test and then a 30 minute driving simulator test. Upon completion, the drivers were 
set up for their diagnostic sleep study, with lights out at approximately 10.15pm. 
Experienced sleep technologists monitored the patient's sleep study and saved the data for 
subsequent scoring and reporting. The drivers were allowed to sleep until approximately 
5.30 am the next day. All leads were then removed, following which they showered and 
had breakfast. After breakfast, subjects were asked to fill out the same questionnaire that 
had been administered to the drivers surveyed in the field.  
 
At seven am, the performance testing battery was administered for a second time. 
Following this, the subjects’ height, weight, neck circumference, and blood pressure were 
measured and recorded. A urine sample was also taken for a biochemical drug screen. 
Finally, a brief battery of neuropsychological tests was performed prior to the last 
performance testing battery, which commenced between 9-10 am. Generally, all testing 
was finished by 10.30 am. 
 
After the drivers’ diagnostic sleep studies were scored and reported in the following 
week, each driver was contacted by telephone and their results discussed. A follow up 
thank you letter, together with a cheque to compensate for their time and inconvenience, 
was then sent to the driver’s home address. This letter again detailed their sleep study 
results, and recommended that they be discussed with the driver’s GP, who could obtain 
further specialist opinion if necessary. Contact details for specialists trained in Sleep 
Medicine were provided. 
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2.1.4 Data Collection Instruments 
The following questionnaires, tests and other instruments were used to collect the data for 
this study. The field questionnaire is first described, as it was common to both parts of the 
study. The rest of the data collection instruments were used only for the drivers studied in 
the sleep laboratory. They are discussed in the approximate order that they were 
administered. 
 
2.1.4.1 Participant Questionnaires 
The participant questionnaire (Attachment 4) collected information about demographic 
and physical measures, daytime sleepiness, obstructive sleep apnoea, and lifestyle/driving 
details.  
 
2.1.4.1.1 Demographic and Physical measures 
Subjects’ age and postcode were recorded and their height, weight and neck 
circumference were measured. 
 
2.1.4.1.2 Epworth Sleepiness Scale 
To assess the extent to which subjects felt “sleepy” during the day, the Epworth 
Sleepiness Scale (ESS) was used (Johns 1991). This self-reporting scale provides a 
measurement of a subject’s general level of daytime sleepiness. It asks about the chance 
of dozing off or falling asleep in eight different low stimulation situations commonly 
encountered in daily life, e.g. sitting and reading, watching TV, sitting inactive in a 
public place. The subject is asked to rate (from 0 – 3) the likelihood of falling asleep in 
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each circumstance.  A total from 0 to 24 is then calculated, with greater scores correlating 
with increased reported somnolence.  
 
The ESS has been validated against objective sleepiness measures, in particular the 
Multiple Sleep Latency Test (MSLT), in both normal sleepers and those with a range of 
sleep disorders (Johns 1991). It has also been demonstrated to be an effective tool for 
measuring persistent daytime somnolence in adults (Johns 1992). In a community sample 
of 510 Australian workers, normal sleepers (no evidence of a sleep disorder) were found 
to have an mean ESS score of 4.6, with a range from 0 to 10; all subjects with an ESS 
score greater than 10 had evidence of a sleep disorder (Johns and Hocking 1997).  The 
ESS is now used extensively throughout the world in sleep medicine research and a score 
of > 10 is generally accepted to represent excessive daytime sleepiness, i.e. the tendency 
to doze in situations that seldom facilitate dozing in normal subjects (Johns and Hocking 
1997).  
 
2.1.4.1.3 Maislin Questionnaire 
The Maislin Questionnaire and equation were used to identify the presence of OSA in the 
questionnaire survey (Maislin et al. 1995). In the Maislin questionnaire, subjects report 
on the frequency of three symptoms of sleep apnoea – loud snoring, snorting or gasping, 
and breathing cessation. For each symptom, they mark a score from 0 to 4, with a higher 
score representing a higher reported frequency of the symptom. The probability that the 
subject has OSA is assessed by a formula that incorporates questionnaire responses 
together with data on the subject’s age, BMI and gender. In a sleep clinic population, this 
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formula has positive and negative predictive values (definition: see Attachment 3) for an 
RDI > 10 of 75% and 74% respectively (Maislin et al. 1995). The Maislin equation has 
been shown to perform similarly to other clinical prediction formulas used in sleep 
medicine research (Rowley et al. 2000). It is more accurate when used in a male 
population, compared with a female population (Rowley et al. 2000). The Maislin 
questionnaire has also been recently used in a large US prevalence study of OSA in 
commercial drivers, where it was used to stratify drivers into high and low risk groups for 
OSA, prior to polysomnography (Pack et al. 2000a). 
 
2.1.4.1.4 Lifestyle and Driving Details 
Questions were asked about usual sleep and work routine, type of driving (e.g., interstate 
or metropolitan, rotating shifts or otherwise), alcohol/caffeine intake and motor vehicle 
accident history. Participants were also asked to list any medical illnesses they suffer 
from, any medications they were taking (including those taken to improve alertness while 
driving) and whether they had had any treatment for OSA.  
 
2.1.4.2 Sleep Diary 
A sleep diary was sent to all subjects studied in the sleep laboratory prior to their hospital 
testing. Subjects were asked to complete the sleep diary for seven days before their 
hospital attendance. The sleep diary sought subjective information about each day’s work 
and sleep hours. Any daytime naps could also be recorded on the sleep diary. Sleep 
diaries have been shown to correlate well with objective sleep measures (Lacks 1988). 
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2.1.4.3 Psychomotor Vigilance Task 
The Psychomotor Vigilance Task (PVT) measures vigilance (sustained, focused 
attention) in terms of the time taken to react to a stimulus. The test is a 10 minute reaction 
time test, which is paced (outside the control of the subject), non stimulating, repetitive, 
measurable, standardised, and relatively lengthy. It provides data on various reaction time 
(RT) outcomes (e.g. mean RT, median RT, standard deviation of RT) and records errors 
(occurrences of false-starts on depressing the button, the use of the 'wrong' button, or 
holding the button down for more than three sec) and lapses (reaction times at least 
500ms in duration).  The lapse count is transformed (square root (x) + square root (x+1)) 
for analysis to remove zero scores and normalise the distribution. Previous studies have 
shown that PVT performance deteriorates with increasing sleepiness, and it can therefore 
be used as a means of gauging the effects of sleep deprivation or impaired sleep quality 
on performance (Chugh et al. 1998;Dinges et al. 1997).   
 
2.1.4.4 AusEdTM Driving Simulator 
The Australia Edinburgh (AusEdTM) driving simulator measures several cognitive skills 
important for driving; it is a test of tracking ability (through steering accuracy), a 
vigilance task (requiring sustained attention over 30 minutes), a divided attention task 
(through speedometer placement – see below), and a reaction time test. 
 
A standardised 30 minute run on the AusEdTM Driving Simulator was performed 
subsequent to each PVT test. The AusEdTM driving simulator is designed to simulate a 
monotonous night time drive on a rural road. In this way the driving environment of the 
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simulator is very conducive to driver fatigue.  Most other simulator programmes have 
used more stimulating protocols to assess driving performance and associated sleepiness.  
 
The AusEdTM driving simulator evolved as a joint research project between the Sleep 
Units of St Vincents’ Sleep Disorders Service and Royal North Shore Hospital in Sydney, 
Australia, and the Respiratory and Sleep Research Unit at the Royal Infirmary in 
Edinburgh, Scotland. Research and development of the AusEd driving simulator began in 
1998 and a multi-centre validation study is presently underway.  
 
The driving simulator was installed on a Windows NT workstation in a sound-insulated 
room in the Sleep Laboratory, with a 21" computer screen, a Thrustmaster T2 steering 
wheel and pedals (Hillsboro, Oregon, USA) and dual stereo computer speakers. A full 
screen projection of the view from the driver's seat of a truck is provided, along with a 
small speedometer in the upper left hand corner of the screen (see figure below).  The 
simulator is controlled using acceleration and brake pedals and the steering wheel.  The 
drive takes place on a dual carriageway highway at night, with forward vision limited to 
"low beam" lights.  During practice sessions the lights in the room remained on, whereas 
during the 30 minute tests, the lights were switched off.  There are no other motor 
vehicles on the road, apart from ten slowly moving trucks, which appear during each 30 
minute drive, traveling in the same direction as the subject.  There are no traffic signs or 
markers apart from regularly placed reflective markers on both edges of the road, similar 
to rural roads in NSW.  A continuous, low frequency, approx. 60 dB simulated engine 
noise is played through the computer speakers for the length of the drive.  For the 
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purpose of this study, 5/7 of the road was straight while 2/7 of the road consisted of 
chicanes.  The layout of the road and time of presentation of the trucks was identical for 
each drive.           
Figure 9 AusEdTM driving simulator view 
This figure shows the subject’s view of the road using the AusEdTM driving simulator.  In 
the top left hand corner is the speedometer. The background on the screen is black (to 
simulate night time). The markers at the side of the road and line markers in the centre of 
the road are white and easily visible.  
NB: subjects in the present study did not have EEG monitoring whilst using the simulator 
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The AusEdTM driving simulator assesses driving ability using four separate measures: 
velocity deviation, steering deviation, crashes and reaction time.  
  
 velocity deviation: subjects are instructed to keep their speed between 60 to 80 
kilometres per hour, using the speedometer as a guide.  As the speedometer lies 
outside of the line of sight for the road, this also represents a divided attention 
task.   
 
 steering deviation: subjects are instructed to stay as close to the middle of the left 
hand lane as possible for the duration of the drive.  In accordance with standard 
road width in New South Wales, each lane on the simulated road is 360 
centimetres wide.  An additional shoulder of 340 cm is provided on either side of 
the road (see figure below).  
 
 crashes: crashes were registered under three conditions:  (1) driving off the 340 
cm limit of either shoulder of the road, (2) hitting the back of a truck and (3) 
remaining stationary for more than 10 seconds.   
 
 reaction time: subjects were instructed to press the brake pedal towards the floor 
as quickly and firmly as possible whenever a truck appeared in the distance.  The 
time to do this was automatically recorded by the computer as the reaction time, 
with 10 truck presentations (reaction times) in total for each 30 minute drive. 
Computer scored reaction times were later manually checked and any necessary 
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corrections made using customized software, prior to calculating final reaction 
time outcomes. 
 
To minimize practice effects, all subjects underwent a five minute practice run on the 
Friday evening prior to their first driving simulator test bout. In addition, the first six 
minutes of every 30 minute drive was not included in the analysis of driving simulator 
outcomes.  
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Figure 10 The road layout of AusEdTM 
 
 
2.1.4.5 Polysomnography 
A supervised overnight sleep study in a sleep laboratory is the gold standard test to 
measure obstructive sleep apnoea and other sleep disorders accurately. It is a time 
consuming and expensive test, which requires very specialised equipment and highly 
trained staff. Over 15 recording leads are attached to each subject and channeled through 
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overhead cabling to a nearby monitoring room, where night staff supervise the collection 
and recording of multiple physiological variables while the subject sleeps. 
 
2.1.4.5.1 Polysomnography Setup 
A standard sleep study (polysomnography) setup was used for all subjects.  The EEG 
placement was according to the 10-20 system with four electrodes attached to the scalp 
(C3, O2, A1 and A2), two eye electrodes (EOGL & EOGR), and two chin or submentalis 
leads (EMG).  There were also two ECG leads, one near the right shoulder and a second 
ECG lead in the sixth intercostal space on the left hand side of the chest.  Sensor leads 
were placed on each leg over the anterior tibialis for recording any leg movements. 
Breathing was monitored by a nasal pressure transducer in all studies and in some studies 
an oral-nasal thermistor (triple thermistor) was additionally added. Inductive Respiratory 
Effort Bands were placed around the chest and abdomen to monitor thoracic and 
abdominal wall movement. A position sensor was attached to monitor body position 
during sleep. A finger probe oximeter recorded the subject’s oxygen saturation 
continuously. Specialised computer software (Compumedics, Melbourne) was used to 
acquire, store and analyse the sleep study data collected. 
 
2.1.4.5.2 Polysomnography Scoring 
One experienced sleep technician scored all sleep studies.  
 
Sleep stages were scored according to Rechtschaffen & Kales criteria (Rechtschaffen and 
Kales 1968), defined as: 
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  1: Low voltage mixed frequency with or without slow rolling eye   
 movements. 
 2: Presence of spindles or K-complexes. 
  The absence of the above excluded epochs from Stage 2. 
 3: Presence of > 20% and <50% delta waves per epoch. 
 4: Presence of > 50% delta waves per epoch. 
 REM:  Low voltage mixed frequency, reduction in chin EMG signal, and fast eye 
movements on the EOG  
 
Arousals were scored according to the Atlas Task Force of the American Sleep Disorders 
Association (Atlas Task Force of the American Sleep Disorders Association 
(ASDA).Guilleminault C 1992); arousals were defined as a > 3 second change in EEG 
sleep state with an increase in chin EMG.  
 
For scoring of respiratory events, thoracic and abdominal bands and nasal 
pressure/thermistor were used as measures of breathing. Apnoeas and hypopnoeas were 
defined as: 
 Apnoea - cessation of airflow for > 10 seconds (with or without a three percent 
oxygen desaturation or arousal) 
 Hypopnoea – clear reduction (>20%, compared with the baseline over the 
preceding two minutes) in one of the measures of breathing during sleep for > 10 
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seconds in association with a > 3% oxygen desaturation or an EEG arousal (or 
both). 
 
In addition, snoring or flattening in the nasal pressure trace terminating in an arousal was 
scored as a sub-criterion respiratory event. These were not included in the total RDI, but 
formed part of the total arousal index (AI) score. 
 
2.1.4.6 Urine Drug Screen 
In order to assess whether subjects studied in the sleep laboratory had taken any 
substances that might influence their performance in the testing battery, they had a urine 
screen for a wide range of prescription and illicit drugs including benzodiazepines, 
barbiturates, anti-depressants, anti-psychotics, amphetamines, opiates and ephedrine.  
 
2.1.4.7 Neuropsychological Measures 
Several neuropsychological tests were administered to determine the effect of OSA on 
cognitive outcomes in transport drivers. Each test is discussed below and presented in the 
order that it was administered. This whole sequence of neuropsychological tests took 
approximately 40 minutes to complete. Test administration was limited to two 
researchers in order to minimise variation attributable to the multiple examiners.  
 
The neuropsychological tests were used to specifically assess language skills (Word 
Fluency Test), psychomotor speed (Trail Making Test), executive function (Stroop Test), 
short term memory (Digits Forward), working memory (Digits Backward), and general 
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intellectual ability/IQ (Shipley Institute of Living Scale). Each of these tests has been 
used previously to demonstrate cognitive deficits in sleep apnoea patients (Decary et al. 
2000;Greenberg et al. 1987;Weaver 2001). 
 
2.1.4.7.1 Word Fluency/Controlled Oral Word Association (COWAT) 
The controlled oral word association test (COWAT) is predominately a test of verbal 
knowledge. It is a timed test requiring reasonable verbal agility.  The subject is presented 
in turn with three consonants: F, A & S.  They are given 60 seconds to call out as many 
words as possible starting with the given letter.  Proper nouns, perseveration and words of 
like structure (e.g. run and ran, eat and eating) are scored correctly for the initial word 
only. 
 
A normative value is derived from age-matched totals for the sum of the three trials.  The 
test has been demonstrated by Axelrod et al to be unrelated to intellectual competence, 
educational experience or general health status of the subject, although there is age 
related decline (Axelrod and Henry 1992).   
 
2.1.4.7.2 Trail Making Test 
Trail making tests part A and B are timed tests of visual tracking and sequencing. 
 
 Part A:  the subject is instructed to join numbered circles in ascending order e.g. 1 
to 2, 2 to 3, 3 to 4, etc.  The circles are spread across the page in random order, 
but in such a manner that no lines are ever crossed.  Time from start to completion 
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is recorded and normal values are derived from controls matched for age and level 
of education. 
 
 Part B:  Follows a similar paradigm to the first part to the test but incorporates an 
added task of mental dexterity.  The subject is required to join the circles in 
sequence. However, they must simultaneously progress through a concurrent 
alphabetic process i.e. 1 to A, A to 2, 2 to B, B to 3, etc.  Normal values are 
derived for age and level of education from tabular data (Smith 1982). 
 
Trails B is deemed harder since it demands greater levels of motor speed and visual 
search (Gaudino et al. 1995).  Furthermore, it is more closely associated with visual non-
verbal intelligence than with attention information processing.  For subjects of average or 
higher intelligence, test performance is independent of intellectual ability (Waldmann et 
al. 1992) and demonstrates good inter-rater variability (Fals-Stewart 1992). 
 
2.1.4.7.3 Stroop 
The Stroop test measures the ease with which a person can shift his or her perceptual set 
to conform to changing demands and suppress a habitual response in favour of an unusual 
one. In other words, it measures cognitive flexibility, a component of cerebral executive 
function. Stroop originally developed this test in 1935 (Stroop 1935), but since then 
others have made minor modifications.  
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The Stroop test consisted of three white sheets of paper (A4 size), each containing 20 
rows of five items. There were three parts to the test: 
 
 In part 1, the subject was instructed to read colour names (blue, green, red, 
yellow) printed in coloured ink (blue, green, red, yellow), ignoring the colour of 
the print (the print colour never corresponded to the colour name).  
 
 In part 2, the subject was instructed to name the colour of the ink (blue, green, 
red, yellow) that was used to print “XXXX” on the page.  
 
 In part 3, subjects were presented with a sheet similar to that used in part 1. In this 
part, however, they were asked to name the colour of the ink the words were 
printed in, ignoring the word that was actually printed.  
 
Of major interest in the Stroop test is the subject’s behaviour when presented with 
coloured words printed in non-matching colours. Stroop reported that normal people can 
read coloured words printed in coloured ink as fast as when the words are presented in 
black ink. However, the time to complete the task increases significantly when the 
subject is asked to name the colour of the ink rather than read the coloured word. This 
decrease in colour-naming speed is called the “colour-word interference effect” (Stroop 
1935).  
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For each part, the subject was asked to stop after 45 seconds, or when they had completed 
the page, whichever took longer. Their scores for each page were then age corrected (Das 
1970), and a predicted colour word score was subtracted from the raw age corrected 
colour word score to determine the colour-word interference effect. 
 
The Stroop test has been studied in psychiatric and brain damaged patients. The test is 
fairly effective in distinguishing between normal controls and brain damaged patients and 
between psychiatric and brain damaged samples (Golden 1976). Impairment on the 
Stroop may relate specifically to frontal lobe damage (Perret 1974). 
 
2.1.4.7.4 Digits Forward and Digits Backward 
Digitspan forward is a test of immediate numerical recall (Wechsler 1981b).  The subject 
is given a series of numbers of increasing length (3 - 8 digits).  They are required to retain 
the sequence and repeat it in exactly the same order.  Two different sequences are 
presented at each length.  The score is derived by the total correct (out of 12) and the test 
terminated once an incorrect sequence has been given at both presentations of a given 
digit length.  Normative scoring for age is then calculated (Wechsler 1981b). 
 
The reverse presentation of digitspan is a test of numerical short term memory and 
attention (Wechsler 1981b).  The subject is presented with a series of single digit 
numbers of progressively increasing length, ranging from two to seven digits.  They are 
required to remember the numbers as presented and call them back to the instructor in 
exactly the opposite order.  For each digit length they are given two trials.  The test is 
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terminated when an incorrect answer is given for both trials of a given length.  A total out 
of 12 is calculated and normal values derived from age-matched tables (Wechsler 1981b). 
 
The test has been demonstrated to be age sensitive in patients over 60 years, possibly due 
to a decreased flexibility in processing changes (Dobbs and Rule 1989).  This needs to be 
considered when using the test in older patients.  
 
2.1.4.7.5 Shipley Institute of Living Scale 
The Shipley Institute of Living Scale (SILS) is a test of general intellectual ability / IQ. 
There are three components. 
 
 Vocabulary component of the Shipley Institute of Living Scale  
 Abstraction component of SILS 
 Estimated WAIS full scale IQ from SILS 
 
The vocabulary component of the SILS is an untimed word matching test.  The subject is 
given a key word and asked to find the appropriate synonym from four given choices.  
Forty words are presented and a score calculated from the total of correct answers.  A t-
score is then derived from the accompanying text manual (Zachary 1991) as corrected for 
age.  Vocabulary as a fixed measure of intellectual ability is generally recognised to be 
unimpaired by cognitive insult, thus the derived Vt was used as a regression covariable to 
control for general intellectual ability across all other cognitive measures.   
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The abstraction component of the SILS is a 10 minute timed test of problem solving.  The 
subject is given a series of words, letters or numbers followed by blank spaces.  They are 
instructed to examine the pattern of the preceding series in order to complete the solution.  
A total of 20 puzzles are given with an instruction to attempt all problems in the time 
allocated.  The total of correct answers is used to derive a t-score from normal tables for 
age-matched controls.  A further sub-analysis is possible using predicted values for the 
test based on the level of education and the Vt.  This is used to derive the abstraction 
quotient again from the normed tabular data.   
 
The WAIS full-scale IQ is calculated from the sum of the t-scores for vocabulary and 
abstraction using normal tables published with the manual for the test.  The use of this 
test as a comparable measure of IQ has been validated by Dalton particularly for grouped 
data (Dalton et al. 1987). 
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2.1.5 Statistical Analysis 
Maislin score, Epworth Sleepiness Scale, and number of accidents were analysed as both 
continuous variables and dichotomized (binary) variables. For the binary analysis of 
Maislin scores, a threshold of 0.5 was used as recommended by the authors of this 
instrument (Maislin et al. 1995) for a diagnosis of OSA. An ESS score > 10 was used to 
define pathological daytime sleepiness (Johns 1991). Two thresholds were used for the 
analysis of number of accidents:  1, as an indicator of any accidents, and 2, as an 
indicator of multiple accidents. RDI was analysed as a continuous, dichotomised or 
categorical variable in separate models. Two alternative RDI thresholds were used to 
identify the presence of OSA: RDI > 5 and RDI > 10 (American Academy of Sleep 
Medicine Task force 1999). In further analysis, the RDI was categorised as absent, mild, 
moderate and severe with cut-points at values of 5, 15, and 30 (American Academy of 
Sleep Medicine Task force 1999). Lifestyle and work variables that were measured on a 
continuous scale were dichotomised at cut-points selected to represent clinically relevant 
risk factors for driver fatigue. Some risk factors (such as night driving or interstate 
driving) were naturally dichotomous. BMI and age were analysed as continuous 
variables. Two alternative criteria were used to define sleep apnoea syndrome: RDI > 5 
with Epworth > 10, and RDI > 10 with Epworth > 10.   
 
All neurocognitive outcomes were adjusted for age and level of education. Oral word 
fluency, Digits forward and backward, and Trails A and B were all transformed to a 
normal distribution, with results expressed as Z scores, representing the extent of 
deviation from expected values. The transformed interference score was used for Stroop 
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analysis. IQ was calculated using Shipley’s Institute of Living Scale (SILS), and the SILS 
vocabulary T score (Vt) was used to control for the effect of general intellectual ability in 
the analysis of the neurocognitive tests.  
 
The value of the Maislin score as a test for OSA was evaluated in this study population 
by constructing an ROC curve in which the sensitivity at various cut-points was plotted 
against the 1 - the specificity at those same cut-points (Sackett Dl et al. 1991). Likelihood 
ratios were calculated for four ranges of the Maislin score as the ratio of the proportion of 
people with RDI > 10 who had a Maislin score within the prescribed range to the 
proportion of people with RDI < 10 who had a Maislin score in this range. The likelihood 
ratio represents the extent to which the prior odds of an individual having RDI > 10 are 
increased (if the LR is greater than one) or decreased (if the LR is less than one) by the 
given Maislin score (Sackett Dl et al. 1991) (see Attachment 3). 
 
Hypothesis testing was undertaken using generalised linear modeling with concurrent 
estimation of effects and their 95% confidence intervals. Effects were expressed as 
means, ratios, differences or odds ratios, as appropriate. Univariate tests and estimations 
of differences between groups were performed using analysis of variance. In cases where 
the measurements were made at different times of the day in the same individuals, a two 
way analysis of variance was implemented to test for diurnal variation in the effects. Age 
was introduced as a covariate in some of these analyses. The effects of multiple potential 
predictors, adjusted for each other, on the outcomes of interest were tested using multiple 
regression. Linear regression was used for outcomes measured on a continuous scale and 
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the logistic regression was used for outcomes measured on a binary scale. A stepwise 
selection procedure was used to identify the final best predictive model. This procedure 
was implemented with the threshold for variable entry set to 0.05 and the threshold for 
variable removal set to 0.10. 
 
For the drivers studied in the sleep laboratory, sample size calculations were performed 
mid way through data collection. These suggested that 60 drivers needed to be studied to 
detect performance decrements due to sleep apnoea. For this reason and partly for 
convenience, data collection for this part of the study was terminated after the 61’st 
participant. 
 
The data analysis described above was undertaken using the SPSS statistical package 
10.0.05 (SPSS Inc., Chicago).  
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2.2 Mild Obstructive Sleep Apnoea Study 
This project involved intensive experimental work on 29 subjects, consisting of a group 
with mild OSA and a group of controls. Each subject was tested continuously for 
between 24 to 36 hours on two separate occasions.  
 
2.2.1 Project Design 
Every subject was tested over two weekends. The testing performed on one weekend was 
under normal sleeping conditions (“baseline testing”) while the testing on the other 
weekend was after 36 hours of acute total sleep deprivation (SD). The order of weekend 
testing was balanced with approximately half of the subjects of each group (mild OSA 
and controls) tested under baseline conditions as their first weekend of testing, and 
approximately half of the subjects tested under SD conditions as their first weekend of 
testing. Subject choice and convenience for the most part determined whether subjects 
did their baseline or SD weekend first. Generally, the second weekend of testing was 
within two to four weeks of the first weekend of testing. Subjects were instructed to 
obtain at least eight hours sleep per night for the four nights preceding each weekend of 
testing to minimize any pre-existing sleep debt at the start of a weekend’s testing. Sleep 
hours for these four nights preceding each weekend were also measured objectively using 
actigraphy and sleep diaries. 
 
Given the nature of the testing, it was impossible to “blind” either the subjects or 
researchers to the order of weekend testing or testing conditions (baseline or SD). 
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However, all the sleep studies were scored by an experienced technician who was blinded 
to the patient’s status.  
 
Subjects were compensated for their time and the inconvenience of participating in the 
study.  The protocol was approved by the Central Sydney Area Health Service Ethics 
Committee (RPA zone) and the University of Sydney Ethics Committee, and informed 
consent was obtained from each patient.  
 
2.2.2 Subjects 
2.2.2.1 Target Population 
Subjects with mild OSA and control subjects with no OSA were sought. Men were 
studied exclusively for several reasons: mild OSA is much more common in men; there is 
very little evidence of increased driving accident risk in women with mild OSA; and 
finally, to avoid known gender differences in some aspects of performance.  
 
2.2.2.2 Eligibility 
Subjects were eligible if they were of driving age (18 to 70 years), held a current N.S.W. 
driver’s license, and drove regularly. Subjects needed to be free of significant 
cardiorespiratory disease, or other medical conditions that might affect their ability to 
perform the experimental protocol adequately and safely (e.g. narcolepsy, epilepsy). 
Subjects were ineligible if they were taking any medications that might affect daytime 
alertness, such as antidepressants or benzodiazepines, or if they were currently being 
treated or had had previous treatment for OSA. Subjects were excluded if they were 
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taking any illicit substances, such as amphetamines or were heavy drinkers (regular 
alcohol consumption greater than 40 gm per day). Subjects needed to be able to 
understand the requirements of the study and had to agree to abide by the study 
conditions. 
 
2.2.2.3 Recruitment 
Subjects were recruited from three sources. Mild OSA patients were identified in 
specialist consulting rooms or outpatient departments and then invited to participate, or 
alternatively, they were identified through an audit of recent sleep study results from 
Royal Prince Alfred Hospital Sleep Investigation Unit. Controls were recruited from 
these same sources and also from advertising among university students.  In this way, 
some of the controls, although not age-matched, would be free of clinic selection biases.  
 
Although many of the subjects had had previous diagnostic sleep studies, classification of 
subjects as having mild OSA or no OSA (i.e. control status) for this study was made on 
the basis of their baseline weekend’s sleep study result. Subjects were regarded as having 
mild OSA if their total RDI was > 5, but < 30 events/hr. Controls had a total RDI < 5 /hr. 
 
2.2.3 Protocol 
The protocol is described in the figure below. All testing was performed on weekends 
(Friday evening to Sunday morning), when the sleep laboratory was for the most part 
free, to create a stable testing environment and to minimize any distractions during the 
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testing procedures. Where possible, subjects were also tested in pairs in order to increase 
motivation and thereby decrease sleepiness and boredom.  
 
Subjects used a sleep diary and an actigraph for the four nights preceding their arrival in 
the sleep laboratory. Subjects were permitted to continue their usual caffeine intake in the 
days prior to attending the sleep laboratory. This usual intake was recorded in responses 
to the questionnaire.    
 
On arrival in the sleep laboratory on the Friday evening (six pm) subjects were briefed 
about the laboratory and the testing schedule, their consent was obtained and, while they 
had their evening meal, they completed a questionnaire. Caffeine products and cigarette 
smoking were not allowed for the duration of the weekend testing. Soon after completing 
dinner, the subjects were familiarized with and practiced the three main instruments of 
the testing battery (Neurobehavioural Assessment Battery (NAB), AusEDTM Driving 
Simulator, and Oxford Sleep Resistance Test (OSLER)), and then at seven pm they 
commenced their first run of the testing battery. The order within the testing battery was 
NAB, driving simulator, and finally OSLER.  Each testing battery took approximately 1 
hour and 45 minutes to complete.  
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  Figure 11: Flow chart of study protocol 
 
Weekend 1 or 2 complete
Subjects return home with 2 to 4 week washout
before final weekend of testing
Saturday Testing
Testing battery repeated throughout the day:
0700; 1100; 1500; 1900
Urine drug screen
Weekend 1 or 2
Full nights sleep, monitored by polysomnography
Weekend 1 or 2 complete
Subjects return home with 2 to 4 week washout
before final weekend of testing
Saturday testing
Testing battery repeated throughout the day:
0300; 0700; 1100;1500; 1900; Urine drug screen
Full nights sleep, monitored by polysomnography
Weekend 1 or 2
no sleep, supervised by sleep laboratory staff
Arrive sleep laboratory 6 pm Friday
Sign consent, Complete questionnaire
Practise testing battery: NAB, driving simulator, OSLER
7 pm - Commence first testing battery
Baseline and SD weekends
Actigraphy and Sleep Diary for 4 nights prior to laboratory testing
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After the seven pm testing battery was complete, the subjects who were undergoing their 
baseline weekend of testing were then set up for overnight polysomnography. Lights out 
was at approximately 10.15 pm, and the subjects slept, while being monitored, until 
approximately six am. Subjects then showered, had breakfast (no caffeine), and 
commenced their next testing battery run at seven am. The testing battery was again 
repeated at 11 am, 3 pm, and finally at 7 pm. A urine sample was also obtained from the 
subjects on the Saturday for laboratory analysis. The baseline testing weekend concluded 
after the completion of the seven pm testing battery, at approximately nine pm.  
 
Subjects who were being sleep deprived were not set up for polysomnography on the 
Friday night, but instead stayed up awake overnight. They were supervised by sleep 
laboratory staff at all times to ensure they did not sleep. The testing battery was repeated 
at 3 am, 7am, 11am, 3pm, and 7 pm. A urine drug screen was also collected. On Saturday 
evening, these subjects were set up for polysomnography, and a sleep study performed on 
their overnight sleep. There was no formal testing after the subjects awoke on Sunday 
morning, and they were then free to make their way home.  
 
A television, computer, videocassette player, DVD player, and video game playstation 
were available for the subjects’ entertainment for both testing weekends. Subjects were 
also free to bring in any other reasonable form of activity, such as reading material or 
academic work. They were not, however, permitted to exercise or drink alcohol. At all 
times subjects were under the close supervision of research staff to ensure they complied 
with the protocol conditions. 
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2.2.4 Data Collection Instruments 
The following questionnaires, tests and other instruments were used to collect the data for 
this study. They are discussed in the approximate order that they were administered. 
Some of the tools used were common to the Commercial Drivers Study, and these have 
not been reviewed again. 
 
2.2.4.1 Actigraphy 
Actigraphs are small electrical devices that look similar to and are worn like conventional 
wrist watches on the non-dominant wrist. They sense and record limb movements over a 
selected threshold using an acceleration sensor (accelerometer). Analysis of actigraphy 
data for the assessment of sleep is based on the principle that fewer limb movements 
occur during sleep than during wakefulness.  
 
Many researchers have substantiated the accuracy of estimating total sleep time using 
actigraphy (Cole et al. 1992;Mullaney et al. 1980;Shinkoda et al. 1998;Stanley et al. 
2000). As early as 1980, Mullaney and co-workers demonstrated that actigraphic data 
could provide a reliable and valid differentiation between sleep and wakeful states 
(Mullaney et al. 1980). They reported a 94.5% agreement between actigraphic data and 
polysomnographic scoring. This is only slightly lower than the usual inter-rater reliability 
of polysomnographic scoring. More recent research in a sample of 41 subjects, including 
some with sleep disorders, found that, compared to overnight polysomnography, 
actigraphy correctly distinguished sleep from wakefulness approximately 88% of the time 
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(Cole et al. 1992). Another recent study has found an agreement of 97% with 
polysomnographic scoring (Shinkoda et al. 1998) . 
 
Actigraphy has a number of advantages when compared with overnight 
polysomnography or sleep EEG. Most importantly, it is far less expensive, less 
technically demanding and can used in the home. However, of course it does not give 
nearly as much information as conventional PSG, in particular it gives no information 
with respect to sleep disordered breathing.  
 
Mini-Mitter Actiwatches (AW64 series) (Cambridge Neurotechnology Cambridge 
U.K/Mini-Mitter, Sunriver, Oregon, USA) were used in this study.  The Actiwatch has a 
large memory capacity and can be worn for many days continuously. Subjects were asked 
to wear the Actiwatch on their non-dominant wrist for the four nights and days prior to 
their presentation to the sleep laboratory. In addition, they were asked to press the round 
event marker on the front of the watch at the time of significant sleep/wake events, such 
as getting into bed, attempting sleep, waking in the middle of the night, and waking in the 
morning. When the subjects presented to the sleep laboratory on the Friday evening, the 
actigraphs were collected and their data downloaded into a PC, where it was then 
manually scored for sleep with reference to the subjects’s sleep diary. 
 
2.2.4.2 Sleep Diary 
A sleep diary was sent to all subjects prior to their weekend testing periods. Subjects 
were asked to complete the sleep diary each morning for the four mornings before their 
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sleep laboratory attendance. The sleep diary sought subjective information about the 
previous nights sleep, such as the estimated time of getting into bed, turning off the light 
and attempting sleep, any known wake periods during the night and final time of 
awakening and getting up in the morning. Any daytime naps could also be recorded on 
the sleep diary. Sleep diaries have been shown to correlate well with objective sleep 
measures (Lacks 1988). 
 
The sleep/wake information from the sleep diary was compared with the recorded data 
obtained from the Actiwatch and using both this subjective and objective sleep data, the 
subjects previous nights’ sleep hours were accurately estimated. 
 
2.2.4.3 Participant Questionnaires 
Two different questionnaires were used, depending on which weekend of testing the 
subjects were attending. The main questionnaire (Attachment 5) was given when the 
subjects presented for their first weekend of testing, regardless of whether this was under 
baseline or SD conditions, whereas the one page additional questionnaire (Attachment 6) 
was given when the subjects attended their second weekend of testing.  
 
The main questionnaire collected basic physical and demographic information, 
information regarding caffeine intake, driving and lifestyle, and also included the 
Epworth Sleepiness Scale. The second questionnaire documented recent caffeine intake 
and any changes in weight. 
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2.2.4.3.1 Demographic and Physical Measures 
Subjects’ age was recorded and their height, weight and neck circumference were 
measured at the initial assessment. Weight was re-measured on the second testing 
occasion, to allow adjustment for any significant change in weight over the interval 
between tests.   
 
2.2.4.3.2 Caffeine Intake 
Questions were asked about the subject’s usual caffeine intake (tea, coffee, cola) in the 
main questionnaire. Additional questions were asked about the amount of caffeine 
containing products the subject had had on each Friday of their testing weekends, to 
control for the possible influence of caffeine on alertness, which may in turn have 
affected their performance on the testing battery that Friday evening. 
 
2.2.4.3.3 Epworth Sleepiness Scale 
See discussion above  
 
2.2.4.3.4 Lifestyle and Driving Details 
In the main questionnaire, questions were asked about average sleep hours, occupation, 
alcohol intake and motor accident history. Subjects were also asked to list any medical 
illnesses they suffer from, any medications they were taking and whether they had had 
any treatment for OSA. These later questions were particularly important to re-confirm 
eligibility criteria. 
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2.2.4.4 Neurobehavioural Assessment Battery (NAB) 
The computerized Neurobehavioural Assessment Battery (D. Dinges, U Penn, USA) was 
selected as it has been shown to be sensitive to performance and mood changes in studies 
of total (Dinges et al. 1994;Kribbs and Dinges 1994) and partial sleep deprivation 
(Dinges et al. 1997). Further, being a PC based battery, it is administered in a fixed and 
reproducible way, free from potential biases that are possible with human administration 
of cognitive tests.  
 
The NAB includes the Stanford Sleepiness Score (SSS), Karolinska Sleepiness Score 
(KSS), Effort to Stay Awake (ESA) questionnaire, Profile of Mood States (POMS) 
questionnaire, Psychomotor Vigilance Task (PVT), Probed Recall Memory test (PRM), 
Serial Addition /Serial Subtraction test (SAST), Adjective Check List (ADCL), Digit 
Symbol Substitution Task (DSST), Time Estimation Task (TET), and visual analogue 
responses to questions on mental and physical exhaustion (VAS).  At the start of the 
computerized battery, subjects are presented with subjective questionnaires of sleepiness, 
including the Effort to Stay Awake questionnaire, the SSS and the VAS.  Performance 
testing then commences after these questionnaires and consists firstly of the SAST, which 
assesses the accuracy and speed of basic mathematical calculations, followed by the 
Word Presentation component of the PRM.  This is separated from the Word Recall 
component of the PRM by a 10 minute run of the PVT.  The PRM involves the 
memorisation of six pairs of unrelated words in a 30 second period and subsequent recall 
of word pairing 10 minutes later.  The PVT is a basic reaction time test, which involves 
pressing a button when numbers begin counting on the computer screen. The second part 
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of the PRM is followed by the Adjective Checklist, a subjective measure of current 
emotional state, the Digit Symbol Substitution Task, which assesses response times and 
error rates on a simple psychomotor task, and the Time Estimation Task, which involves 
estimating time of presentation of a visual stimulus.  Finally, subjects complete a 
computerised version of the POMS, another survey of emotional state, and the Subjective 
Effort Questionnaire (SEQ), where subjects rate their own perceived performance on the 
NAB.   
 
For technical reasons, the NAB is best administered in a fixed fashion from start to finish. 
The whole automated battery usually takes between 30 to 40 minutes to complete. The 
NAB was administered in its entirety in this way for each testing session in this study. 
However, analysis of NAB outcomes was limited to the PVT, DSST, PRM, SSS and 
POMS tests. This was done in order to focus on the NAB outcomes that were most 
relevant to the objectives of this project and, hence, to reduce the risk of Type 1 error in 
the data analysis. 
 
2.2.4.4.1 Psychomotor Vigilance Task 
See discussion above 
 
2.2.4.4.2 Digit Symbol Substitution Task 
The Digit Symbol Substitution Task (DSST) of the NAB is a computerized test of 
attention based on the pen and paper version from the standardized Wechsler Adult 
Intelligence Scale Revised (WAIS-R), of which there is normative data available 
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(Wechsler 1981a).  The original version presented a table of nine line symbols with 
associated numbers, followed by 175 boxes, each containing a number from one to nine.  
The subject was instructed to draw the symbol associated with that number into the box.  
The NAB computerized version has inverted the task by showing all the symbols with 
associated numbers and then presenting stimulus symbols, one at a time, and asking the 
subject to type the associated number.  As soon as a response is made a new symbol is 
presented.  The same symbol will not be presented twice in succession. An initial practice 
period of 15 seconds is allowed in every presentation of the DSST, in which no score is 
kept but feedback is provided to the subject by signaling correct choices with a screen 
message.  After the practice period, scoring of responses begins and no feedback is 
provided.  The test terminates automatically after a total time of 105 seconds (15 seconds 
practice + 90 seconds test time).  
 
By computerizing the DSST, further information relating to performance and specifically 
reaction times can be calculated.  The outcome measures from each DSST test include 
the number correct, number wrong, % correct, number of times the 10 second 'wake-up' 
reminder had to be flashed on the screen, mean response time of all items, and the 
response rate (number of seconds per item).  
 
2.2.4.4.3 Probed Recall Memory Test 
The Probed Recall Memory test (PRM) measures short-term memory. This test is based 
on a standardised paired word memory test developed by Wechsler which was 
incorporated into the Wechsler Memory Scale (WMS-R) (Wechsler 1945;Wechsler 
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1981a).  In the original format subjects were presented with 10 word pairs, of which six 
were ‘easy’ associations such as “dog – barks”, and then four were ‘hard’ associations 
such as “onion – floor”.  The paired words were read to the subjects three times and the 
subject was given a memory trial after each reading.  All the associations in the NAB are 
‘hard’ associations, for example “seed – aeroplane”, and there is no memory trial after the 
initial presentation.  The addition of a 10 minute task following the initial presentation of 
the paired words allows for the measurement of retention.  
 
The words used in this test are randomly selected from a reference list of 450 most 
commonly used English nouns.  Six paired words are initially presented on the screen for 
30 seconds from 1 of 24 predetermined patterns.  The subject is prompted by the 
instructions on the screen to memorize the words paired together. Following an 
intervening task (the PVT), the left-hand word of each word pair previously presented is 
shown, but in a different order. The subject is instructed to type the missing (right-hand) 
word for all six pairs, guessing if he/she can't remember.  The program allows the subject 
to enter or edit words in any order at any of the assigned screen locations. The program 
halts automatically after 150 seconds even if word spaces are blank.  The subject is 
prompted to press the <ESC>ape key if he/she finishes the task before the time limit. 
This option is not allowed until all the blanks have an entry.  The actual working time is 
logged. 
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2.2.4.4.4 Stanford Sleepiness Scale 
The Stanford Sleepiness Scale (SSS) is a quick and simple test, which measures 
subjective sleepiness at a particular moment in time. It is one of the most widely used 
subjective scales in sleep research.  The SSS consists of seven statements relating to 
subjective sleepiness, which range from 1 – “feeling active and vital” to 7 – “almost in 
reverie; sleep onset soon; lost struggle to remain awake” (Hoddes et al. 1972).  The SSS 
was first validated in 1973 with college students in a protocol involving sleep deprivation 
and performance testing (Hoddes et al. 1973).  Some researchers have found that the SSS 
is poorly correlated with objective sleepiness parameters (Carskadon and Dement WC 
1985;Dement WC et al. 1978). However, this is also true of other subjective scales of 
sleepiness (Cook et al. 1988;Johns 1991). Nonetheless, the SSS is a useful and commonly 
applied tool that can measure subjective sleepiness at a particular time. 
 
2.2.4.4.5 Profile of Mood States 
The Profile of Mood States (POMS) is a validated 65-item mood questionnaire which 
asks subjects to mark on a five point Likert scale (ranging from 1 “not at all’ to 5 
“extremely”) how affected they currently feel by certain common feelings (eg, being 
“worn out”, “unhappy”, “tense”, “friendly”) (Nyenhuis et al. 1999). These 65 different 
feelings cover six main emotional domains - fatigue (f), confusion-bewilderment (cb), 
tension-anxiety (ta), vigour (v), depression-dejection (dd) and anger-hostility (ah).  The 
POMS has been used in research with cancer patients, head injury patients, epilepsy 
patients and HIV/AIDS patients (Lezak 1995).  Recently, the POMS has been applied to 
sleep research, where it has been shown to be altered after partial sleep deprivation 
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(Dinges et al. 1997).  This is also consistent with a recent meta-analysis which has shown 
that the effects of sleep deprivation on mood are greater than the effects of sleep 
deprivation on cognitive or motor performance (Pilcher and Huffcutt 1996). 
 
2.2.4.5 AusEDTM Driving Simulator 
A 30 minute run on the AusEdTM driving simulator was performed after each sequence of 
the NAB. See discussion above. 
 
2.2.4.6 Oxford Sleep Resistance Test (OSLER) 
This test was used to provide an objective measure of daytime sleepiness. It was 
commenced immediately following the completion of the driving simulator testing. 
Compared to conventional polysomnographic tests of daytime sleepiness (MWT, MSLT), 
this test offers the advantage of simplicity, low cost, automatic reading, and low 
requirements for technical personnel. In this test, subjects are asked to press a switch in 
response to a light emitting diode (LED) regularly illuminated for one second in three. 
When the subject fails to respond for 21 seconds (i.e. seven illuminations) the test is 
terminated and sleep is concluded to have occurred. In this way the test is based on a 
behavioural, rather than a polysomnographic, definition of sleep. This is particularly 
important, as the polysomnographic definition of sleep is still debated and also open to 
subjective interpretation.  
 
The OSLER test has been shown to discriminate normal subjects from sleep apnoea 
subjects (mean sleep latency (min) normal group 39.8, OSA group 10.5) as well as the 
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traditional MWT (normal group 38.1, OSA group 7.3) (Bennett et al. 1997). Sleep 
latency on the OSLER is also significantly shorter after sleep deprivation, compared with 
no sleep deprivation, in normal subjects (25 minutes versus 38 minutes) (Priest et al. 
2001).  
 
When the number of consecutive missed responses during the OSLER test increases from 
zero to seven, generally the probability that the subject is asleep (defined 
electrophysiologically) during the intervening period also increases and is equal to or 
greater than 95% for four or more consecutive missed responses. In addition, the total 
number of missed responses per OSLER session has been shown to correlate very highly 
with cumulative microsleep time within an OSLER session (r = 0.94, p< 0.005), 
suggesting that the total number of missed stimuli per minute duration of the test could 
also add valuable information as a quantification of sleep pressure or propensity, perhaps 
allowing for additional discrimination between subjects (Priest et al. 2001). 
 
2.2.4.7 Polysomnography 
See discussion above 
 
2.2.4.8 Urine Drug Screen 
A urine drug screen was performed on all subjects on both testing weekends. See 
discussion above. 
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2.2.5 Statistical Analysis 
Determinants of daytime driving performance and cognitive function were evaluated 
using three-way analysis of variance (ANOVA). There were two within subject variables, 
sleep condition (baseline, sleep deprivation) and time of day (1900, 0700, 1100, 1500, 
1900), and one between subject variable, the presence or absence of mild OSA.  During 
the sleep deprivation condition, an additional night time (0300) time point was analysed. 
Hence, a separate two-way ANOVA (subject group and time) was conducted to fully 
evaluate the effect of diurnal variation on driving performance and cognitive function in 
the sleep deprived state. . 
  
Because of missing data in five subjects for the baseline weekend’s final testing battery 
(1900), ANOVAs were performed with and without data from this final time point 
included. When the final time point was included, the analysis of daytime outcomes was 
limited to 24 subjects with complete data sets (primary analysis). When the final time 
point was excluded, 28 subjects had complete daytime data sets and could be analysed 
(secondary analysis). One subject failed to complete the baseline weekend’s final two 
testing battery’s (1500, 1900), and hence his data was not included in either the primary 
or secondary analyses for the daytime outcomes.  
 
For the driving performance and cognitive function outcomes, the following potential 
confounding factors were tested as covariates and retained where they were significant 
predictors of the outcome variable: age, sleep hours in preceding four nights, average 
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caffeine or alcohol intake, and caffeine intake on day of admission. Of these, only age 
and average alcohol intake were significant predictors (P < 0.05) in any of the analyses.  
  
The effect of sleep deprivation on polysomnographic measures in subjects with and 
without OSA was evaluated using two-way analysis of variance (subject group and 
intervention).  
 
All interactions were tested and, where these were significant (P < 0.05), separate models 
were constructed for each level of the interaction. Pairwise comparisons between levels 
of each factor were assessed where the factor was found to be significantly associated 
with the outcome in the ANOVA model. Effects sizes were estimated with 95% 
confidence intervals. P values  < 0.05 were considered statistically significant and are 
presented in the results. 
 
Differences in preceding sleep hours and questionnaire data were assessed with t tests, 
and results expressed as mean differences with 95% confidence intervals. 
 
The data analysis described above was undertaken using the SPSS statistical package 
10.0.05 (SPSS Inc., Chicago).  
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2.3 Medico-Legal Case Series 
In order to evaluate the effects of OSA on driver fatigue in a broader and more clinically 
relevant way, a review was conducted of consecutive referrals to the Sleep Disorders 
Centres at Royal Prince Alfred Hospital (n = 6) and Westmead Hospital (n = 1), Sydney, 
for medico-legal opinions in fall asleep fatality associated road accidents where the driver 
who caused the accident survived. Each subject underwent detailed sleep investigations 
to identify sleep disorders that might have contributed to the fall-asleep road accident. In 
all cases, the driver had at least one overnight sleep study. In six of the seven cases, an 
objective test of daytime sleepiness was also performed.  
 
2.3.1 Polysomnography 
See discussion above 
 
2.3.2 Objective Tests of Daytime Sleepiness 
The extent of daytime sleepiness was objectively measured by one of two different 
polysomnographic tests.  
 
The Maintenance of Wakefulness Test (MWT) consists of four trials, two hours apart, 
where the subject is seated in a dark, quiet room, in a comfortable chair, and instructed to 
stay awake for 40 or 20 minutes at a time, depending on the specific protocol used 
(Doghramji et al. 1997;Mitler et al. 1982). While sitting, the subject is monitored 
polysomnographically for sleep onset. When 20 minute trials are used and sleep onset is 
defined as the first occurrence of one epoch of any stage of sleep, excessive daytime 
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sleepiness exists if the mean latency to sleep onset for all trial periods is less than 11 
minutes (Doghramji et al. 1997).  
 
The Multiple Sleep Latency Test (MSLT) is very similar to the MWT. In this test, the 
subject is offered four or five opportunities to fall asleep, every two hours, in an 
environment conducive to sleep (dark, quiet room, comfortable bed) (Association of 
Sleep Disorders Centers Task Force on Daytime Sleepiness 1986). The average time 
from lights out to the first epoch of sleep measures the multiple sleep latency (MSL). In 
the first MSLT studies, Richardson et al investigated 14 control subjects and compared 
them to 27 narcoleptics (Richardson et al. 1978). They reported that an MSL < 5 minutes 
is indicative of pathological sleepiness, while an MSL > 10 is normal. This test lacks 
good normative data and these first recommendations remain accepted norms. Scores 
between these pathological and normal ranges are regarded as a diagnostic gray area 
(Association of Sleep Disorders Centers Task Force on Daytime Sleepiness 1986;Kreiger 
J 2000).  
 
An overnight polysomnogram is always performed on the night prior to a MWT or 
MSLT, so that factors such as the previous night’s sleep quality and sleep length, and the 
presence or absence of sleep disorders can be considered when interpreting the results. In 
addition, urine samples are collected on the day of MWT or MSLT testing to detect any 
pharmacological agents that may affect the test results. 
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Chapter 3: Results: Prevalence of OSA 
 
3.1 Response rates 
3.1.1 Drivers surveyed in the field 
In total, the questionnaire was administered at 42 sites around NSW. The exact locations, 
dates of the visits, numbers of drivers surveyed and types of sites visited are set out 
below in table 11. By the end of the recruitment period, 1002 drivers had completed the 
field survey.  
 
The overall response rate was 83% among the drivers who were at the above locations at 
the time of the sampling and who had at least 10 minutes available for the questionnaire 
completion. In other words, 17% of the drivers at the above locations at the time of the 
sampling and who had at least 10 minutes available for the questionnaire completion 
refused to aprticipate. Few drivers who presented to the above locations did not have at 
least 10 minutes available for potential questionnaire completion.  
 
 
 
 
1 the small discrepancy between the total number of drivers in table 1 and the total 
number of drivers surveyed arises because the drivers who underwent sleep studies also 
completed the same survey that was administered in the field and these numbers are not 
recorded in table 1 
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Table 1 Site visits for drivers surveyed in the field 
DATE LOCATION No. SURVEYED SITE
Jun 1 2000 Wentworthville Leagues Club             206 meeting 
Jul 24 2000 Campsons, Minchinbury              6 truck yard
Aug 17 2000 Tolls, Smithfield             17 truck yard
Aug 24 2000 Mobil, Silverwater             15 meeting 
Aug 29 2000 First Fleet, Wetherill Park              4 truck yard
Sep 7 2000 Refrigerated Roadways, Ardell Park             11 truck yard
Sep 14 2000 Tolls Coca-Cola, Northmead             30 truck yard
Oct 24 2000 Mains Paper/APM, Chullora              7 truck yard
Oct 26 2000 Refrigerated Roadways, Girraween                 8 truck yard
Nov 5 2000 Orange                 25 meeting 
Nov 8 2000 Blackwoods, Smithfield             14 truck yard
Nov 23 2000 Caltex, Wyong, north bound             37 truck stop
Dec 7 2000  Caltex, Wyong, north bound             35 truck stop
Dec 13 2000 Caltex, Newell Highway, Dubbo             17 truck stop
Jan 22 2001 Mobil, Marrangaroo             6            truck stop
Jan 31 2001 Mobil, Pheasants Nest             5 truck stop
Feb 20 2001  Caltex, Wyong north bound            29 truck stop
Mar 7 2001 BP Marulan, south bound             18 truck stop
Mar 9 2001 BP Marulan, south bound             20 truck stop
Mar 12 2001  BP Potts Hill               13 truck stop
Mar 14 2001  BP Potts Hill              16 truck stop
Mar 15 2001 Toll Ipec Villawood             30 truck stop
Mar 20 2001 Tarcutta café              32 truck stop
Mar 21 2001 Tarcutta café               25 truck stop
Mar 26 2001 Shell, Sutton Forest, south bound             16 truck stop
Apr 2 2001 Caltex, Dubbo              10 truck stop
Apr 3 2001 Ampol, Gilgandra              5 truck stop
Apr 5 2001  Hardware and General, Brookvale              28 truck yard
Apr 10 2001  Shell, Sutton Forest              15 truck stop
Apr 18 2001 Shell, Tomingley              24 truck stop
Apr 19 2001  Shell, Tomingley               24 truck stop
May 14 2001  BP Marulan south bound              17 truck stop
May 16 2001 Caltex Wyong north bound              20 truck stop
May 22 2001 BP Willow Tree               19 truck stop
May 23 2001 BP Willow Tree               15 truck stop
May 31 2001  Shell Sutton Forest              16 truck stop
Jun 6 2001 Shell Wyalong              31 truck stop
Jun 13 2001     Shell Gundagai South             16 truck stop
Jun 14 2001 Shell Gundagai               22 truck stop
Jun 19 2001 BP Potts Hill                18 truck stop
Jun 27 2001 Caltex Coolongolook             5 truck stop
Aug 19 2001 Star Track Express, Minchinbury              47 truck yard
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3.1.2 Drivers undergoing sleep studies 
Sixty one NSW drivers had sleep laboratory investigations as part of this study.  
 
In total, 149 letters introducing this part of the study were sent to a randomly selected 
population of NSW transport drivers. Only 106 of these drivers (71%) were subsequently 
contactable by telephone, either at home or through work, and were current drivers. Sixty 
one (58%) of these contactable, current drivers agreed to participate in the laboratory 
investigations. In other words, the response rate for eligible drivers was 58%, which 
represented 41% of drivers from the overall mail out. 
 
Seven and a half percent of the eligible drivers had already been diagnosed with OSA 
when the study was discussed with them on the telephone; most were on CPAP treatment 
for this. Five of these were subsequently enrolled and re-tested. Three drivers with 
already diagnosed OSA refused involvement in the study. 
 
Forty two percent of eligible drivers refused to participate in the study. Most drivers 
refused to become involved because they were too busy and couldn’t afford the time 
commitment. Others could never be certain of their roster, so were not willing to commit 
to a definite date for their sleep study. A small proportion felt that “they had no problem”, 
so could not foresee any need for their involvement, and a smaller proportion were 
uncomfortable because of the RTA or TWU collaboration. Seventy six percent of these 
‘non-participants’ agreed to provide their age, height and weight, so that these 
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characteristics could be compared between those who did and did not participate in the 
laboratory investigations. 
 
3.2 Demographic and Physical Characteristics 
 
3.2.1 Physical Characteristics 
Basic demographic and physical characteristic data are presented below for both the 
drivers surveyed in the field and those who underwent sleep laboratory studies. Data are 
compared with those for ‘non-participants’ in the laboratory study.  
 
In the field cohort, all drivers were male, except three (99.7% male). In the laboratory 
cohort, all drivers were male. The main difference in the demographic data presented 
between the field cohort and the laboratory cohort is in age. Members of the laboratory 
cohort of drivers (both participants and non-participants) were older than those surveyed 
in the field. Body Mass Index (BMI), a measure of obesity, and measured neck 
circumference, did not differ between the field and the laboratory groups.  
 
Table 2 Age and obesity: comparison between subjects in the field study and 
laboratory study 
 Age (years)* BMI (kg/m2) Neck Circumference (cm) N 
Field 41.6 (41.0 to 42.3) 29.8 (29.4 to 30.1) 41.9 (41.7 to 42.1) 925 
Laboratory 48.3 (46.1 to 50.6)  30.2 (28.8 to 31.6) 42.2 (41.4 to 43.0) 61 
Difference 6.7 (4.2 to 9.2) 0.4 (-1.8 to 1.0) 0.3 (-1.3 to 0.7)  
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Table 3 Age & obesity in laboratory study: comparison of participants and non-
participants 
 Age (years) BMI (kg/m2) N 
Laboratory 48.3 (46.1 to 50.6)  30.2 (28.8 to 31.6) 61 
Non-Participants 45.7 (42.3 to 49.1) 28.8 (27.3 to 30.3) 35 
Difference -2.6 (-6.5 to 1.2) -1.4 (-3.5 to 0.7) -- 
values for tables 2 & 3 are means ± 95% confidence intervals (CI) 
 
3.2.2 Driving Characteristics 1 
Further descriptive data about the transport drivers that were studied is set out below in 
table 4. In both cohorts, company drivers were more frequently studied than owner 
drivers. Most drivers undergoing sleep laboratory investigations reported metropolitan 
driving, while approximately half of the drivers surveyed in the field reported interstate 
driving. Similarly, a much greater proportion of the drivers surveyed in the field were 
long distance drivers (defined as driving > 100,000 km/yr at work) – 47% compared to 
23% of those who underwent sleep laboratory testing.   Approximately one half of the 
drivers in both cohorts reported night driving shifts and approximately one quarter 
reported rotating shifts. 
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 Table 4 Driving characteristics of participants in the field study and the laboratory 
study 
 Field Drivers Laboratory Drivers Mean Diff (CI) 
% Company Drivers 72% 62% 10 (-3 to 23) % 
% Owner Drivers 25% 38% 13 (-2 to 27) % 
% Metropolitan Driving* 52% 79% 27 (18 to 40) % 
% Country Driving 28% 39% 11 (-1 to 25) % 
% Interstate Driving* 48% 18% 30 (21 to 42) % 
% Long Distance Drivers* 47% 23% 33 (21 to 43) % 
% Driving at Night 56% 46% 10 (-3 to 23) % 
% Rotating Shifts 25% 30% 5 (-7 to 16) % 
% NSW Residence* 70% 100% 30 (18 to 48) % 
 
 
3.2.3 Driving Characteristics 2 
Drivers surveyed in the field drove more kilometres per year, worked and drove more 
hours per week, and on average reported a greater longest work shift. However, the 
number of days worked per week was approximately the same between the two cohorts. 
Both groups reported sleeping only just over 6 hours per day while at work, and both 
groups compensated for this by attempting to catch up their sleep hours on days off. 
Intake of caffeine beverages per day was high in both groups, averaging around five per 
day. Similarly, many drivers admitted to taking tablets to stay awake while driving (see 
table 6). However, reported alcohol consumption was more modest, averaging 
approximately one drink per day for both groups. 
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 Table 5 Sleep and other habits of drivers in the field study and laboratory study 
Values for table 5 are means ± 95% CI 
 Field Drivers Laboratory Drivers Difference 
Longest shift worked (hours)* 15.7 13.7 2.0 (0.6 to 3.3) 
Number of days worked per wk 5.5 5.4 0.1 (-0.003 to 0.326) 
Number of hours worked per 
wk* 63.6 54.7 9.3 (5.9 to 12.7) 
Number of driving hours per wk 
at work* 52.3 42.2 10.7 (6.8 to 14.6) 
Number of km driven per yr for 
work* 135,265 76,156 61,998 (42,736 to 81,260)
Number of hours of sleep on 
work days 6.2 6.4 -0.2 (-0.5 to 0.1) 
Number of hours of sleep on 
days off* 8.5 7.6 0.9 (0.6 to 1.3) 
Number of glasses of alcohol 
each day* 0.7 1.2 0.5 (0.01 to .9) 
Number of cups of caffeine 
beverages each day 5.6 4.9 0.7 (-0.3 to 1.7) 
 
3.2.4 Medical Health 
Medical health data for the two groups is presented below in table 6. The drivers 
undergoing sleep laboratory testing reported more medical illnesses in general, including 
hypertension and ‘sleep apnoea’. The high reported prevalence of illicit drug taking in the 
groups of drivers has already been commented on above. 
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Table 6 Medical health of drivers in the field study and laboratory study 
 Field Drivers Laboratory Drivers 
% with medical illnesses (other than OSA) 20% 48% 
% reporting hypertension 9% 20% 
% reporting heart disease 2% 2% 
% reporting ‘sleep apnoea’ 4% 10% 
% using ‘tablets to stay awake while 
driving’ 24% 11% 
 
 
3.2.5 Accident rates 
Information regarding self-reported motor vehicle accidents is presented below in table 7. 
For the 1002 drivers surveyed in the field, 270 (27%) reported at least one motor vehicle 
accident in the last three years. In comparison, 26 (43%) of the 61 drivers undergoing 
sleep laboratory investigations reported at least one motor vehicle accident. This is 
equivalent to 7% and 16% of drivers respectively reporting at least one motor vehicle 
accident in a year/100,00km driven. 
 
In total 471 and 38 accidents respectively were reported in the two groups over a three 
year period. This represents an accident rate of 0.12 and 0.24 accidents per year per 
100,000 km driven for the two groups respectively (figure 12). 
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Table 7 Self-reported accidents for field and laboratory drivers 
Number of 
Accidents 
Field Drivers 
Frequency 
 
Percent 
Laboratory Drivers 
Frequency 
 
Percent 
0 732 73.1 35 57.4 
1 147 14.7 15 24.6 
2 79 7.9 10 16.4 
3 25 2.5 1 1.6 
4 10 1 0 0 
5 4 0.4 0 0 
6 4 0.4 0 0 
7 1 0.1 0 0 
 1002 100 61 100 
 
 
Figure 12 Accident rate of drivers in the 2 study groups 
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3.3 Prevalence of Daytime Sleepiness 
In the group who were surveyed in the field, 258 (26%) of the 996 drivers who completed 
the Epworth Sleepiness Scale fully, had an Epworth Score of greater than 10, a score 
which is consistent with pathological daytime sleepiness. Similarly, 20% of the drivers 
undergoing sleep investigation in the laboratory had pathological daytime sleepiness. 
There was no statistical difference between the two groups in terms of their Epworth 
Sleepiness Scores (figures 13 and 14).  
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Figure 13 Driver sleepiness: drivers surveyed in the field 
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Figure 14 Driver sleepiness: drivers studied in the laboratory 
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3.4 Prevalence of Obstructive Sleep Apnoea 
3.4.1 Prevalence of OSA and Sleep Apnoea Syndrome 
In the group of transport drivers surveyed in the field, the prevalence of OSA was 
estimated using the Maislin questionnaire and equation. From this, the estimated 
prevalence of OSA for an RDI > 10 was found to be 41%. Furthermore, 14% of the 
drivers had both an RDI > 10 and an Epworth score > 10, i.e. met the diagnostic criteria 
of sleep apnoea syndrome. This is illustrated below in table 8. 
 
Table 8 Relation between OSA and pathological sleepiness in drivers in the field 
study 
 Maislin score < 0.5 Maislin Score > 0.5 TOTAL 
ESS < 10 44% 25% 70% 
ESS > 10 11% 14% 25% 
 
 
The drivers who underwent sleep laboratory investigation had their degree of OSA 
exactly quantified using the gold standard for diagnosis, an overnight sleep study. Table 9 
shows the prevalence of OSA in this group of drivers for different diagnostic cut-offs and 
different degrees of severity. 
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Table 9 Prevalence of OSA for drivers studied in laboratory 
OSA Definition  % Of Laboratory Drivers 
RDI > 5 71% 
RDI > 10 51% 
Mild OSA (RDI 5 –15)  36% 
Moderate OSA (RDI 15 – 30) 20% 
Severe OSA (RDI > 30) 15% 
 
 
The prevalence of sleep apnoea syndrome in this group of drivers is illustrated below in 
table 10. Importantly, 15% of the drivers studied in the sleep laboratory had both OSA on 
their overnight sleep study and a history of excessive daytime sleepiness. Only one third 
of the drivers with sleep apnoea syndrome came from the severe OSA group, indicative 
of the weak relationship between severity of polysomnographically identified OSA and 
the presence of excessive daytime sleepiness (this is discussed more fully in the next 
chapter, section 4.1). The percentages in the first two columns of table 10 represent the 
minimum true prevalence of sleep apnoea syndrome, assuming all those who did not have 
sleep investigations (from the original mail out list or telephone contact) did not have 
sleep apnoea syndrome.  
 
When the group of drivers with sleep apnoea syndrome (RDI > 5, Epworth > 10) was 
directly compared with the group who did not have sleep apnoea syndrome, the mean 
difference in RDI between the groups was 15/hr (CI: 3 – 26/hr) and in Epworth 8 (CI: 6 – 
10). 
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Table 10 Prevalence of sleep apnoea syndrome for drivers studied in laboratory 
 % Of Mail Out 
Group 
% Of Contactable 
Group 
% Of Laboratory 
Studied Drivers 
RDI > 5 29% 41% 71% 
ESS > 10 8% 11% 20% 
“Sleep Apnoea Syndrome” 
 RDI > 5 + ESS > 10 
6% 9% 15% 
 
 
Although an overnight sleep study is the most accurate way of diagnosing OSA, drivers 
who underwent sleep laboratory testing were also asked to complete the Maislin 
questionnaire and equation, so that their Maislin scores could be compared with the 
scores of those drivers who were surveyed with the Maislin in the field. Using the 
Maislin, their estimated prevalence of OSA for an RDI > 10 was found to be 60%. This 
compares to the prevalence figure of 51% that was found for an RDI > 10 using the 
overnight sleep study data (table 9). This suggests that the Maislin tends to overestimate 
the number of drivers with sleep apnoea. 
 
3.4.2 Analysis of Accuracy of Maislin Prediction of OSA 
Because of the small difference in the prevalence of OSA in this group when it was 
estimated using the Maislin (60%), compared to when it was measured using the 
overnight sleep study data (51%), which is the gold standard of diagnosis, the accuracy of 
the Maislin as a screening tool for OSA in this group of transport drivers was further 
evaluated. To do this the drivers Maislin scores were compared with their sleep study 
results directly. 
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This analysis found that for the Maislin cut-off (0.5) that was used, the sensitivity for 
diagnosing OSA (RDI > 10) is 82% and the specificity is 66% (for definitions, see 
attachment 3). The sensitivity and specificity of the Maislin for diagnosing OSA can be 
further discussed in the context of its receiver operator characteristic (ROC) curves 
(figure 15). This illustrates some additional points about the Maislin as a screening tool 
for OSA in this population: 
 
 As the sensitivity of the Maislin rises above 70% (marked with blue asterisk “*”), 
the specificity of the test drops rapidly. In other words, the number of false 
positive test results dramatically increases. 
 The optimal Maislin cut-off  (marked with red asterisk “*”) that combines both 
good levels of sensitivity and specificity appears to be around 0.51, where 
sensitivity is 82% and specificity is approximately 70%. A cut-off of 0.5 was used 
for the analysis above.  
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Figure 15 ROC curve: Maislin prediction of OSA 
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Using the Maislin and sleep study data, likelihood ratios (see Attachment 3) for 
predicting OSA for four different ranges of Maislin scores were calculated (table 11). 
This data illustrates that in a population of transport drivers, a Maislin score above 0.55 
increases the odds for having OSA almost three fold.  
 
Table 11 Likelihood ratios for predicting OSA for Maislin score quartiles 
Maislin Quartile Likelihood Ratio 
< 0.4 0.45 
0.4 to 0.55 0.36 
0.55 to 0.75 2.9 
> 0.75 2.9 
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Chapter 4: Results: Correlates of OSA 
 
4.1 Relationship of Obstructive Sleep Apnoea to Driver Sleepiness 
As discussed in the introduction, not all patients with OSA report excessive daytime 
sleepiness. There are potentially many reasons for this, including a lack of awareness or 
under-reporting of daytime sleepiness in patients suffering from OSA prior to treatment 
(Engleman H et al. 1997a). In Chapter 3, the percentage of drivers with both OSA and 
excessive daytime sleepiness (i.e., those drivers with ‘sleep apnoea syndrome’) was given 
for both of the groups of drivers tested. These results are again summarised below in 
Table 12. 
 
Table 12 Prevalence of sleep apnoea syndrome for drivers in the field and 
laboratory 
 Field Drivers  
(RDI > 10 (Maislin), 
Epworth > 10) 
Laboratory Drivers  
(RDI > 5, Epworth > 
10) 
Laboratory Drivers  
(RDI > 10, Epworth > 
10) 
Sleep Apnoea 
Syndrome 
 (OSA, Epworth > 
10) 
14% 15% 12% 
 
 
In this section the relationship between having OSA and reporting excessive daytime 
sleepiness has been examined further in the study populations. In the group of drivers 
surveyed in the field, those with suspected OSA reported higher Epworth scores (mean 
difference in Epworth =1.79; CI: 1.23 to 2.35) and were 2.1 times more likely to have an 
Epworth score > 10 (CI: 1.5 to 2.8). Further, a 0.1 unit increase in their Maislin scores led 
 147
to a 1.2 fold increase in the odds of being pathologically sleepy (i.e. Epworth > 10) (OR 
= 1.2 (1.1 to 1.3)). In the drivers who underwent sleep laboratory investigation, there was 
a significant, but weak, correlation between actual RDIs and Epworth scores (Pearson 
Correlation R=0.32, P=0.02, N=61). This is illustrated in figure 16. 
         
 Figure 16 Correlation between driver sleepiness and OSA 
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4.2 Relationship of OSA to Self-Reported Accident Rates 
4.2.1 Drivers Surveyed in the Field 
For the drivers surveyed in the field, there was a very weak but significant relationship 
between reporting motor vehicle accidents in the last three years and the drivers Epworth 
scores (R2= 0.005: P=0.04). Further, a one unit increase in the drivers Epworth scores 
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was associated with a four percent increase in the odds of reporting one accident or more 
(OR = 1.04; CI: 1.001 to 1.072). However, there was no relationship between reporting a 
motor vehicle accident and having OSA (R2=0.0002: P=0.6). Similarly, no relationship 
was found between reporting multiple accidents (i.e. more than one in a three year 
period) and Epworth or Maislin scores.  
 
Because of the lack of association between OSA and self-reported accidents, the 
subgroup of drivers who had sleep apnoea syndrome were analysed separately to see if 
this group was associated with increased self-reported motor vehicle accidents. This 
analysis was performed for three levels of reported accidents – total reported accidents, at 
least one reported accident, and multiple accidents. Table 13 illustrates that there was no 
significant difference in any of the self-reported accident outcomes between drivers with 
and without sleep apnoea syndrome.  
  
Table 13 Comparison of accident rates between drivers with and without sleep 
apnoea syndrome 
 Mean Difference Lower 95% CI Upper 95% CI 
Total Reported Accidents -0.15 -0.37 0.07 
At Least 1 Accident -0.04 -0.12 0.04 
Multiple Accidents -0.01 -0.07 0.04 
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4.2.2 Drivers Studied in the Sleep Laboratory 
For the group of drivers studied in the sleep laboratory, RDI was not significantly 
correlated with the total number of accidents (P=0.2, R= -0.130, N=57). Similarly, there 
was no statistically significant difference in the RDIs of those drivers with one or more 
accidents compared to those drivers with no accidents (Table 14, Figure 17). 
 
Table 14 OSA (RDI) in drivers with and without a history of accidents 
* mean difference ± 95% confidence interval 
Mean RDI of drivers  
with no accidents (n=35) 
Mean RDI of drivers  
with at least 1 accident (n=26) Difference* 
15.9 14.6 1.3 (-10.2 to 7.5)
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Figure 17 Accidents compared to RDI for drivers studied in the  laboratory 
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Other analyses to assess for a relationship between self-reported accidents and RDI in 
this small cohort of drivers did not show any significant associations. Similarly, those 
drivers with sleep apnoea syndrome did not show increased accidents. However, 
statistical significance was not expected given the very small numbers in these later 
analyses. 
 
4.3 Relationship of OSA to Driving Impairment (Driving Simulator) 
The drivers studied in the sleep laboratory had their driving performance objectively 
measured using a driving simulator. Each driver performed a 30 minute driving simulator 
task at 8 pm on the day of admission, then again at 7 am and approximately 10 am the 
next day after their sleep study. Repeated measures analysis of variance was used to 
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assess differences in driving simulator performance between drivers with and without 
various risk factors. 
 
4.3.1 Obstructive Sleep Apnoea 
The effects of OSA (classified as no OSA (RDI <5), mild OSA (RDI 5-15), moderate 
OSA (RDI 15-30), severe OSA (RDI >30)), pathological sleepiness (ESS > 10) and time 
of day (8pm, 7am, 10am) on driving simulator performance were assessed by repeated 
measures analysis of variance.  
 
This analysis demonstrated that neither the presence nor level of OSA, the time of day, 
nor the interaction between these, had any significant effect on the driving simulator 
outcomes. Similarly drivers with pathological sleepiness (Epworth > 10) were not 
significantly different to other drivers in driving simulator performance. 
 
Table 15 below shows the AusEdTM mean reaction time (RT), averaged for the three time 
periods, by OSA status. Figure 18 illustrates the same information graphically. This was 
one of approximately 15 driving simulator outcome variables that were compared 
between the groups  
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Table 15 AusEd mean reaction time by OSA status  
 Mean RT  95% upper CI 95% lower CI 
No OSA 1137.5  1039.6 1235.4 
Mild OSA 1159.7  1074.2 1245.1 
Moderate OSA 1064.7  934.2 1195.2 
Severe OSA 1213.0  1065.0 1361.0 
P = 0.5 
 
 
Figure 18 AusEd mean reaction time by OSA status 
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4.3.2 Sleep Apnoea Syndrome 
The effect of sleep apnoea syndrome on some aspects of driving simulator performance 
differed according to the time of day at which the test was done. However, other driving 
simulator performance measures were worse at all times of day for the sleep apnoea 
syndrome group (table 16). After adjustments were made for age, and this analysis was 
repeated, there was little change in the results. 
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Table 16 Effect of sleep apnoea syndrome on driving simulator performance 
 (adjusted for diurnal variation) 
 
 
Dependent Variable Time of day Effect of Sleep Apnoea 
Syndrome 
P Interaction1 
Median Lane 
Position All None 0.1 0.6 
Sd lane position 
median 8pm  Worse performance 0.04 0.02 
Sd lane position 
median 10am Worse performance 0.02 0.02 
Sd lane position 
median 7am None 0.2 0.02 
Area dev steering 
centre All None 0.3 0.1 
Av dev steering 
centre All None 0.97 0.3 
Area steer dev 
median All None 0.09 0.3 
Av steer dev median All Worse performance 0.02 0.3 
RT Mean 10am Worse performance 0.00 < 0.001 
RT Mean 8pm  None 0.2 <0.001 
RT Mean 7am None 0.07 <0.001 
RT sd mean 10am Worse performance 0.00 < 0.001 
RT sd mean 8pm None 0.3 <0.001 
RT sd mean 7am None 0.9 <0.001 
RT median All Worse performance 0.01 0.2 
RT sd median 10am Worse performance 0.00 0.001 
RT sd median 8pm None 0.8 0.001 
RT sd median 7am None 0.2 0.001 
RT 95% percentile 10am Worse performance 0.00 < 0.001 
RT 95% percentile 8pm  None 0.9 <0.001 
RT 95% percentile 7am None 0.4 <0.001 
Area speed dev zone All None 0.9 0.5 
Av speed dev zone All None 0.3 0.4 
Crashes 8pm Worse performance 0.02 0.02 
Crashes 7am None 0.2 0.02 
Crashes 10am None 0.1 0.02 
1. Significant test for diurnal variation in the effect of SAS on driving performance. 
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 In summary, the drivers with sleep apnoea syndrome performed worse than drivers 
without sleep apnoea syndrome in three key driving simulator performance outcome 
measures:  
 
1) Tracking (steering) – drivers with sleep apnoea syndrome showed greater variability in 
the lane positions they adopted on the road, i.e., more erratic driving. This is 
demonstrated by a difference between the groups in the variable “Av steer dev median” 
(average steering deviation outside the median lane position adopted for the 30 minute 
drive – see figure 20) and “sd lane position median” (standard deviation of the lane 
position from the median lane position for the 30 minute drive). 
 
2) Reaction time – drivers with sleep apnoea syndrome showed longer reaction times, as 
measured by both the mean and median reaction times, together with greater variability in  
reaction times (standard deviation and 95% percentile of reaction times were greater in 
the sleep apnoea syndrome group). Many of these changes were seen at the 10 am time 
point. See figure 19. 
 
3) Number of crashes – drivers with sleep apnoea syndrome crashed more than those 
drivers without sleep apnoea syndrome (at 8 pm). 
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 Figure 19 is a plot of the AusEdTM mean reaction times for drivers with sleep apnoea 
syndrome and without sleep apnoea syndrome across the three time periods tested. The 
graph shows that the effect of sleep apnoea syndrome on this driving performance 
measure varied with time; an important difference was apparent only at the 10 am test. 
 
Figure 19 AusEd mean reaction times for drivers with and without sleep apnoea 
syndrome  
(illustrated across the three time periods) 
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 Figure 20 shows that average steering deviation from the median lane position, a measure 
of tracking, was worse overall in the drivers with sleep apnoea syndrome. 
 
Figure 20 Tracking ability in drivers with and without sleep apnoea syndrome 
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These analyses were repeated using a broader definition of sleep apnoea syndrome (RDI 
> 5, ESS > 10. See table 12). The findings were broadly consistent with those described 
above: drivers with sleep apnoea syndrome performed worse than drivers without sleep 
apnoea syndrome on several reaction time variables and crashes. 
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4.4 Regression Models 
 
4.4.1 Factors Predicting Driver Sleepiness 
The effect of various lifestyle, work and medical factors (Table 17) on the risk of 
reporting excessive daytime sleepiness (Epworth Sleepiness Scale > 10) was assessed 
using logistic regression modeling with stepwise selection.  
 
Table 17 Predictor variables for driver sleepiness 
Variable Type of Variable 
Maislin Score > 0.5* Medical 
Body Mass Index Medical 
Age Medical 
> 2 hours sleep difference between work and off-work days* Lifestyle 
At least 3 caffeine drinks per day* Lifestyle 
Less than 6 hours sleep per work night* Lifestyle 
At least 6 day working week* Work 
At least 10 hours driven per day* Work 
Greater than 50 hours worked per week* Work 
At least 14 hours longest work shift* Work 
Rotating shifts* Work 
Night shifts* Work 
Interstate driving* Work 
Metropolitan driving* Work 
Country driving* Work 
Long distance driving* Work 
* = dichotomised variable 
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Of the 16 medical, lifestyle and work factors that were tested, only three were found to be 
statistically significant predictors of excessive driver sleepiness: Maislin score > 0.5, > 2 
hours sleep difference between work and off-work days, and at least a six day working 
week. Table 18 presents the odds ratios and 95% confidence intervals for these 
independent, significant predictors of sleepiness. It illustrates that individuals with OSA 
(Maislin > 0.5) are 2.9 times more likely to be pathologically sleepy (Epworth > 10) 
compared to individuals without OSA, when corrected for the effects of factors reflecting 
lifestyle and work habits.   
 
Importantly, Maislin > 0.5 (i.e., having OSA) was the most important factor predicting 
driver sleepiness in this population. It was more important than many of the traditionally 
recognized fatigue promoting factors, such as night driving, chronic sleep deprivation 
(represented by the variable “less than 6 hours sleep per work night”), driving many 
hours per day (represented as “at least 10 hours driven per day” and “at least 14 hours 
longest work shift”), and long distance driving, all of which failed to be statistically 
significant predictors of driver sleepiness in this group. 
 
Table 18 Predictors of excessive driver sleepiness 
Variable OR 95% CI 
Maislin score > 0.5 2.9 1.9 - 4.6 
> 2 hours sleep difference  
between work and off-work days 1.6 1.1 – 2.4 
At least 6 day working week 1.5 1.01 - 2123 
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4.4.2 Factors Predicting Reported Accidents 
A multiple logistic regression analysis was performed to look for factors predicting self-
reported accidents for the drivers surveyed in the field. All the work, lifestyle and 
medical factors used in the last analysis (table 17) were tested, together with driver 
sleepiness (dichotomised at Epworth  > 10). Metropolitan drivers (OR 1.9, 95% CI 1.2 – 
3.2) and those reporting a longest work shift duration of at least 14 hours (OR 1.46, 95% 
CI 1.01 – 2.08) had significantly increased odds for reporting at least one accident. None 
of the other variables significantly predicted self-reported accidents. 
 
When the outcome of multiple self-reported accidents (i.e. more than one) was assessed 
using a similar multiple logistic regression analysis, metropolitan drivers were 2.7 times 
more likely to report multiple accidents compared to non-metropolitan drivers (OR 2.7, 
95% CI 1.3 – 5.7), and country drivers showed a significantly lower odds for reporting 
multiple accidents than non-country drivers (OR 0.54, 95% CI 0.29 – 0.99). No other 
variables were significant. 
 
To assess whether driving simulator performance could predict self-reported accidents in 
the drivers who underwent sleep laboratory testing, several multiple logistic regression 
analyses were performed for the outcome variables of reporting at least one accident and 
reporting multiple accidents. Several driving simulator variables representing reaction 
time, steering, and speed were entered as independent predictors. None of these variables 
at any of the 3 times (8 pm, 7 am, 10 am) or averaged across all three times were 
statistically significant predictors of self-reported accidents.  
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4.4.3 Factors Predicting Driving Impairment (Driving Simulator) 
The effect of age, RDI and pathological sleepiness (Epworth > 10), and time of testing, 
was tested for each of the driving simulator performance measures by linear regression 
modeling. Age explained up to 15% of the variance in 13 of the tracking and reaction 
time measures in these models. In total 48 performance measures were modeled. 
Sleepiness was not a statistically significant independent predictor of driving simulator 
performance and RDI partially explained two tracking measures (Table 19). 
 
Table 19 Driving simulator variables partially explained by RDI 
Driving Variable - outcome measure 
Explained variance of RDI 
(P value, adjusted for age and ESS)  
Area of steering deviation from median 7% (P = 0.047) 
Average of steering deviation from 
median 7% (P = 0.047) 
 
 
In separate models, the effect of sleep apnoea syndrome (RDI > 10, Epworth > 10) was 
tested, with adjustment for the effects of age. Similar to the results in section 4.3.2 above, 
sleep apnoea syndrome was a significant independent predictor of tracking, reaction time 
and crash outcomes on the driving simulator, explaining up to 26% of the variance in 
some of these outcomes. This was apparent at all three testing sessions. See table 20. 
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Table 20 Driving simulator variables explained by sleep apnoea syndrome 
Driving Variable - outcome measure 
% of variance explained by SAS  
(P value, corrected for Age) 
Standard deviation of lane position from median, 10 am 11% (P = 0.02) 
Area steering deviation of lane position from median, 10 
am 11% (P = 0.02) 
Average steering deviation of lane position from median, 
10 am 11% (P = 0.02) 
Mean reaction time, 10 am 24% (P = 0.00) 
Standard deviation of mean reaction time, 10 am 24% (P = 0.00) 
Median reaction time, 10 am 16% (P = 0.00) 
95’th percentile of median reaction time, 10 am 26% (P = 0.00) 
Mean reaction time, 7 am 7% (P = 0.045) 
Median reaction time, 7 am 9% (P = 0.02) 
Median reaction time, 8 pm 9% (P = 0.02) 
Number of crashes, 8 pm 9% (P = 0.02) 
 
 
4.4.4 Factors Predicting Obstructive Sleep Apnoea 
The value of simple medical evaluation in screening for the presence of OSA was 
assessed by logistic regression analysis. For the drivers studied in the sleep laboratory, 
reporting the combination of snorting or gasping (one or more nights per week), loud 
snoring (one or more nights per week), and breathing pauses (once or more nights per 
week) increased the odds for having an RDI > 10 by 3.4 times (OR = 3.4, 95% CI 1.2 – 
10.2). 
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Neck circumference was a significant independent predictor of an RDI > 10 in this 
population (OR= 1.7, corrected for age and BMI, CI 1.2 – 2.6), but BMI and age were 
not. See table 21. 
 
Table 21 Predictor variables of OSA 
Predictor of OSA OR CI 
Neck Circumference 1.74 1.17 – 2.59 
Body Mass Index .87 0.70 – 1.07 
Age 1.07 0.99 – 1.15 
 
 
Similarly, neck circumference was correlated with RDI (R=0.389; P=0.002), but BMI 
was not (R=0.228; P=0.08). 
 
4.5 Effect of OSA/Sleepiness on Vigilance (Psychomotor Vigilance Task) 
The effect of RDI, pathological daytime sleepiness (Epworth > 10) and age on PVT 
outcomes was assessed by multiple linear regression.  
 
After accounting for the effects of age and OSA (measured as RDI), the presence of 
pathological sleepiness was significantly related to PVT lapses (i.e. poor reaction time 
performance) at 10 am (R = 0.30, P = 0.03). Age also had an independent effect on 
several PVT outcome measures, but RDI did not predict PVT performance. 
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In a separate model, sleep apnoea syndrome (corrected for age) was a significant 
independent predictor of 3 PVT outcomes at 10 am (PVT median, R2 = 13% P = 0.008; 
PVT lapses, R2 = 18% P = 0.001; PVT 1/reaction time slowest 10%, R2 = 12% P = 0.01) 
 
After adjusting for age, the effect of sleep apnoea syndrome (RDI > 10, Epworth > 10) on 
PVT performance at various times of the day was assessed by analysis of variance. 
Where the interaction between sleep apnoea syndrome and time of testing was 
significant, the significant effects of sleep apnoea syndrome have been analysed and 
presented at the time points at which they occurred (table 22). When the interaction was 
not significant, any significant group effects have been presented. Table 22 shows that 
drivers with sleep apnoea syndrome had poorer PVT reaction time performance than 
those drivers without sleep apnoea syndrome, mainly at 10 am. After adjusting for age, 
differences in PVT reaction time between groups of drivers were not seen when drivers 
with OSA (RDI > 10) were compared with drivers without OSA. However, drivers with 
pathological sleepiness (Epworth > 10) had significantly more lapses at 10am (P=0.03) 
than drivers without pathological sleepiness. 
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Table 22 Effect of sleep apnoea syndrome on PVT performance, adjusted for 
diurnal variation 
 
Dependent Variable Interaction Interpretation 
PVT Median .02 
Drivers with SAS had slower median reaction times 
at 10 am  
(49ms, 95% CI 14-83, p=0.01) 
Lapses .001 
Drivers with SAS had more lapses  
at 10 am  
(3, 95% CI 1-5, p=0.00) 
Fast 10% .90 
 
 
 
1/RT Slow 10% .08 
Drivers with SAS showed poorer performance, 
averaged across all 3 times  
(Effect of group –0.4, P=0.03) 
Errors .93 
 
 
 
 
 
4.6 Effect of OSA/Sleepiness on neuropsychological measures 
 
After controlling for IQ, there was no significant relationship between RDI and any of the 
normed neuropsychological test results. However, those drivers with sleep apnoea 
syndrome (RDI > 10, Epworth > 10) had a significantly lower Trails B Z score (a test of 
psychomotor speed) than those drivers without sleep apnoea syndrome (P=0.049).  In 
other words, drivers with sleep apnoea syndrome performed poorer on a motor and visual 
search task.  
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4.7 Summary of Results for Chapters 3 and 4 
 
4.7.1 Response Rates 
 For the transport drivers surveyed in the field, 42 randomly selected NSW truck 
yards or truck stops were visited over an approximate 15 month period. The 
overall response rate for the 1002 questionnaires completed by the drivers at these 
sites was 83%. 
 Sixty one randomly selected transport drivers were studied in the sleep laboratory 
over a 20 month period. The response rate for the eligible drivers in this cohort 
was 58%.  
 
4.7.2 Demographic and Physical Characteristics 
 The drivers surveyed in the field had an average age of 42 years, an average Body 
Mass Index of 30 kg/m2, and an average neck circumference of 42 cm.  
 The drivers who underwent sleep laboratory investigations were older (average 
age of 48 years), but otherwise their body mass index and neck circumference did 
not differ from the other cohort. 
 In both cohorts, company drivers were more frequently studied than owner drivers 
 Drivers surveyed in the field performed more interstate and long distance driving 
than the drivers studied in the sleep laboratory, who reported more metropolitan 
driving. 
 Drivers surveyed in the field drove more kilometres per year, worked and drove 
more hours per week, and on average reported a greater longest work shift. 
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 Both cohorts slept on average just over six hours per day while at work, and 
reported high caffeine and illicit drug use. 
 The drivers undergoing sleep laboratory testing reported more medical illnesses in 
general, including hypertension and ‘sleep apnoea’. 
 Seven percent of the drivers surveyed in the field and sixteen percent of the 
drivers who were studied in the sleep laboratory reported at least one motor 
vehicle accident in a year/100,00km driven 
 
4.7.3 Prevalence of Daytime Sleepiness 
 In the group who were surveyed in the field, 26% reported pathological daytime 
sleepiness. For the other cohort of drivers, this was reported in 20%. 
 
4.7.4 Prevalence of Obstructive Sleep Apnoea 
 For the drivers surveyed in the field, the prevalence of OSA was estimated at 
41%. Furthermore, 14% of the drivers had both OSA and excessive daytime 
sleepiness, i.e., sleep apnoea syndrome. 
 The drivers studied in the sleep laboratory showed a prevalence of OSA of 51% 
(RDI > 10). Fifteen percent of the drivers had severe OSA. The prevalence of 
sleep apnoea syndrome in this cohort was 12% (RDI > 10, Epworth > 10). 
 When the Maislin Questionnaire was ‘re-validated’ within the laboratory cohort, 
the Maislin threshold score of 0.5 that was used showed a sensitivity of 82% and a 
specificity of 66% for diagnosing OSA (RDI > 10). This threshold score 
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compared very favourably to the optimal threshold suggested by the Maislin’s 
ROC curve. 
 
4.7.5 Relationship of Obstructive Sleep apnoea to Driver Sleepiness 
 Obstructive sleep apnoea was related to driver sleepiness. In the group of drivers 
surveyed in the field, those with OSA reported higher Epworth scores and were 
2.1 times more likely to report pathological daytime sleepiness. In the drivers who 
underwent sleep laboratory investigation, there was a statistically significant 
correlation between actual RDIs and Epworth scores (Pearson Correlation 
R=0.32).  
 
4.7.6 Relationship of Obstructive Sleep Apnoea to Self-Reported Accident Rates 
 For the drivers surveyed in the field, there was a very weak but significant 
relationship between reporting motor vehicle accidents in the last three years and 
the driver’s Epworth scores.  
 However, there was no relationship between reporting a motor vehicle accident 
and having OSA or sleep apnoea syndrome in either of the study groups 
 
4.7.7 Relationship of Obstructive Sleep Apnoea to Driving Impairment (Driving 
Simulator) 
 Drivers with sleep apnoea syndrome performed worse than drivers without sleep 
apnoea syndrome in three key driving simulator performance outcomes – steering, 
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reaction time and number of crashes. Driving simulator differences between the 
groups were not apparent for RDI alone or pathological sleepiness alone. 
 
4.7.8 Predictors of pathological sleepiness, accident risk, poor performance on the 
driving simulator and OSA 
 Maislin > 0.5 (i.e., having OSA) was the most important factor predicting 
pathological sleepiness in the drivers surveyed in the field. It was more important 
than many of the traditionally recognized fatigue promoting factors, such as night 
driving, chronic sleep deprivation, driving for many hours per day, and long 
distance driving, all of which failed to be statistically significant predictors of 
driver sleepiness in this group. 
 Metropolitan driving and having a longest work shift duration of at least 14 hours 
were the only significant predictors for reporting at least one accident. 
Metropolitan drivers were also 2.7 times more likely to report multiple accidents 
compared to non-metropolitan drivers, while country drivers showed a 
significantly lower odds for reporting multiple accidents than non-country drivers. 
Driving simulator performance did not predict self-reported accident rates. 
 Sleep apnoea syndrome was a significant independent predictor of tracking, 
reaction time and crash outcomes on the driving simulator (when adjusted for the 
effects of age). 
 Simple medical questioning about sleep apnoea symptoms and neck 
circumference measurements were the most significant clinical predictors for the 
presence of OSA 
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4.7.9 Effect of OSA/Sleepiness on Vigilance (Psychomotor Vigilance Task) 
 Sleep apnoea syndrome was a significant independent predictor of several PVT 
reaction time outcomes (when adjusted for the effects of age). RDI alone did not 
predict PVT outcomes, while pathological sleepiness alone predicted one PVT 
outcome. 
 After adjusting for age, drivers with sleep apnoea syndrome showed poorer 
performance on PVT reaction time tests compared to drivers without sleep apnoea 
syndrome. These differences in PVT reaction time between groups of drivers 
were not seen for OSA alone (RDI > 10). However, drivers with pathological 
sleepiness (Epworth > 10) showed significant differences on one PVT outcome. 
 
4.7.10 Effect of OSA/Sleepiness on Neuropsychological Measures 
 After controlling for IQ, drivers with sleep apnoea syndrome performed worse on 
a test of psychomotor speed than those drivers without sleep apnoea syndrome. 
However, there was no significant relationship between RDI alone and any of the 
normed neuropsychological test results. 
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Chapter 5: Results: Interactive Effects of Mild OSA 
 
5.1 Demographic and Physical Measures 
Subjects with OSA did not differ in age from control subjects, but they were more obese, 
as indicated by a higher body mass index and larger neck circumference. See table below. 
 
Table 23 Demographic & physical measures: comparison between OSA & control 
groups 
 Mean Age 
 (years) 
Mean BMI 
(kg/m2) 
Mean Neck 
Circumference (cm) 
N  
Controls 38 25.5 38.9 16  
OSA 45 30.3 41.4 13  
Difference* 7 (-18 to 4) 4.7 (1.1 to 8.3) 2.5 (0.4 to 4.5)   
*values are mean differences ± 95% confidence intervals (CI) 
 
5.2 Lifestyle Details 
Subjects with OSA tended to report less sleep on work days and have less actual recorded 
sleep in the four nights preceding their laboratory admissions, compared to subjects 
without OSA (although these differences were not statistically significant). Both subject 
groups reported consuming several caffeine drinks per day, but there was no significant 
difference in amount consumed between the two groups. See table below. 
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Table 24 Lifestyle details: comparison between OSA and control groups 
 Controls OSA Difference* 
Av. reported sleep work days 
(hours) 5.9 1.2 (-0.01 to 2.4) 
Av. reported sleep days off (hours) 8.2 8.0 0.2 (-1.0 to 1.4) 
Av recorded sleep preceding 4 
nights (average sleep hours/night) 7.1 6.6 0.5 (-0.3 to 1.2) 
Av. caffeine intake (drinks/day) 2.9 4.3 1.4 (-0.8 to 3.6) 
Av. ETOH work days (drinks/day) 0.3 1.0 0.6 (-0.5 to 1.8) 
Av. ETOH days off (drinks/day) 1.1 2.8 1.7 (-0.1 to 3.5) 
N 16 13  
7.0 
*Values are mean differences ± 95% Confidence Intervals (CI) 
 
There was no difference in caffeine intake on the day of admission or in average sleep 
hours during the preceding four nights in the subjects prior to the two testing weekends. 
Thus, neither of these factors could be expected to explain differences in performance 
outcomes between the two testing weekends. See table below. 
 
Table 25 Caffeine intake and sleep hours immediately prior to testing weekends 
 Baseline 
Weekend 
Sleep Deprivation 
Weekend Difference* 
Caffeine intake on day of admission 
(drinks/day) 1.72 1.67 0.05 (-0.55 to 0.66) 
Sleep preceding 4 nights (average 
sleep hours/night) 6.7 6.9 0.3 (-.006 to 0.6) 
N 29 29  
*values are mean differences ± 95% confidence intervals (CI) 
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5.3 Driver Details 
Neither of the subject groups showed pathological daytime sleepiness, as measured by 
the Epworth Sleepiness Scale. There was no difference in Epworth scores or self-reported 
motor vehicle accident rates between the two groups. See table below. 
 
Table 26: Driver details: comparison between OSA and control groups 
 Epworth Sleepiness Score 
Reported Motor Vehicle Accidents 
(number in 3 years)  N  
Controls 7 0.6  16  
OSA 9 0.3  13  
Difference* 2 (-6 to 2) 0.3 (-0.5 to 1.1)    
*values are mean differences ± 95% confidence intervals (CI) 
 
5.4 Baseline Polysomnography 
Table 27 confirms that the OSA status was different between the two groups. Subjects 
with OSA had a mean total RDI of 12, compared to a mean total RDI of 2 in the control 
group. Similarly, there was a significant difference between the groups in NREM RDI, 
arousal index and minimum oxygen saturation. Based on these polysomnographic results, 
OSA subjects had mild disease, whereas controls had no OSA. 
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Table 27 Baseline polysomnography: comparison between controls and OSA 
subjects 
 Controls OSA  
Total RDI (events/hr) 1.9 (-0.7 to 4.4) 12.1 (9.2 to 15.0)  
NREM RDI (events/hr) 0.7 (-2.5 to 3.8) 10.1 (6.6 to 13.5)  
REM RDI (events/hr) 7.9 (1.4 to 14.5) 19.9 (12.7 to 27.1)  
Arousal Index (arousals/hr) 9.3 (6.2 to 12.4) 17.2 (13.8 to 20.7)  
Minimum O2 saturation (%)  92 (90.8 to 93.2) 89.2 (87.7 to 90.7) 
 
* values are mean +/- 95% confidence intervals 
 
5.5 Daytime Driving Performance and Cognitive Function Outcomes 
The effects of mild OSA, sleep deprivation and time of day on daytime driving 
performance and cognitive function were assessed by analysis of variance. No subjects 
had any crashes in any of the driving simulator testing sessions, so this AusEdTM outcome 
could not be analysed.  
 
5.5.1 Effect of Time of Day and Sleep Deprivation 
There was an effect of sleep deprivation and diurnal variation, or an interaction between 
these, for many of the daytime driving performance and cognitive function outcomes. 
Sleep deprivation consistently resulted in poorer driving and cognitive performance for 
many of the outcome measures. Time of day influenced performance, and the worst 
daytime performance was most often seen at 1500. These data are presented in tables 28 
and 29 below. Data from subjects with mild OSA and subjects without OSA have been 
grouped together in these tables because the effect of sleep deprivation, time of day and 
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the interaction between them did not differ between OSA patients or controls for any of 
these outcomes. However, this was not the case for the Stanford Sleepiness Score and the 
PVT reaction time mean fastest 10% outcome. Both of these are discussed separately 
below. 
 
5.5.1.1 Effect of Sleep Deprivation 
Table 28 shows that the effect of sleep deprivation on most of the daytime driving 
performance and cognitive function outcomes differed according to the time of day at 
which the test was done. Impairments due to sleep deprivation were seen for tests of 
driving ability (AusEdTM reaction time, steering and speed outcomes), vigilance (PVT 
lapses), sleepiness (OSLER sleep latency), and mood (POMS fatigue and vigour sub-
scores). However, there was no effect of sleep deprivation on the DSST, a test of 
attention, or the PRM test, a test of memory. 
 
Table 28 Effect of sleep deprivation on outcomes (adjusted for diurnal variation) 
Table 28 legend: 
1. Interaction between time of day and sleep deprivation (‘Intervention’). A 
significant result for this interaction indicates that there was significant diurnal 
variation in the effect of sleep deprivation on the outcome. 
2. Results of secondary analysis presented 
3. Age significant covariate 
4. “All”: 1900, 0700, 1100, 1500, 1900 
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Dependent Variable Time of day Effect of Sleep Deprivation Effect Size (95% CI) 
OSLER sleep latency 7 am shorter sleep latency 851 (466 to 1236) secs, p=0.00 
 11 am shorter sleep latency 551 (181 to 921) secs, p=0.01 
 3 pm shorter sleep latency 566 (233 to 899) secs, p=0.00 
(Interaction1, p=0.00) 7 pm none 359 (-12 to 731) secs, p=0.06 
AusEd mean reaction 
time (RT) 2,3 7 am longer RT 127 (21 to 232) ms, p=0.02 
 11 am longer RT 127 (0.5 to 254) ms, p=0.05 
(Interaction1, p=0.03) 3 pm longer RT 125 (26 to 224) ms, p=0.02 
Aus Ed standard 
deviation mean RT 2 
(Interaction1, p=0.12) 
All 4 greater variability RT 97 (36 to 157) ms, p=0.00 
AusEd average Steering 
Deviation from median 
position 
(Interaction1, p=0.43) 
All 4 none 7.6 (-3.1 to 18.3) cm, p=0.16 
AusEd standard 
deviation of lane position 7 am 
greater variability  
position 24 (13 to 35) cm, p=0.00 
 11am greater variability  position 20 (10 to 29) cm, p=0.00 
 3 pm greater variability  position 23 (9 to 37) cm, p=0.00 
(Interaction1, p=0.00) 7 pm greater variability  position 18 (6 to 29) cm, p=0.00 
AusEd average speed 
deviation 2 7 am greater variability speed 1.7 (0.1 to 3.3) km/h, p=0.03 
 11 am none 1.5 (-0.2 to 3.2) km/h, p=0.08 
(Interaction1, p=0.02) 3 pm greater variability speed 2.3 (0.2 to 4.4) km/h, p=0.03 
PVT transformed lapses 7 am more lapses 1.8 (0.5 to 3.0) lapses, p=0.01 
 11 am more lapses 1.8 (0.8 to 2.9) lapses, p=0.00 
 3 pm more lapses 2.2 (0.9 to 3.5) lapses, p=0.00 
(Interaction1, p=0.01) 7 pm more lapses 1.6 (0.6 to 2.7) lapses, p=0.00 
POMS fatigue sub-score 7 am greater reported fatigue 8.6 (5.8 to 11.3), p=0.00 
 11 am greater reported fatigue 9.3 (6.1 to 12.6), p=0.00 
 3 pm greater reported fatigue 9.3 (6.5 to 12.0), p=0.00 
(Interaction1, p=0.00) 7 pm greater reported fatigue 8.5 (5.9 to 11.1), p=0.00 
POMS vigour sub-score 7 pm lesser reported vigour 7.6 (4.3 to 10.9), p=0.00 
 11 am lesser reported vigour 6.8 (4.3 to 9.3), p=0.00 
 3 pm lesser reported vigour 6.3 (3.8 to 8.8), p=0.00 
(Interaction1, p=0.00) 7 pm lesser reported vigour 4.5 (2.2 to 6.8), p=0.00 
PRM number correct  
(Interaction1, p=0.55) All 
4 none 0.2 (-0.1 to 0.6), p=0.22 
DSST % correct 
(Interaction1, p=0.42) All 
4 none 0.1 (-0.5 to 0.8) %, p=0.67 
DSST mean RT 3 
(Interaction1, p=0.27) All 
4 none 0.01 (-0.002 to 0.18) sec, p=0.11 
DSST response rate 3 
(Interaction1, p=0.30) All 
4 none 0.01 (-0.002 to 0.19) sec/item, p=0.10 
5.5.1.2 Effect of Time of Day 
Table 29 shows that the daytime diurnal effect on most of the driving performance and 
cognitive function outcomes differed according to whether the subject was sleep deprived 
or not (‘Intervention’). When daytime driving and cognitive performance was compared 
to the pre-intervention time point, i.e. first 1900 evening testing session prior to either a 
normal nights sleep or sleep deprivation, the worst performance was most often seen at 
1500, the expected time of the circadian nadir in performance and alertness. This 
physiological circadian effect was seen for AusEdTM reaction time and PVT outcomes. 
However, subjective mood outcomes (POMS fatigue and vigour sub-scores) and 
sleepiness measures (OSLER sleep latency) showed an earlier maximal impairment 
(0700, 1100). There was no effect of time of day on the DSST, PRM test, or AusEdTM 
average speed deviation. 
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Table 29 Effect of time of day on outcomes (adjusted for intervention) 
Table 29 legend 
1. Differences are relative to pre-intervention time point, i.e. first 1900 evening 
testing session prior to either a normal nights sleep or sleep deprivation 
2. Interaction between time of day and sleep deprivation (‘Intervention’) 
3. Results of secondary analysis presented 
4. Age significant covariate 
5. Whether a significant effect was present for time of day at that level of 
intervention; ‘*’ with no overall significant effect of time of day, the 
significance of the maximal differences presented in the last column is 
questionable 
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Dependent Variable Intervention Effect of Time of Day 5 Maximal mean difference from 19001 (95% CI) 
OSLER sleep latency Baseline none 1900: 117 (-85 to 320) secs, p=0.24 
(Interaction2, p=0.00) Sleep deprived sleep onset quickest 0700  0700: 934 (534 to 1335) secs, p=0.00 
AusEd average 
reaction time (RT) 3,4 Baseline RT longest 1500  
1500: 90 (36 to 143) ms, 
p=0.00 
(Interaction2, p=0.03) Sleep deprived RT longest 1500 1500: 218 (115 to 321) ms, p=0.00 
AusEd standard 
deviation of average 
RT 3 
(Interaction2, p=0.12) 
Both variability greatest 1500 1500: 106 (42 to 169) ms, p=0.00 
AusEd average 
steering deviation 
from median position 
(Interaction2, p=0.43) 
Both none 0700: 21 (-0.7 to 42.3) cm, p=0.06 
AusEd standard 
deviation of lane 
position 
Baseline none 1900: 5.3 (-6.0 to 16.7) cm, p=0.34 
(Interaction2, p=0.00) Sleep Deprived variability greatest 0700 
0700: 29 (18 to 39) cm, 
p=0.00 
AusEd average speed 
deviation 3 
(Interaction2, p=0.02) 
Baseline none 1500: 0.2 (-0.6 to 0.9) km/h, p=0.69 
 Sleep Deprived none * 
1500: 2.4 (0.1 to 4.8) km/h, 
p=0.04  
PVT transformed 
lapses Baseline none 
0700: 0.5 (-0.3 to 1.3) lapses, 
p=0.23 
(Interaction2, p=0.01) Sleep Deprived lapses greatest 1500 
1500: 2.7 (1.5 to 3.9) lapses, 
p=0.00  
POMS fatigue sub-
score Baseline none 0700: 1.2 (-1.5 to 3.9), p=0.36 
(Interaction2, p=0.00) Sleep Deprived fatigue greatest 1100 
1100: 8.7 (6.0 to 11.4), 
p=0.00 
POMS vigour sub-
score Baseline none 1900: 2.5 (-0.2 to 5.1), p=0.06 
(Interaction2, p=0.00) Sleep Deprived vigour least 0700 
0700: 8.9 (6.2 to 11.5), 
p=0.00 
PRM number correct  
(Interaction2, p=0.55) Both none   0700: 0.5 (-0.2 to 1.1), p=0.18 
DSST % correct 
(Interaction2, p=0.42) Both none 
1500: 0.6 (-0.3 to 1.5) %, 
p=0.21 
DSST mean RT 4 
(Interaction2, p=0.27) Both none 
0700: 0.01 (-0.002 to 0.16) 
sec, p=0.86 
DSST response rate 4 
(Interaction2, p=0.30) Both none * 
0700: 0.01 (-0.0005 to -0.17) 
sec/item, p=0.04 s 
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5.5.2 Effect of Obstructive Sleep Apnoea Status 
Consistent with the effect of sleep deprivation on objective sleepiness (OSLER sleep 
latency) shown in table 28, sleep deprivation was also associated with increased 
subjective sleepiness (Stanford Sleepiness Score), compared with the non-sleep deprived 
state, in subjects with mild OSA (difference 1.3, 0.8 to 1.7, p=0.00) and subjects without 
OSA (difference 1.9, 1.5 to 2.3), p=0.00). However, the extent of increased subjective 
sleepiness due to sleep deprivation was less in those subjects with OSA than in those 
without OSA (p=0.03). This difference was not due to differences in initial sleepiness 
between the OSA and control groups (pairwise comparison of initial difference, p=0.77). 
This interaction suggests that the OSA subjects were less aware of their impairment due 
to sleep deprivation. The effect of sleep deprivation on all other daytime outcomes, 
except one described below, did not differ between subjects with OSA and controls. 
Similarly, there was no difference in the effect of daytime diurnal variation between 
subjects with mild OSA and subjects without OSA. Further, subjects with mild OSA did 
not show different driving performance and cognitive function compared with subjects 
without OSA. 
 
5.5.3 Impact of Sleep Deprivation on Diurnal Variation Differed with OSA Status 
For one outcome measure, PVT reaction time, mean fastest 10%, there was a significant 
three-way interaction. In other words, the effect of sleep deprivation on diurnal variation 
in reaction time differed between OSA subjects and controls (P = 0.02). Separate 
analyses for both subject groups (mild OSA subjects and those without OSA) showed 
that after sleep deprivation subjects with mild OSA had significantly poorer performance 
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throughout the day and were worst at the end of the day (1900), whereas control subjects 
showed worst performance at 0700 with a transient relative improvement mid-morning 
(1100). See table and figure below. 
 
Table 30 Impact of sleep deprivation on diurnal variation differed with OSA status 
Group Intervention Mean RT Difference from 19001 LCI UCI 
Controls2 Sleep Deprived 0700: 30 ms 19 41 
  1100:  13 ms -1 27 
  1500:  24 ms 6  41 
  1900:  24 ms 6 41 
OSA 3 Sleep Deprived 0700: 31 ms 16 47 
  1100: 29 ms 11 48 
  1500:28 ms 5 50 
  1900:34 ms 21 47 
1. Differences are relative to pre-intervention time point, i.e. first 1900 evening testing 
session prior to sleep deprivation 
2. Intervention by time interaction, p = 0.01 
3. Intervention by time interaction, p = 0.00 
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Figure 21 Impact of sleep deprivation on diurnal variation differed with OSA status 
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5.6 Night Time Driving Performance and Cognitive Function Outcomes 
5.6.1 Effect of Time of Day 
For the analyses that included the night period after sleep deprivation, a time of day effect 
was again evident, with the worst performance most often seen at 1500. Maximal 
performance impairment was not seen at 0300 for any of the statistically significant 
outcomes (Table 31). 
 
Table 31 includes effect estimates of time of day on all the outcomes. The mean 
difference in the outcome variable due to diurnal variation is presented in units of that 
variable with 95% confidence intervals. The difference presented is the maximal diurnal 
difference relative to the pre-intervention 1900 testing session. These effect estimates are 
 183
similar to the sleep deprived effect estimates in table 28. Minor differences arise due to a 
more complete data set for these later analyses (see Statistical Analysis section). 
 
 
Table 31 legend 
1. Age significant covariate 
2. Interaction between time of day and OSA status (‘Group’) 
3. Differences are relative to pre sleep deprivation time point, i.e. first 1900 
evening testing session of the SD weekend 
4. Average alcohol intake significant covariate   
5. Whether a significant effect was present for time of day at that level of group; 
‘*’ with no overall significant effect of time of day, the significance of the 
maximal differences presented in the last column is questionable 
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Table 31 Effect of time of day on outcomes in the sleep deprived state (adjusted for 
OSA status) 
 
Dependent Variable Group Effect of Time of Day5 
Maximal mean 
difference from 1900 3 
(95% CI) 
OSLER sleep latency 
Interaction2, p=0.74 Both sleep onset quickest 0700 
0700: 966 (605 to 
1327) secs, p=0.00 
AusEd av RT 1 
Interaction2, p=0.39 Both none * 
1500: 225 (125 to 326) 
ms, p=0.00 
Aus Ed sd Av RT 1 
Interaction2, p=0.30 Both none * 
1500: 188 (60 to 317) 
ms, p=0.01 
AusED av Steer Dev 
from median position 
Interaction2, p=0.54 
Both variability greatest 1500 1500: 21.0 (12.6 to 29.4) cm, p=0.00 
AusEd sd Lane 
Position 
Interaction2, p=0.66 
Both variability greatest 1500 1500: 29.2 (16.9 to 41.6) cm, p=0.00 
AusEd av Speed 
Deviation  
Interaction2, p=0.80 
Both none * 1500: 2.4 (0.2 to 4.7) km/h, p=0.04 
SSS  
Interaction2, p=0.98 Both sleepiness greatest 1100 
1100: 2.8 (2.3 to 3.2), 
p=0.00 
PVT transformed 
lapses 
Interaction2, p=0.50 
Both lapses greatest 1500 1500: 2.4 (1.4 to 3.5) lapses, p=0.00 
PVT mean fast 10% 
Interaction2, p=0.31 Both reaction time slowest 0700 
0700: 27.9 (20.3 to 
35.4) ms, p=0.00 
POMS Fatigue 
Interaction2, p=0.92 Both fatigue greatest 1900 
1900: 8.6 (6.3 to 10.9), 
p=0.00 
POMS Vigour 4 
Interaction2, p=0.50 Both vigour least 0700 
0700: 8.5 (6.3 to 10.7), 
p=0.00 
PRM correct  
Interaction2, p=0.57 Both none * 
1900: 0.8 (0.03 to 1.5), 
p=0.04 
DSST % correct 
Interaction2, p=0.50 Both correct least 1500 
1500: 1.1 (-0.01 to 
2.2), p=0.06 
DSST mean RT  
Interaction2, p=0.62 Both none * 
1100: 0.1 (0.003 to 
0.2) sec, p=0.01 
DSST response rate 
Interaction2, p=0.54  Both none * 
1100: 0.1 (0.003 to 
0.2) sec/item, p=0.01 
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5.6.2 Effect of OSA Status 
There was no difference in the effect of diurnal variation between subjects with mild 
OSA and subjects without OSA after sleep deprivation. Similarly, subjects with mild 
OSA did not show different driving performance and cognitive function compared with 
subjects without OSA after sleep deprivation. 
 
5.7 Effect of Sleep Deprivation on Polysomnographic Measures on OSA 
After sleep deprivation, subjects slept longer, had greater sleep efficiency and increased 
amounts of REM sleep (REM rebound). However, RDI, arousal index and the length of 
the longest apnoea were not different. The effect of sleep deprivation on minimum 
oxygen saturation differed according to OSA status. Subjects with OSA showed an even 
lower minimum oxygen saturation after sleep deprivation, whereas control subjects did 
not. See table below. 
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Table 32 Effect of sleep deprivation on PSG measures (adjusted for group) 
Variable Group Effect of Sleep Deprivation:  
mean difference (95% CI) 
P Interaction1 
Total Sleep 
Time both longer sleep time: 53 min (15 to 91) 0.01 0.91 
REM Sleep 
Time both longer REM sleep: 17 min (4 to 30) 0.01 0.40 
Sleep Efficiency both greater sleep efficiency: 9% (6 to 13) 0.00 0.41 
Total RDI both none: 1.0 (-1.9 to 3.8) 0.50 0.77 
REM RDI both none: 1.2 (-3.7 to 6.0) 0.62 0.69 
NREM RDI both none: 1.4 (-1.5 to 4.2) 0.33 0.58 
Arousal Index both none: 2.2 (-0.8 to 5.3) 0.14 0.78 
Longest Apnoea both none: 0.0 (-7.4 to 7.4) 1.0 0.87 
Minimum O2 
Saturation controls none: 0.1 (-1.3 to 1.6) 0.85 0.03 
 OSA lower saturation: 2.5% (0.70 to 4.3) 0.01  
1. Interaction between sleep deprivation and OSA status (‘Group’) 
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Chapter 6: Results: Case Series 
 
6.1 Cases 
These cases represent consecutive referrals to the Sleep Disorders Centres at Royal 
Prince Alfred Hospital (n = 6) and Westmead Hospital (n=1), Sydney, for medico-legal 
opinions in fall asleep road accidents where the driver who caused the accident survived. 
Drivers were aged between 30 and 60 years at the time of their accidents. Five of the 
cases involved commercial drivers and two involved non-commercial drivers. For each 
case, police investigations did not identify the weather, road environment, or vehicle 
mechanics as significant contributors to the accidents. The contribution of alcohol was 
ruled out by breath or blood tests. Each subject underwent detailed sleep investigations to 
identify sleep disorders that might have contributed to the fall-asleep road accident. In all 
cases, the driver had at least one overnight sleep study. In six of the seven cases, an 
objective measurement of daytime sleepiness was also performed. See table 33 below.  
 
Case A: under-treated OSA and undiagnosed Periodic Limb Movement Disorder  
In this first case, A’s truck ran into the back of a stationary car, killing that vehicle’s 
driver, and injuring two others. A reported drifting off to sleep at the time of the accident. 
Several years before this accident, A was diagnosed with severe OSA and commenced on 
continuous positive airway pressure (CPAP), but was not regularly followed up. A’s 
subjective compliance with CPAP was good, but despite this, A remained sleepy, to the 
extent that, A’s spouse would frequently share any long distance driving. Following A’s 
fall asleep accident, A had further sleep studies which showed under-treated OSA 
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(residual respiratory events on CPAP), and in addition, a new sleep disorder (Periodic 
Limb Movement Disorder), which was also fragmenting A’s sleep. A MWT verified that 
A had residual severe daytime sleepiness. A’s legal case was no billed (i.e. was not 
prosecuted) and A remained licensed to drive. 
 
Case B: undiagnosed mild OSA and upper airway resistance syndrome  
Case B was involved in a fatal road accident where B’s car veered to the other side of the 
road, colliding with an oncoming vehicle, killing that vehicle’s driver and seriously 
injuring the passenger. B has no recollection of the period immediately preceding the 
accident and there was no evidence of any aversive action taken. B reported 8 hours sleep 
the night prior to the accident, and 5 ½ hours sleep 2 nights prior. Clinical evaluation 
after the accident noted that B infrequently snored, was sleepy during the day, and was 
obese. B’s diagnostic sleep study showed an AI of 40 per hour. The arousals were partly 
due to OSA events (AHI 10 per hour), but mostly due to other more subtle obstructive 
events that did not reach the full scoring criteria for OSA (upper airway resistance 
syndrome) (Guilleminault C. et al. 2001). An MSLT confirmed pathological daytime 
sleepiness. B’s legal case was no billed and B remained licensed to drive. 
 
Case C: “sleep attack” in a private driver 
In case C, C’s vehicle veered across the road into the path of an oncoming vehicle, killing 
multiple occupants in that vehicle. C reported to have fallen asleep suddenly at the time 
of the accident. C also reported being “slightly sleep deprived” in the preceding week, but 
did not recall being drowsy prior to the accident occurring. C’s history did not suggest an 
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untreated sleep disorder or a problem with chronic excessive daytime sleepiness (EDS). 
After the accident, two overnight sleep studies and an objective test of daytime sleepiness 
have failed to show any abnormalities. In the absence of any other medical explanation, 
legal counsel argued that cumulative sleep debt from inadequate sleep hours over the 
preceding week could have caused C’s “sleep attack”. C was acquitted by a judge and 
contested his license suspension by the Roads and Traffic Authority.  
 
Case D: undiagnosed OSA in a truck driver 
Case D was involved in an accident where D’s truck collided with, and over-rode a car, 
which was stopped in a line of traffic, killing two people and damaging five cars. There 
was no evidence of braking prior to the accident. Two witnesses at the time noted D to be 
leaning and apparently looking to the left at the time of the accident. Medical assessment 
after the accident revealed a long history of snoring, witnessed nocturnal apnoeas, and an 
easy ability to doze when inactive. In addition, D recalls sleeping six hours the night prior 
to the accident. Subsequent sleep studies have shown D to have untreated severe OSA 
with an RDI of 30 per hour. Daytime sleepiness was also objectively confirmed with a 
MWT. D was subsequently found guilty of culpable driving and was sentenced to a 
prison term. D still remained licensed to drive immediately after the accident. 
 
Case E: undiagnosed idiopathic hypersomnolence in a truck driver 
Case E caused a five vehicle, one fatality accident by failing to stop on approaching a line 
of traffic in a road work zone. E’s accident occurred in the evening towards the end of a 
16 hour working day. Just prior to E’s accident, E had rested and had dinner at home. On 
 190
subsequent medical questioning, E reported being excessively sleepy since childhood, 
more so than peers. E even felt that the inability to stay awake during class had impaired 
education. When E later took up work as a truck driver, E noted that, compared to other 
truck drivers, E needed to pull over to the side of the road more than average to nap. On 
one occasion, E had even fallen asleep driving, but fortunately no accident had ensued. 
E’s overnight sleep study did not show a sleep disorder, but a MWT confirmed an 
inability to stay awake. E’s objectively confirmed long standing EDS, together with 
negative polysomnography, suggests a diagnosis of idiopathic hypersomnolence. After 
the accident, E pleaded guilty to culpable driving. E still remained licensed to drive 
immediately after the accident. 
 
Case F: undiagnosed OSA in a truck driver 
F’s semi-trailer collided into the back of a stationary car, which was stopped at traffic 
lights, killing two people.  F has no recollection of the period prior to this accident. F 
gave a long history of sleep talking and occasional sleep walking. However, in the two 
years immediately before this accident, F’s spouse had also become aware of worsened 
snoring and apnoeas during F’s sleep. During this time, F described a problem with EDS, 
including a habit of frequently taking pseudoephedrine while driving. An overnight 
polysomnogram was performed on F after the accident. This showed moderate OSA with 
an AHI of 23 per hour. F’s daytime sleepiness was also objectively confirmed. F’s urine 
was found to be positive for amphetamines on testing at the time of the accident. F 
pleaded guilty to the culpable driving offence and was jailed. F remained licensed to 
drive immediately after the accident. 
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Case G: untreated OSA in a truck driver 
In this last case, G's truck veered into the side lane on a major freeway after G fell asleep, 
killing a cyclist. G’s accident occurred in the morning, after G had driven interstate 
overnight. Importantly, G had been diagnosed with OSA several months prior to this 
accident and had ignored medical advice to undergo further management. During G’s 
initial medical assessment prior to the accident, G described a history of almost dozing 
off while driving on a few occasions, in addition to other symptoms of OSA. G’s 
subsequent diagnostic sleep study showed moderate OSA with an AHI of 17 per hour. G 
failed to return for a follow up appointment to discuss these results, even when reminded 
to do so by letter.  G then went on to have the fall-asleep road accident several months 
later. Recently, a judge has jailed G for 3 years and withdrawn G’s driving license for 5 
years. 
Table 33 Case details of fall asleep road fatalities 
1. Arousal Index (AI): normal range, 0-10/hour 
2. Respiratory Disturbance Index (RDI), Apnoea-Hypopnoea Index (AHI): normal 
range, 0-5/hour 
3. Periodic Limb Movement Index (PLMI): normal range, 0-5/hour  
4. Maintenance of Wakefulness Test (MWT), 20 minute protocol, sleep onset as the 
first occurrence of one epoch of any stage of sleep: normal range, 11-20 min 
5. Multiple Sleep Latency Test (MSLT): normal range, 10-20 min 
6. Maintenance of Wakefulness Test (MWT), 40 minute protocol, sleep onset 
defined as three consecutive epochs of stage 1 sleep or any single epoch of 
another sleep stage: normal range, 19-40 minutes.  
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 Case 
(Diagnosis) 
Driver 
Type 
Overnight 
Sleep Study
MSLT or 
MWT 
Accident 
Outcome 
Legal 
Outcome 
Remained 
Licensed? 
case A  
 
(OSA & PLMD) 
truck CPAP 
review  
AI130 
(RDI2 10; 
PLMI3 20) 
MWT4 
SL 4.75 
min  
2 vehicle 
1 fatality  
2 others 
injured 
no billed yes 
case B  
 
(OSA & UARS) 
private diagnostic 
AI1 41 
(AHI2 10) 
MSLT5  
SL 9.4 
min 
2 vehicle 
1 fatality 
2 others 
injured 
no billed  yes 
case C 
 
(sleep deprivation) 
private diagnostic 
RDI2 2.4, 
RDI2 1 
MWT6 
SL 40 
min 
4 vehicle 
5 fatalities 
several 
others 
injured 
acquitted 
by judge 
yes. Later 
withdrawn 
by RTA 
and then 
contested  
in court 
case D  
 
(OSA) 
truck diagnostic 
RDI2 30 
MWT6 
SL 11 
min 
6 vehicle 
2 fatalities 
12 others 
injured 
found 
guilty; 
jailed 
yes 
case E  
 
(idiopathic 
hypersomnolence) 
truck diagnostic 
RDI2 0.4 
MWT4: 
SL 8 min 
5 vehicle 
1 fatality 
2 others 
injured 
pleaded 
guilty 
yes 
case F  
 
(OSA) 
truck diagnostic 
AHI2 23 
MSLT5 
SL 5.5 
min 
3 vehicle 
2 fatalities 
pleaded 
guilty; 
jailed 
yes 
case G 
 
(OSA) 
truck diagnostic 
AHI2 17 
not 
performed 
2 vehicles, 
1 fatality 
found 
guilty; 
jailed 
Yes. Later 
withdrawn  
by Judge 
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Chapter 7: Discussion 
 
7.1 Commercial Drivers Study 
This study was designed to gather in a systematic and scientific way important 
information about obstructive sleep apnoea in commercial drivers. The impetus for the 
research was the escalating medical evidence published in the mid to late 1990’s, which 
showed the important role of obstructive sleep apnoea in driver fatigue and road 
accidents in private drivers, and the hypothesis that commercial drivers would be equally, 
if not more severely, affected by this medical illness and its road safety consequences. 
Primarily, the study was designed to determine the prevalence of obstructive sleep 
apnoea and excessive daytime sleepiness in commercial drivers, and to identify the 
relationship between OSA and driving. The study involved recruiting two groups of 
commercial drivers, with the drivers studied in the sleep laboratory undergoing much 
more detailed testing, including a full overnight sleep study and driving simulator testing.  
 
The response rate for the drivers surveyed in the field was excellent (83%), suggesting 
that this data was quite representative of the transport drivers in the truck yards and truck 
stops. However, as only transport drivers who had at least 10 minutes available (time 
taken to complete the questionnaire) were asked if they would like to participate, this 
high response rate needs to be interpreted with a little caution. The response rate for the 
drivers who underwent sleep investigations was lower (58%), but given the much more 
intensive protocol involved, this was expected. In fact, most of the drivers who declined 
involvement in this part of the study did so because of the time commitment involved. 
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Non-participants did not differ from the participants in age or body mass index (table 3), 
both of which have been shown to be important predictors of OSA (Bearpark et al. 1995). 
The two cohorts of drivers consisted essentially of men, who were middle-aged and 
overweight (table 2). As discussed in the background section, all three of these 
characteristics are frequently seen in association with OSA, heralding the high OSA 
prevalence figures that were subsequently found in both cohorts.  
 
The two groups of drivers did differ in some respects, despite an attempt to obtain a 
random sample of drivers for both groups. The drivers studied in the sleep laboratory 
were older, and reported more medical illnesses. This most likely represents a selection 
bias, with drivers that are older and medically unwell being more likely to volunteer 
themselves for detailed sleep investigations because of existing concern about their 
health. The drivers studied in the sleep laboratory also reported more metropolitan 
driving, while those surveyed in the field performed more interstate and long distance 
driving. This difference in the groups probably represents two biases. Firstly, since the 
sleep laboratory investigations were performed in Sydney, those drivers driving and 
living locally (metropolitan drivers) were more likely to find this part of the study 
convenient and accessible and hence volunteer to be studied. Secondly, because many 
drivers from the field study were surveyed at truck stops, which tend to be located on 
major freeways, this form of recruitment would be expected to pick up more interstate 
and long distance drivers. This difference in the groups is also reflected in the data 
showing that the drivers surveyed in the field drove more kilometres per year, worked 
and drove more hours per week, and on average reported a greater longest work shift.  
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Of note is the observation that the drivers from both cohorts slept on average just over six 
hours per day while at work. This suggests that those drivers without OSA are 
experiencing inadequate sleep on a chronic basis and that those drivers with OSA are 
being further compromised by sleep deprivation on top of their already broken sleep from 
OSA. Both groups reported high levels of caffeine use and illicit drug use while driving. 
This is of concern, because these countermeasures may have limited value and may be 
ineffective if both sleep loss and sleep apnoea are present.  Further, treating daytime 
sleepiness in transport drivers with alerting agents is inappropriate, as this strategy fails to 
deal with the underlying causes of their sleepiness, such as sleep deprivation and 
obstructive sleep apnoea. 
 
The drivers in this study reported an accident rate of 0.12 (field drivers) and 0.24 
(laboratory drivers) accidents per year per 100,000 km driven. Maycock and co-workers  
have reported on accident rates in transport drivers in the UK (Maycock 1997). Their data 
was collected in a similar way, as it was based on a driver’s self-report of motor vehicle 
accidents in the preceding three year period. All of these drivers had been sampled at 
motorway service stations (n = 996). Using this similar methodology, they found an 
accident rate of 0.09 accidents per year (mean annual mileage was 69,700). Stoohs et al 
used both self reported and company recorded data from the prior five years to measure 
accident rates in US transport drivers passing through the main hub of a long-haul 
trucking company (Stoohs et al. 1994a).  Their results suggest an accident rate of 0.13 per 
year per 100,000 km driven. The accident rate reported in this study for the group of 
drivers surveyed in the field (0.12) appears in line with the above estimates from the UK 
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and USA. However, there are several reasons why this accident data needs to be 
interpreted with caution. Firstly, these accidents were self-reported and hence subject to 
recall bias. Secondly, there is likely to be some stigma associated with the self-reporting 
of motor vehicle accidents for transport drivers and this may have contributed to them 
being under-reported in this study. Finally, one study has also shown that drivers with 
OSA under-report accidents or driving impairment prior to CPAP treatment (Engleman H 
et al. 1997a). In this study, 25% of initial deniers retrospectively admitted compromised 
driving ability after they had been treated with CPAP. This potential measurement error 
in the estimation of accident rates, effects not only the overall estimate of accident rates, 
but also the validity of the identification of predictors of accidents.  
 
A major finding of this study is a high prevalence of OSA in NSW transport drivers. This 
has been shown on the basis of a questionnaire diagnosis in a very large sample of 
randomly surveyed transport drivers, and also by objective testing, in a smaller subset of 
randomly selected drivers, who have had full overnight sleep studies in a sleep 
laboratory, the gold standard for diagnosis of OSA. 
 
The prevalence of OSA in the field was found to be 41%. This was estimated using the 
Maislin equation, a validated screening tool (Maislin et al. 1995), which can be used to 
predict the likelihood of having OSA, based on the subjects reported symptoms of OSA, 
their sex, age and body mass index. The Maislin score predicts the likelihood of having 
OSA at a severity level of at least 10 apnoeas/hour (RDI > 10/hr). The Maislin was also 
‘re-validated’ in this population of transport drivers and the threshold score that was used 
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in the analyses compared very favorably to the optimal threshold suggested by the 
Maislin’s ROC curve. 
 
For the group of drivers studied in the sleep laboratory, the prevalence of OSA (RDI > 
10/hr) using the sleep study data was 51%, whereas the prevalence using the Maislin was 
60%. Both estimates for OSA prevalence are very high, but from an accuracy point of 
view, it is reassuring that, despite the different measurement techniques (including 
inherent differences in respiratory scoring definitions for hypopnoeas and apnoeas), the 
difference in OSA prevalence between the two measurement methods was relatively 
small.  However, there was a more obvious difference in the prevalence of OSA between 
the two different cohorts of drivers studied, with the drivers studied in the sleep 
laboratory showing a generally higher prevalence than those surveyed in the field. This 
most likely represents a selection bias in the drivers studied in the sleep laboratory. 
Drivers who were concerned about sleep apnoea symptoms, such as snoring or poor 
sleep, were perhaps more likely to volunteer themselves for the intensive laboratory 
protocol in the hope of obtaining a diagnosis for their symptoms or perhaps medical 
advice on further management. Regardless of which prevalence figure is examined, these 
values are considerably higher than the general population prevalence of OSA for 
middle-aged men (10% to 15% for RDI > 10/hr).  Prevalence values of 40% to 50% for 
transport drivers are in line with the prevalence figures previously reported by Stoohs et 
al (Stoohs et al. 1995b) for professional truck drivers in the USA (46% for a similar RDI 
level) and Hui et al (Hui et al. 2002) for commercial bus drivers in Hong Kong (41% had 
an RDI of at least 10/hr). However, all these values are well above the commercial driver 
 198
prevalence figures recently reported in abstract form by Pack et al (Pack et al. 2000a) and 
Diaz et al (Diaz et al. 2001). This study differs from those by Stoohs et al and Hui et al in 
that full overnight sleep studies were used together with a very large questionnaire 
sample to define OSA prevalence, and from the study by Pack et al because of a much 
higher response rate and a larger sample of long distance drivers. Further, drivers in this 
study were randomly selected, an important methodological advantage compared to 
several of the earlier studies. Clearly this study adds critical and accurate information 
about the prevalence of OSA in transport drivers to the current literature.  
 
Approximately a quarter of both driver groups reported excessive daytime sleepiness. 
Previously, the conventional view has been that long work hours and time of day of 
driving are the dominant causes of fatigue and sleepiness in commercial drivers (Arnold 
et al. 1997;Neville 2000;Williamson et al. 1992). However, in the present study, a 
diagnosis of OSA was the most important factor predicting pathological daytime 
sleepiness (odds ratio 2.9, p < 0.05): OSA (measured by the Maislin questionnaire) was 
more important than 15 other work-related, lifestyle and medical factors that could be 
expected to promote, or be associated with, daytime sleepiness. 
 
A few studies have previously found that OSA may be a determinant of driver sleepiness 
in commercial drivers. In one study, which examined factors associated with falling 
asleep at the wheel in a sample of 600 truck drivers, symptoms of a sleep disorder (higher 
body weight, snoring, breathing stopping during sleep, and self-reported poor sleep at 
home) were one of six variables found to be significant predictors of a driver ever having 
 199
fallen asleep at the wheel (odds ratio 1.39, p < 0.01) (McCartt et al. 2000). Other 
predictors included more arduous work schedules (odds ratio 1.80, p < 0.01), shorter, 
poorer sleep on the road (odds ratio 1.43, p < 0.01), and greater tendency to night time 
drowsy driving (odds ratio 1.44, p < 0.01). In another study, work related factors, such as 
shift length and shift type, individual factors, such as driver age and experience, and 
symptoms of sleep apnoea syndrome (snoring, respiratory disturbances, Epworth score) 
all significantly predicted self-reported difficulties in staying alert while driving, dozing 
off at the wheel and near misses in commercial drivers (Hakkanen and Summala 2000). 
However, in this study, each of these three factors predicted only a minority of the driver 
sleepiness-related problems (in all cases, R 2 < 10%). Finally, in a study of 1000 UK 
heavy goods vehicle drivers, drivers who reported snoring every night, or who were 
obese, or who had a large collar size, also suffered from higher levels of daytime 
sleepiness (Epworth score) (Maycock 1997).  
 
Many of the other fatigue promoting factors (such as sleep deprivation and night driving 
in transport drivers) that were examined in this study as predictors of excessive driver 
sleepiness alongside OSA, are known to be associated with increased motor vehicle 
accident rates. There is no clear reason why OSA in transport drivers should prove to 
have less impact on accident rates than these other comparable fatigue promoting factors.  
However, there is very little published literature (section 1.2.3.5) that examines this 
specific issue. One study, often quoted, reported that accident rates (self reported and 
company recorded) in community sampled truck drivers with OSA were double of those 
who did not have OSA (Stoohs et al. 1994a). However, this difference was not 
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statistically significant. The data from this study has not shown an increased motor 
vehicle accident rate in transport drivers with OSA or sleep apnoea syndrome. This is 
perhaps not unexpected as the accident data may be potentially flawed for the reasons 
discussed above.  
 
Nonetheless, this study has shown that those drivers with sleep apnoea syndrome (both 
OSA and pathological daytime sleepiness) do have an increased driving accident risk, 
using driving simulator and PVT performance as proxy measures for accident risk. This 
group of drivers showed poorer reaction time performance, poorer steering performance 
and an increased number of crashes on a driving simulator task, and poorer reaction time 
performance on a vigilance task (PVT). Importantly, these abnormalities were generally 
not present when drivers with OSA alone or sleepiness alone were assessed. This finding 
that a specific sub-group of transport drivers with OSA do have an increased driving 
accident risk, using these proxy measures and in particular a PC based driving simulator 
task, is novel and represents an important discovery in driver fatigue research. 
Specifically, it suggests which commercial drivers with OSA are at most driving accident 
risk. Twelve to fourteen percent of drivers had sleep apnoea syndrome in this study. 
Resources should now be focused on identifying through screening this particular high 
risk group of NSW drivers, treating their sleep apnoea and hence potentially reducing 
road accident risk.  Apart from the road safety reasons, there are also of course other 
major medical health and quality of life benefits to be gained from treating these patients. 
Only one other study, reported in abstract form, has examined predictors of impaired 
driving ability (PVT, driving simulator) in transport drivers with OSA. This has found 
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that an increasing RDI was associated with greater impairment on these performance tests 
(Dinges et al. 1998). 
 
This study failed to show a statistically increased motor accident risk for the whole group 
of drivers with OSA. This however, as discussed in the background section, has been 
shown for private drivers in many studies. This study was limited in this respect by self-
reporting of motor vehicle accidents and by proxy measures of accident risk in a sample 
of only 60. A more robust study, incorporating objective accident records (e.g., from 
government, company or insurance databases) in a larger sample of transport drivers, 
would be important to extend this current research. Other ways of extending this research 
to more accurately define accident rates due to OSA in this population could be to 
prospectively follow a cohort of drivers, measuring OSA and actual accidents, or 
alternatively, to launch a pilot screening and treatment program for OSA to see whether 
accidents and performance can be improved.  
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7.2 Mild Obstructive Sleep Apnoea Study 
This study primarily sought to examine the added effect of other fatigue promoting 
factors (sleep deprivation and time of day) on driving performance and cognitive function 
in mild OSA patients. The results for the most part suggest that this group of drivers with 
mild OSA were not different to the control group in their response to sleep deprivation or 
time of day influences. Consistent with previous literature, there were clear effects of 
sleep deprivation and time of day in all subjects. However, the subjects with mild OSA 
were less aware of their impairment due to sleep deprivation and in one reaction time task 
showed greater impairment than controls at certain times of the day after sleep 
deprivation. These latter results, together with the limitations of this study that are 
discussed below, suggest that more research is needed in this area before firm 
conclusions can be made.  
 
The group of subjects with OSA was clearly different in their OSA status from the 
control group. Table 27 shows that the baseline polysomnography categorised the OSA 
subjects to be in the mild range of OSA severity, and the controls to have lesser sleep 
disordered breathing. Consistent with the difference in OSA status between the groups 
are the results of table 23, which show the OSA subjects to have the expected 
demographic and physical characteristics associated with this disease; the OSA group 
tended to be older (though this difference was not statistically significant), and had an 
increased BMI and neck circumference, compared with the controls.  However, table 26 
shows that neither group reported excessive daytime sleepiness, as measured by the 
Epworth Sleepiness Scale. Hence the study subjects with OSA are more representative of 
 203
those patients with obstructive sleep apnoea alone (snoring, nocturnal apnoeas, 
obstructive respiratory events on polysomnography), rather than those with “sleep apnoea 
syndrome” (clinical combination of OSA and excessive daytime sleepiness; see section 
1.2.3.1). The implications that this may have had for the study outcomes are discussed in 
more detail later.  
 
An attempt was made in this study to control for factors outside the study that might 
affect performance on the testing weekends. All subjects completed a sleep diary and 
wore actigraphs for four nights prior to their hospital presentations, so that sleep hours or 
sleep deprivation in the days prior to testing could be controlled for. Table 25 shows that 
there was no statistical difference in the amount of sleep the subjects had prior to their 
two testing weekends. Hence, differences in performance between the two testing 
weekends would not be expected to be explained by differences in sleep debt from the 
days immediately prior to the subjects’ laboratory admissions. Similarly, caffeine intake 
on the day of laboratory admission was not different between the two testing weekends. 
These two variables, together with age, average caffeine intake, and average alcohol 
intake were also tested as covariates in the analyses and retained where they were 
significant predictors of the outcome variable.  
 
Table 24 shows the actual recorded sleep that the subjects obtained prior to the two 
testing weekends. There was no statistically significant difference between the two study 
groups. Hence, differences in prior sleep debt would not be expected to explain any 
differences between the two groups during the testing weekends. However, it can be seen 
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that both groups of subjects obtained less than the ideal average amount of sleep 
(approximately eight hours per night), consistent with the notion that many individuals in 
society are chronically and partially sleep deprived (see section 1.2.1.3). 
 
This study found that sleep deprivation resulted in poorer driving and cognitive 
performance for most of the outcome measures. There was some variation in the effects 
of sleep deprivation according to the time of day, with the most consistent effect being at 
three pm, coinciding with the expected circadian drop in performance.  Impairments due 
to sleep deprivation were seen for tests of driving ability (AusEdTM reaction time, 
steering and speed outcomes), vigilance (PVT lapses), sleepiness (both subjective and 
objective), and mood (POMS fatigue and vigour sub-scores). However, there was no 
effect of sleep deprivation on the DSST, a test of attention, or the PRM test, a test of 
memory.  
 
This study found that time of day influenced performance. For some outcomes, this 
diurnal effect differed according to whether the subject was sleep deprived or not. 
However, for other outcomes it was evident with or without sleep deprivation. The worst 
daytime performance was most often seen at three pm, which is consistent with known 
circadian effects on performance. However, there was no maximal circadian effect at 
three am for any of the variables in this study, perhaps due to the fact that subjects had 
been less sleep deprived at this time point compared with three pm, where the maximal 
effect was most often seen. 
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This study found that OSA status influenced the outcome of two variables (Stanford 
Sleepiness Score and PVT reaction time, mean fastest 10%). Although there is a risk of 
Type 1 error in the interpretation of these significant results, an attempt was made to 
minimise this by limiting the analysis of all the outcome variables to only those that were 
considered most relevant to the study objectives. For the Stanford Sleepiness Score, a 
measure of subjective sleepiness, the extent of increased subjective sleepiness due to 
sleep deprivation was less in those subjects with OSA than in those without OSA 
(p=0.03). Given the consistent effect of sleep deprivation on most of the objective 
outcome measures, where there was no difference between the two groups, this 
apparently paradoxical result is very important. This is because it suggests that the OSA 
subjects were less aware of their impairment due to sleep deprivation. This is particularly 
important if individuals are relying on their degree of subjective sleepiness to make 
decisions about stopping driving when fatigued. For the outcome measure, PVT reaction 
time mean fastest 10%, there was a significant three-way interaction. In other words, the 
effect of sleep deprivation on diurnal variation in reaction time differed between OSA 
subjects and controls (P = 0.02). Further analyses showed that subjects with mild OSA 
had poorer performance throughout the day, whereas control subjects showed a transient 
relative improvement mid-morning. This suggests that OSA subjects when sleep deprived 
may be less affected by circadian improvements in performance for some tasks, 
compared to controls.  Although this study did not show any other differences or 
interactions for daytime or night time performance outcomes between the OSA and 
control groups, the effect of OSA status on the above two outcomes within the study 
limitations that are discussed below, suggests that more work is still needed in this area 
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before definite conclusions can be made. Such work should also focus on the additive or 
interactive effects of chronic partial sleep deprivation, as opposed to acute total sleep 
deprivation, on performance in OSA subjects.  
 
A separate aim of this study was to determine the effect of sleep deprivation on 
polysomnographic measures of OSA (see table 32). Sleep deprivation was found to 
significantly increase total sleep time, sleep efficiency and REM sleep time. Because the 
order of the testing weekends was balanced, with approximately half of the subjects of 
each group (mild OSA and controls) tested under baseline conditions as their first 
weekend of testing, and approximately half of the subjects tested under sleep deprivation 
conditions as their first weekend of testing, these differences in polysomnographic 
outcomes due to sleep deprivation could not due to ‘first night effects’ (subjects sleeping 
worse on their first weekend of testing because of unfamiliarity). Subjects did not show a 
different RDI, arousal index or length of the longest apnoea after sleep deprivation. 
However, subjects with OSA showed an even lower minimum oxygen saturation after 
sleep deprivation. A reduction in minimum oxygen saturation in OSA patients after sleep 
deprivation has been noted previously, but others have also found significant worsening 
of additional OSA parameters after sleep deprivation (e.g., RDI, see section 1.3.2). Given 
the relatively mild disease of the OSA patients and the small numbers in this study, it is 
possible that night to night variability in polysomnography blunted some of the potential 
differences due to sleep deprivation. 
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This study found that OSA status influenced the outcome of only two variables. One 
reason why there was little difference between the subjects with mild OSA and the 
control subjects in driving performance and cognitive function may be lack of sleepiness 
in the mild OSA group. With minimal daytime symptoms, this group of mild OSA 
subjects may behave differently to other mild OSA subjects that do report daytime 
sleepiness (i.e. those with sleep apnoea syndrome); it is possible that daytime sleepiness 
needs to be present for there also to be impaired cognitive or driving performance in mild 
OSA subjects. However, as discussed in section 1.2.3.10 above, no studies have yet been 
able to clearly demonstrate that daytime sleepiness predicts accident risk or driving 
impairment in subjects with OSA. Further research is urgently needed into predictors of 
accident risk or driving impairment in OSA drivers, particularly for the mild OSA group. 
Similar research to this, but studying drivers with mild OSA who have significant 
daytime sleepiness would be part of such a research agenda.  
 
Another selection bias, which may also partially explain why the mild OSA group was 
not different in most outcomes compared with the control group, may have occurred 
because of the way in which the control group was recruited. Part of the control group 
was recruited from patients presenting to sleep clinics for assessment or from patients 
who had had negative laboratory sleep studies. All these patients therefore had initially 
presented with a sleep disturbance to a physician, and were therefore unlikely to be 
totally disease free with respect to sleep abnormalities. Even the presence of simple 
snoring or a minimal amount of OSA in the control group, may have blunted the 
differences that this study might be expected to show between the OSA and “control” 
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groups. In fact a careful inspection of the baseline polysomnography for the control group 
(table 27) shows that, although their total RDI was < 5, their mean REM RDI was 7.9, 
with a 95% confidence interval of 1.4 to 14.5. The significance of mild REM OSA on its 
own is uncertain, but it is possible that this has biased the control population against 
finding a difference between the two study groups. A more ideal control group for this 
study would consist of subjects with absolutely no sleep disordered breathing (no 
snoring, total RDI < 5, REM RDI < 5, NREM RDI < 5, oxygen saturation > 95%, arousal 
index < 10). Such a cohort however would be very hard to find without screening many 
individuals, as few would qualify, and would also probably include mainly young males, 
who may not have appropriate driving experience for this kind of research. In addition, 
because of night-to-night variability in polysomnography results, each potential subject 
identified in this way would need at least two overnight sleep studies to ensure that they 
were truly free of sleep disordered breathing. 
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7.3 Medico-Legal Case Series 
This case series describes seven recent medico-legal cases associated with road fatalities 
on NSW roads since1995. In each case, the driver who caused the accident suffered from 
an unrecognised or under-treated sleep disorder. The nature of many of the accidents 
suggests inattention, with the vehicles crashing into the back of other stationary cars or 
veering to the other side of the road, while showing little or no preventative action (e.g., 
braking). The inattention of each of the drivers could have other causes besides the driver 
having fallen asleep. Neurological clinical assessment and/or further neurological tests 
did not suggest neurological causes for any of the accidents. When taken together with 
the results of the driver’s clinical history and sleep investigations, each episode of 
inattention was probably a consequence of sleep or sleepiness. Although untreated sleep 
disorders could explain these possible episodes of sleep, inappropriate work and sleep 
schedules may also have compounded driver sleepiness in some of the cases, especially 
those involving commercial drivers.   
 
The outcomes in these cases were variable in that some of the drivers have been acquitted 
and other drivers have been jailed.  Almost all the drivers remain licensed, even when 
they successfully used the defence that their accident was caused by a sudden unexpected 
period of sleep. The cases highlight important medico-legal aspects of driver fatigue, in 
particular, some of the apparent inconsistencies and difficulties in this area. 
 
It is important to first note the variability in the legal outcomes of some of the cases, 
despite comparable circumstances. For instance, Case A had a known diagnosis of OSA, 
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continued to drive while sleepy, and was no billed, whereas Case G also had a known 
diagnosis of OSA, continued to drive while sleepy, but was jailed. As a second example, 
the legal outcome of Case B contrasts with that of Case D. Case B had undiagnosed OSA, 
and a history of excessive daytime sleepiness, yet was no billed, whereas Case D also 
suffered from undiagnosed OSA but denied an awareness of excessive daytime 
sleepiness. D in turn was found guilty and jailed. One of the potential reasons for these 
apparent judicial inconsistencies could relate to current medical difficulties in 
apportioning blame to OSA in fall asleep road accidents. While drivers with OSA as a 
group show increased sleepiness and driving accident risk, some individuals with OSA 
may in fact be safe drivers (George CF et al. 1996). However, there are currently no 
definite clinical markers or laboratory tests that can identify those drivers with OSA that 
have the most or least accident risk (see section 1.2.3.10). Another reason for the 
apparent judicial inconsistencies, may relate to an individual’s awareness of their medical 
illness. It has been held that a person is not liable if they are not aware of their illness 
(Britts 1998), that is, if their incapacity comes upon them unexpectedly. Many 
individuals with OSA, including some of the cases presented, are unaware of their 
diagnosis. However, while an individual with a sleep disorder may not be aware of their 
specific diagnosis, they may be very aware of their symptom of excessive daytime 
sleepiness. The majority of the people involved in these cases had prior knowledge of 
their excessive sleepiness.  
 
The legal proceedings for Cases A, B, and C all took into consideration the Jiminez 
defence, the basis of which is the issue of lack of foreseeability (Commonwealth Law 
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Reports 1992). In these cases, the claim was that they had no warning that they were 
going to fall asleep. As discussed in section 1.2.3.8.1, the argument that sleep can occur 
without warning is very controversial. The Canadian and English courts maintain that, 
regardless of the circumstances, the ordinary person who allows themselves to fall asleep 
at the wheel is liable for their actions. These judgements are predicated on the “prior 
fault” principle (McCutcheon JP 1997) that there was a period of time prior to being 
asleep, of voluntary conduct when a person chose to take the risk of continuing to drive. 
This is consistent with medical evidence which suggests that healthy people do not fall 
asleep without significant symptoms of sleepiness for some period of time (Atzram et al. 
2001;Lisper HO et al. 1986;Reyner and Horne 1998). Similar evidence looking at an 
individual’s perception of sleepiness prior to sleep onset is now needed for other groups, 
especially for those with OSA.  
 
The fact that individuals have been allowed to continue driving until after their trials 
seems illogical and dangerous. Whether or not an individual can later escape liability on 
the basis of a Jiminez defence does not remove the implication that they may be unsafe in 
medical terms to drive (immediately following the accident). Further, if they do later 
successfully use the Jiminez defence, should they ever be allowed to drive again? The 
NSW RTA has recently tried to address this apparent licensing inconsistency.  An 
amendment to the NSW Road Transport (Driving Licensing) Regulation 1999 (1999), 
enacted in 2001, has effectively removed some of the legal constraints on license 
suspension which had previously handicapped the NSW RTA in managing fall asleep 
MVA’s. The new regulation gives the RTA explicit power to suspend a license 
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immediately where the driver has fallen asleep or has lost consciousness and caused 
death or injury.  This can occur regardless of whether the person has been prosecuted for 
an offence.  The courts will only allow an appeal if the person can demonstrate that the 
individual is medically fit to have their license renewed. 
 
Health practitioners have a duty of care to their patients to provide treatment at the 
prevailing, acceptable standard. The Australasian Sleep Association guidelines 
(Australian Sleep Association 2002) recommend that health professionals should refer 
patients with suspected sleep apnoea to a sleep specialist for assessment and further 
investigation.  These guidelines go on to advise periodic review of drivers with OSA to 
ensure that adequate treatment is maintained. However, the extent to which a practitioner 
needs to ensure follow up, and how much responsibility for this the patient must also bear 
is unclear.  In this case series, Case A who was a truck driver, was not followed up by the 
practitioner to ensure that they no longer posed a significant risk to the public. However, 
at the same time, A did not follow up the fact that there was persisting sleepiness despite 
CPAP. In contrast to Case A, the practitioner tried to encourage Case G to have treatment 
for OSA, but G did not attend follow up appointments and continued to drive.  
 
Legislators, medical and road safety specialists must recognise the change in knowledge 
in this area and help to clarify the important medico-legal issues. In particular, the 
Jiminez defence, which is at odds with legal opinion in other countries and current 
medical evidence, should be challenged. At the same time, more research is needed to 
further delineate the relationship between the symptoms of sleepiness and falling asleep 
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(especially for certain at risk groups, such as drivers with OSA), and in trying to identify 
driver characteristics or tools which predict which drivers with OSA are at most risk of 
road accidents. Regulation of early assessment and treatment and automatic suspension of 
licenses until drivers are medically fit to drive are important steps forward in ensuring the 
safety of individuals and the rest of the community.   
 
 
 
 
 214
7.4 Final Summary and Implications 
This body of work has investigated the area of obstructive sleep apnoea and driver fatigue 
in several ways. The Commercial Drivers Study is a large epidemiological study, which 
has clearly shown a high prevalence of OSA in commercial drivers, a strong association 
between OSA and driver sleepiness, and an increased driving accident risk in those 
commercial drivers with both OSA and daytime sleepiness (sleep apnoea syndrome). The 
Mild Obstructive Sleep Apnoea Study went on further to explore the interaction between 
mild OSA, the commonest form of OSA, and other driver fatigue risk factors (sleep 
deprivation and time of day). This study for the most part suggested that drivers with 
mild OSA were not different to the control group in their response to sleep deprivation or 
time of day influences. However, the subjects with mild OSA did show important 
differences to the control group in two outcome measures, suggesting that the additive 
effects of OSA and other fatigue risk factors need to be further investigated with more 
research. This would be particularly important for the commercial driver population, who 
are often exposed to many fatigue promoting factors, apart from OSA. The case series 
has demonstrated the day to day potential for devastating road accidents due, at least in 
part, to un-recognised or untreated sleep disorders. In addition, some of the current 
medico-legal controversies and difficulties in this area have been discussed. 
 
Two findings from this body of work deserve special emphasis. Firstly, the finding that 
OSA was the most important predictor of excessive daytime sleepiness in commercial 
drivers. OSA was shown to be a more important contributor to pathological driver 
sleepiness than many other commonly recognised causes, such as work hours, sleep hours 
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and time of day influences. This is important as current fatigue guidelines for transport 
drivers, including the latest Commonwealth parliamentary report into fatigue in transport 
drivers (Neville 2000) emphasise work hours and time of day influences, but do not 
address the issue of OSA as a cause of driver fatigue in any significant way.   
 
Another important finding of this work is the identification of a subgroup of commercial 
drivers who have increased driving accident risk (those with sleep apnoea syndrome). It 
seems that those commercial drivers who report daytime sleepiness in association with 
polysomnographically identified OSA, may be the most vulnerable to driver fatigue 
effects. As a treatable condition, there is now a compelling argument for screening all 
commercial drivers for the presence of sleep apnoea syndrome in order to potentially 
reduce road accident risk through treatment. At the same time, attention should continue 
to be directed towards reducing other important fatigue promoting factors, such as sleep 
deprivation.  
  
Finally, future research should examine the relationship between objective accident rates 
and OSA/sleep apnoea syndrome in commercial drivers, the interaction between mild 
sleep apnoea syndrome and other fatigue risk factors, and driver perception of sleepiness  
prior to sleep onset in drivers with sleep disorders. 
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Chapter 8: Publications 
 
8.1 Papers 
1. A. Desai, E. Ellis, J. Wheatley, R. Grunstein. Fatal Distraction. A Case Series of Fatal   
Fall-Asleep Road Accidents and their Medico-Legal Outcomes, submitted Medical 
Journal of Australia, 30.8.2002 
 
8.2 Abstracts 
1. A. Desai, G. Marks, J. Williamson, B. Harris, D. Joffe, R. Grunstein. Driving 
Impairment In NSW Transport Drivers With Sleep Apnoea Syndrome. Abstract at 
Annual Scientific Meeting Australasian Sleep Association, Hobart, 10-13/10/2002 
2. M. Howard, A. Desai, C. Worsnop, D. Campbell, P. Swann, D. Joffe, R. Grunstein, 
R. Pierce. Sleep Apnoea Prevalence and Crash Risk in Australian Commercial 
Vehicle Drivers. Abstract at Annual Scientific Meeting Australasian Sleep 
Association, Hobart, 10-13/10/2002 
3. A. Desai, D. Joffe, R. Grunstein. NSW Transport Drivers have a high prevalence of 
obstructive sleep apnea. AJRCCM 4/2002, 165, 8, A513 
4. A. Desai, J. Wheatley, R. Grunstein. Fatal Distraction. A case series of fatal fall-
asleep road accidents and their medico-legal outcomes. Does the law need changing? 
AJRCCM 4/2002, 165, 8, A513 
5. A. Desai, E. Ellis, J. Wheatley, R. Grunstein. Fatal Distraction. A case series of fatal 
fall-asleep road accidents and their medico-legal outcomes. Does the law need 
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Glenelg, 12-14/10/2001. 
6. A. Desai, B. Wilsmore , D. Joffe, R. Grunstein. NSW Transport Drivers have a high 
prevalence of obstructive sleep apnea. Abstract at Annual Scientific Meeting 
Australasian Sleep Association, Glenelg, 12-14/10/2001. 
7. A. Desai, D. Joffe, R. Grunstein. NSW Transport Drivers have a high prevalence of 
obstructive sleep apnea. Respirology, 2001; 6 (suppl.) A56 
8. A. Desai, J. Newcombe, D. Bartlett, D. Joffe, R. Grunstein. Sleep Apnea and Driving 
in NSW Transport Drivers – Abstract at 2000 Road Safety Research, Policing and 
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